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Antimicrobial resistance (AMR) is a worldwide public health concern. While it is 
evident that the use of antibiotics creates selection pressure for the evolution of 
antibiotic resistance genes, there are still considerable knowledge gaps relating to the 
status quo of antibiotic use, emergence of resistant pathogens in different livestock 
production systems and spread within human and animal communities.  
This thesis includes a survey of antibiotic use in the dairy sector within a specific area 
of Zambia and analysis of AMR and virulence factors in E. coli isolated from dairy 
cattle and diarrhoea human patients with the following objectives. 
1. To investigate the usage of antibiotics in the dairy sector and the drivers for 
use. 
2. To determine the prevalence and patterns of antimicrobial resistance in E. coli 
isolated from faecal samples of dairy cattle. 
3. To use whole genome sequencing (WGS) to investigate the molecular 
epidemiology of resistance determinants in E. coli strains isolated from both 
dairy cattle and humans. 
4. To assess the zoonotic potential of isolated E. coli focusing on Shiga toxin-
producing E. coli (STEC) and relationship to STEC associated with clinical 
disease in the UK.  
In view of these objectives, the first part of the work was carried out in Zambia and 
involved a questionnaire, a field survey, isolation of E. coli from dairy cattle faecal 
samples and phenotypic testing for AMR. In addition, E. coli isolates were obtained 
from another study that was focused on human patients presenting with diarrhoea at 
the University Teaching Hospital in Lusaka. The second part involved whole genome 
sequencing and molecular analyses of E. coli for resistance and virulence genotypes at 
the Roslin Institute (UK). For the field study, a stratified random sample of 104 farms 
was studied, representing approximately 20% of all dairy farms in the region. On each 
farm, faecal samples were collected from a random sample of animals and a 
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standardised questionnaire on the usage of antibiotics was completed. An E. coli 
isolate was obtained from 98.67% (371/376) of the sampled animals and tested for 
resistance against the six types of antibiotics (tetracycline, ampicillin, 
sulfamethoxazole/trimethoprim, cefpodoxime, gentamicin and ciprofloxacin). These 
E. coli were then analysed together with those from humans for genotypes in the 
laboratory and from Illumina short read whole genome sequences using bioinformatics 
tools.  
Tetracylines and penicillin were the commonly used antibiotics in dairy herds. This 
finding was in line with the resistance phenotypes detected in E. coli isolated from the 
dairy cattle. The most prevalent AMR was to tetracycline (10.61; 95%CI: 7.40-13.82), 
followed by ampicillin (6.02; 95%CI: 3.31-8.73), sulfamethoxazole/ trimethoprim 
(4.49; 95%CI: 2.42-6.56), cefpodoxime (1.91; 95%CI: 0.46-3.36), gentamicin (0.89; 
95%CI: 0.06-1.84) and ciprofloxacin (0%). The risk analysis indicated that AMR was 
associated with livestock diseases (lumpy skin disease and foot rot), exotic breeds 
(Jersey and Friesian), location, farm size and certain management practices.  
Analysis of whole genome sequences showed that isolates from humans had both 
higher levels and a greater diversity of resistance alleles than the cattle isolates. 
Common genotypes in both populations were: tetA (16%), tetB (10%), tetC (2%) for 
cattle isolates with tetA (32%), tetB (22%) and tetD (1%) in human isolates. Other 
common genotypes were blaTEM (56%), sul1 (29%), sul2 (66%), strA4 (57%) and 
strB1 (64%) in isolates of human origin while blaTEM (15%), sul1 (3%), sul2 (17%), 
strA4 (13%) and strB1 (19%) were in the cattle isolates. 
Whilst the E. coli isolates from cattle encoded resistance to common antibiotics of 
limited significance to human clinical medicine, isolates from humans had additional 
extended spectrum beta-lactamases (blaOXA, blaCMY, blaNDM, and blaDHA, blaOKP and 
blaCTX-M) that encode for resistance to essential antibiotics such as third generation 
cephalosporins and carbapenems. This was an evidence that AMR is an ongoing public 
health subject in Zambia but the exclusivity of certain resistances in the human 
population points to limited or no exchange of genotypes between E. coli of human 
origin and those from cattle. AMR in humans was probably independently selected by 
xiii 
 
the use of antibiotics of clinical importance such as cephalosporin and 
fluoroquinolones.  
The virulence analysis focused on STEC, 11% (41/371) of E. coli isolates from cattle 
contained Shiga toxin genes (stx) while none (0/73) of the human isolates were 
positive. Phylogenetic analysis showed a random distribution of bovine STEC, with 
no indication of clonal spread. Although 89% (16/18) of the STEC tested had a 
cytotoxic effect on Vero cells, indicative of Shiga toxin production, only three (O45, 
O111, O157) belonged to one of the seven serogroups (O26, O157, O111, O103, 
O121, O145 and O45) associated with life-threatening enterohaemorrhagic E. coli 
(EHEC) infections in humans. In line with this, only the O157 serotype encoded a type 
3 secretion system. This shows that, while Stx-encoding strains are common in these 
dairy herds of Zambia, they are not strain backgrounds known to pose an immediate 
threat to human health as they lack colonisation factors that are found in typical human 
EHEC. However, we must remain vigilant as emergence of EHEC strains in these 

















There is global concern regarding the increasing threat to human health from drug 
resistant bacterial infections. The extensive use of antibiotics in animal production has 
been proposed to be a major factor driving the emergence of antimicrobial resistance 
(AMR) in bacteria that can transmit through the food chain and environment to people. 
However, our understanding of how antibiotic use in farm animals relates to the levels 
of AMR in different types of farming systems and the extent to which AMR can be 
found in potentially pathogenic microbes harboured by animals is simplistic. We 
therefore lack a clear evidence base to inform policy to reduce and refine antibiotic 
use on farms to minimise selection for resistant bacteria and limit the spread to humans 
or vice versa.  
 
This study involved analysis of the prevalence of AMR among small, medium and 
commercial dairy farms of central Zambia. A common bacterium that inhabits the gut 
known as E. coli was used as a model organism owing to its relative abundance and 
ease of culture. The aims were; 1) to investigate the usage of antibiotics and their 
drivers among the dairy farmers; 2) to establish the prevalence of AMR and the types 
of resistance genes in the E. coli isolates obtained from cattle; 3) to determine if AMR 
types and drug use may be correlated; 4) to establish whether the E. coli isolates from 
Zambian cattle belong to a group that produce toxins associated with serious disease 
in humans; and 5) to compare their genetic blueprints with isolates obtained from 
European human cases to assess the risk that toxin-producing strains may pose.  
 
We selected 104 dairy farms at random representing about 20% of all such farms in 
central Zambia. Faeces was collected from randomly selected dairy cattle on those 
farms and E. coli was isolated from a total of 371 animals. A questionnaire was used 
to collect information on the type of antibiotics used on each farm and for what 
purpose. In addition, we obtained 79 E. coli from a study of human patients with 
diarrhoea at a hospital in Lusaka in Central Zambia. This enabled us to compare the 
types and patterns of resistances in animals and humans in order to examine the 




The E. coli from dairy cattle were tested for resistance in the laboratory against six 
types of antibiotics (tetracycline, ampicillin, sulfamethoxazole/trimethoprim, 
cefpodoxime, gentamicin and ciprofloxacin). A subset of these, together with all the 
ones from humans, were subjected to whole-genome sequencing in order to define 
their genetic make-up and the types of drug resistance and virulence-associated genes 
present.  
 
Tetracycline and penicillin proved to be the most widely used antibiotics among the 
dairy farmers. However, antibiotics that are important in treatment of human infection 
such fluoroquinolones and cephalosporin were rarely used in cattle. Resistance to 
antibiotics varied among the E. coli isolates obtained from cattle (tetracycline, 10.6%; 
ampicillin, 6.0%; sulfamethoxazole/ trimethoprim, 4.5%; cefpodoxime, 1.9%; 
gentamicin, 0.9%; and ciprofloxacin, 0%). We analysed risk factors for detection of E. 
coli with AMR and found that cattle diseases such as lumpy skin disease, foot rot, 
theileriosis, location of the farms, and exotic cattle breeds (Friesian and Jerseys) were 
associated with AMR. 
 
In whole-genome sequences of E. coli from human origin, some rare and dangerous 
resistance genes responsible for resistance to antibiotics of last resort such as 
carbapenems and extended-spectrum beta-lactam antibiotics such as cephalosporin 
were detected (e.g.  blaOXA, blaCMY, blaNDM, and blaDHA, blaOKP and blaCTX-M ). This is 
an important public health concern and was compounded by detection of other 
common resistance genes that were detected in E. coli from both animals and humans.  
Analysis of E. coli isolates from Zambian cattle found that carriage of the gene(s) for 
production of Shiga toxin (associated with E. coli that cause kidney disease and bloody 
diarrhoea in humans) was common, with 11% (41/371) of isolates testing positive. 
However, the majority of Shiga toxin-encoding isolates did not belong to types 
currently associated with foodborne infections in Europe and America such as E. coli 
O157. A risk analysis showed that small and medium dairy farming types harboured 
more Shiga toxin-producing E. coli (STEC) than the commercial farming types. We 
found that the majority of STEC isolates lacked a key gene that is important for the 
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bacteria to attach to human or animal cells and cause disease. However, extracts of 
89% of the STEC examined were highly toxic to cultured cells in the laboratory, 
indicating that the toxin genes are likely to be functional. The presence of STEC in 
dairy cattle therefore remains a public health concern and surveillance and monitoring 
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Chapter 1 : Introduction 
1.1 General introduction 
1.1.1 Antimicrobial resistance (AMR) 
Antimicrobial resistance (AMR) is a growing concern for both developed and 
developing nations as it poses a huge threat to the effectiveness of antibiotics for the 
treatment of human and animal infections (Aiken et al., 2014; Avery et al., 2014). The 
recent increase in the global use of antibiotics in both human medicine and the 
agricultural sector is associated with an increase of reports of antimicrobial resistance 
among pathogenic and commensal microorganisms (Aiken et al., 2014; Van Boeckel 
et al., 2015; Van Boeckel et al., 2014). Antibiotics have also been used in sub-
therapeutic amounts in agriculture as growth promoters as they enhance feed 
conversion in poultry, swine and cattle husbandry (Dibner and Richards, 2005). 
However, some studies have reported the selection of antibiotic resistance because of 
the sub-therapeutic use of antibiotics (Andersson and Hughes, 2014) and addition of 
antibiotics in feed for livestock has since been banned in European countries in order 
to help restrict the development of antibiotic resistance in microbial populations 
(Anadón, 2006). In view of the general increase in the global prevalence of antibiotic 
resistance in bacterial pathogens, various public health international bodies and many 
countries have implemented mitigation measures such as encouraging the appropriate 
use of antibiotics, formulation of policies that encourage good antibiotic stewardship 
and funding of research into various aspects of antimicrobial resistance and 
development of alternative approaches (Gorbach, 2001; Hulscher et al., 2010). Efforts 
are being made to control and monitor the use of antibiotics in livestock production 
systems but the misuse of antibiotics is still on increase, especially among the middle 
income countries such as China, Brazil, South Africa, Russia and India (Van Boeckel 




The development of antibiotic resistance is not fully understood and is progressively 
becoming a complex problem for humans to comprehend as antimicrobial resistant 
bacteria have been detected even in the absence of obvious antibiotic exposure (Allen 
et al., 2010; Bywater, 2004). To make matters worse, some resistance genes are 
encoded and co-selected with virulence genes in some pathogenic microorganisms 
such as E. coli such that the usual treatment of many infections is ineffective with 
limited and sometimes no options for successful antibiotic treatment (Woolhouse et 
al., 2002). In this study and as explained in the section below, E. coli was used as a 
sentinel organism to estimate the prevalence of AMR but also provided an opportunity 
to examine certain pathotypes of E. coli from the study area. 
1.1.2 The background of Zambia as a study area 
As with most other developing countries, Zambia is increasingly experiencing 
problems associated with human and animal bacterial pathogens that are resistant to 
antimicrobials (Joshi et al., 2004). Although there is limited literature on antibiotic 
resistance in sub-Saharan Africa, the available information suggests increased reports 
of antibiotic resistance in hospitals and community settings (Mubita et al., 2008; 
Mshana et al., 2013b; Leopold et al., 2014; Kabwe 𝑒𝑡 𝑎𝑙., 2016). In addition, although 
reports on infections caused by E. coli, particularly the Shiga toxin producing E. coli, 
is common in Europe and North America, little information is available in most 
African countries including Zambia. 
Briefly, Zambia is a landlocked country that is surrounded by eight neighbouring 
countries (Zimbabwe, Namibia, Angola, Botswana, Angola, Malawi, Tanzania, and 
Congo (DRC)) and is situated in the centre of southern Africa (Figure 1.1). It has a 
land mass of about 752 000 km2 of which 58% can be used for agriculture but only 
4.52% was being utilised for this purpose as of 2013 and 1% of the land is covered 
with soft water as lakes and rivers (Mulemba, 2009). The country is mainly located on 
a plateau with hills and mountains as high as 2000 m above sea level. The climate is 
subtropical with an average temperature of 21oC. The average annual rainfall ranges 




(Lusaka, Southern, Western, Eastern, Central, Copperbelt, Luapula, Northwestern, 
Northern and Muchinga) that are further subdivided into 103 districts (Figure 1.2). The 
human population is estimated at 15 million as of 2013, whose main economic 
activities largely depend on mining and agriculture (Fuller, 2015). A variety of crops 
are produced in Zambia but maize is the staple food crop. Livestock is one of the major 
agriculture activity in the country, contributing about 23% per capita supply of protein 
and 61% of this is from cattle through beef and milk (Robinson et al., 2007). The cattle 
population is estimated at 3 million animals (Robinson et al., 2007). The dairy industry 
is smaller compared to beef production in the country; mostly composed of 
smallholder farmers (~ 2,500) and concentrated largely in the southern and central 







Figure 1.1. The location of Zambia (green) in relation to other African countries. This 
map was generated for this study in ArcGIS 10.2.1 software, the shape files were 





Figure 1.2. Map of Zambia depicting the location of 10 Provinces in the country. Note 
that Northern Province was recently subdivided into Northern and Muchinga 
Provinces. The red circle indicates the approximate extent of the study area. The study 
was confined within Zambia. This map was generated for this study in ArcGIS 10.2.1 





1.1.3 Economics of dairy farming in Zambia 
Dairy farming economically empowers communities in poorly developed countries 
such as Zambia. There are a number of Non-Governmental Organisations (NGOs) that 
are involved in uplifting the life of poor people in Africa through the use of the 
smallholder dairy industry. Governments and the NGOs import high milk yielding 
animals and provide these to vulnerable groups such as widows, people living with 
HIV/AIDS and orphanages. The people gain much needed protein from the 
consumption of milk and associated products and also earn much needed revenue 
through the sale of milk to co-operatives and local communities. It is clear that 
peoples’ livelihoods are steadily improving through such investment in dairy farming 
(Mumba et al., 2012). 
In Zambia, dairy farming can be broadly categorised into three scales: small scale 
smallholders with the majority keeping low numbers of traditional animals; medium 
scale smallholders where the animals are of improved breeds by cross-breeding of 
traditional and Friesian/Jersey breeds and finally the commercial scale dairy farms that 
have mostly pure Friesians/Jersey cattle breeds (Mumba et al., 2013; Neven et al., 
2006). The small scale dairy farms only provide about 25% of the raw milk marketed 
in Zambia  (Kaluba, 1993). This milk is either consumed unpasteurised by the farmers 
themselves or is marketed through informal markets to the local communities where it 
is also consumed raw (Mumba et al., 2012).  
The medium smallholder dairy farming is an improved category of dairy farming in 
Zambia compared to the small scale (traditional farming). This is also a new entrant 
category for the smallholders that are supported by the government and the Non-
Government Organisation (NGOs) with the quest of poverty alleviation among the 
most impoverished communities. Medium scale smallholders are organised in 
cooperatives and they market their milk through the Milk Collection Centres for 
subsequent supply to processing plants and the formal marketing chain. This category 
accounts for over 50% of the milk in the formal sector of milk marketing in Zambia 




The third category is the commercial dairy farming that has more farm investment in 
mechanisation and farm infrastructures. Commercial farms in Zambia have pure dairy 
cattle breeds of Friesians and Jerseys. The animals are heavily supplemented in order 
to maintain the milk production levels even in summer when the pastures are dry. 
Eighty percent of the milk produced is pasteurised and marketed through the formal 
markets (Neven et al., 2006). 
The use of antibiotics and emergence of AMR due to treatment of various diseases in 
dairy herds has been reported (Redding et al., 2014). The AMR microorganisms 
evolving in dairy herds have the potential to spread to humans through contamination 
of food of animal origin and direct contact. The magnitude of this problem in Zambia 
is not yet documented. Only through in-depth studies of the epidemiology of resistance 
alleles and host bacterial strains can we determine the potential risks and advise 
accordingly. 
It is intended that data from this study will inform risk assessments and the 
identification of critical control points and opportunities for risk management on the 
safe production of milk to the benefit of communities and the country as a whole. 
1.1.4 Different types of E. coli as studying model organism 
E. coli is a Gram-negative rod and facultative anaerobe which lives in the gastro-
intestinal tract of animals and also in the environment such as water and the soil 
(Tenaillon et al., 2010). It was selected as a study model in preference to other species 
of bacteria because of the following attributes. 1) It is readily available in the 
gastrointestinal tract of animals and humans as part of the commensal flora and it is 
easily isolated from the faecal samples (within 16 hours of incubation at 37⁰C). 2) It 
is a genetically sociable microorganism and easily exchanges genetic material with 
other bacteria of the same or different species (Coque et al., 2008). 3) It is able to 
utilise oxygen and grow aerobically but can also grow anaerobically through anaerobic 
respiration and fermentation in the absence of oxygen (Tenaillon et al., 2010). These 




survival in intestinal and extra-intestinal environments. E. coli is used in the 
monitoring of hygienic standards in water and food producing industries as an 
indicator of faecal contamination (Edberg et al., 2000). Commensal E. coli in the 
gastrointestinal tract of animals and humans are not usually associated with any 
disease. However, some species of E. coli causes disease in different hosts and can be 
categorised into four different pathotypes. The first group are referred to as 
diarrhoeagenic as these E. coli are associated with the symptoms of diarrhoea in the 
host animal. Uropathogenic E. coli are those that are associated with urinary tract 
infections. The meningitis/sepsis-associated E. coli are those that are linked to 
meningitis and the avian pathogenic E. coli those causing disease in avian hosts. This 
study used E. coli isolates from cattle and humans to study AMR and it also 
investigated some virulence factors that are associated with some diarrhoeagenic E. 
coli. Diarrhoeagenic E. coli can be further classified into six pathotypes based on their 
distinctive virulence mechanisms; enterotoxigenic E. coli (ETEC), enteropathogenic 
E. coli (EPEC), enteroaggregative E. coli (EAEC), enteroinvasive E. coli (EIEC), 
diffusely adherent E. coli (DAEC) and enterohaemorrhagic E. coli (EHEC). The 
diarrhoeagenic E. coli and the distinct mechanisms of pathogenesis that are key in 
differentiating them are outlined in Table 1.1. Among the diarrhoeagenic pathotypes 
EHEC are a subgroup of Shiga toxin producing E. coli (STEC) that have caused 
disease outbreaks and mortality in humans in many countries, more especially in 
Europe and North America (Islam et al., 2014; Pearce et al., 2006). There is no 
documented record of EHEC infections in Zambia and yet STEC have been reported 








Table 1.1 Diarrhoeagenic E. coli and the associated pathogenesis 
Pathotype Pathogenesis 
Enterotoxigenic  
E. coli (ETEC) 
Uses fimbriae to adhere to the host and produces 
enterotoxin, heat-labile toxin and/or heat-stable toxin to 
cause disease.  
Enteropathogenic  
E. coli (EPEC) 
Forms attaching and effacing lesions after intimate 
attachment to the host cell.  
Enteroaggregative  
E. coli (EAEC) 
Forms a characteristic aggregative-adherence pattern on 
Hep-2 cells, described as stacked-brick configuration. 
Enteroinvasive  
E. coli (EIEC) 
Produces invasion associated protein encoded by ial 
gene. It causes non-bloody diarrhoea and dysentery 
similar to the infection caused by Shigella species. 
Diffusely adherent E. 
coli (DAEC) 
Forms characteristic diffusely-adherence pattern on 
Hep-2 cells.  
Enterohaemorrhagic 
E. coli (EHEC) 
Forms attachment and effacing lesions after intimate 
attachment to the host cell and produces Shiga toxins. 
Can progresses into haemorrhagic colitis and haemolytic 
uremic syndrome. 
 
This thesis includes a survey of antibiotic use in the dairy sector and an analysis of 
antibiotic resistance phenotypes in E. coli isolated from dairy cattle within a specific 
area of Zambia (Figure 1.2). The resistance alleles and virulence determinants in E. 
coli from both cattle isolates (n=186) and humans (n=77) sampled at a clinic in the 





1.1.5 Statement of the problem 
AMR is one of the biggest threats to global health today in any part of the world (World 
Health Organization, 2014). AMR has been reported in enteric microorganisms that 
causes diarrhoea in humans. The annual incidence rate of diarrhoea diseases in Zambia 
is about 85 per 1000 persons (Kelly et al., 1996; World Health Organization, 2014). 
The virulence and antimicrobial resistance profiles of the causative agents remain 
unknown because of lack of diagnostic facilities in many hospitals of developing 
nations including Zambia (Vernet et al., 2014). However, studies and surveillance 
reports from different parts of the world suggest that both commensal and pathogenic 
E. coli are among the common bacteria isolated from diarrhoea patients with a possible 
link with livestock (Brzuszkiewicz et al, 2011; Scallan et al, 2011; Luna-Gierke et al, 
2014). Livestock are a known reservoir of some of the most common pathogenic E. 
coli such as Shiga toxin producing E. coli (STEC) and humans may become infected 
by consumption of contaminated food of animal origin or food/water contaminated 
with animal waste. 
The limited number of studies that have been carried out in Zambia shows the presence 
of antimicrobial resistant E coli pathotypes and commensals from both human and 
animal samples (Kabwe et al., 2016; Mubita et al., 2008), but they is no systematic 
analysis of AMR prevalence in any of the livestock farming systems nor any 
discussion of potential risk factors in the communities. Therefore, the nature and 
consequences of animal production practises such as antimicrobial use in Zambia are 
still ill-defined (Marshall and Levy, 2011) and a need exists to establish if the current 
practices are driving the evolution of bacteria resistant to antimicrobials in livestock 
and if possible relate this to AMR that is present in human populations in the same 






The hypothesis to be tested is that the prevalence of AMR in enteric E. coli from dairy 
cattle is determined by the type of antibiotics that are used in routine treatment of 
livestock diseases and there is less burden and diversity of resistance genes in E. coli 
population isolated from cattle than those from humans.  
1.1.7 Study objectives 
1.1.7.1 General objective 
The overall objective was to survey the use of antibiotics in dairy cattle and assess the 
impact of the use on the prevalence of AMR and thereafter explore any relationship 
with AMR genes in the human population in central Zambia.  
1.1.7.2 Specific objectives 
 To investigate the usage of antibiotics and the drivers for use in dairy 
herds. 
 To determine the prevalence and patterns of AMR in E. coli isolated 
from faecal samples of dairy cattle. 
 To use WGS to investigate the molecular epidemiology of resistance 
determinants in E. coli strains isolated from both dairy cattle and 
humans. 
 To assess the zoonotic potential of isolated E. coli focusing on STEC 









1.2 Literature review 
1.2.1 Definition of antibiotics 
Antibiotics are natural or synthetic low molecular weight molecules that have 
inhibitory (bacteriostatic) or killing (bacteriocidal) effects on bacteria (Schwalbe et al., 
2007; Gillings, 2013). Antibiotics are produced as secondary metabolites (by products) 
during the normal growth phases of some microorganisms (Kanfer et al., 1998). 
Secondary metabolites are diverse compounds in nature of which some of the classes 
contain antibiotics (Arumugam et al., 2015). Examples include, Tetracyclines, 
Benzoquinones, Courins, Quinolones, Macrolides and Flavonoids (Kanfer et al., 
1998). 
1.2.2 The action of antibiotics on bacteria 
How antibiotics actually inhibit or kill bacteria has been widely studied from 1928 
onwards when penicillin was first discovered (Fleming et al., 1964). Antibiotics gain 
entry into the bacteria through the bacterial cell wall. Bacteria cell walls are made up 
of peptidoglycan layer, amino sugars, and peptides and have different permeability 
properties. The Gram negative bacteria such as E. coli have thin peptidoglycan layer 
in between the cytoplasmic membrane and the outer membrane. The outer membrane 
only allows substances to enter the bacteria through small channels known as porins 
(Seltmann and Holst, 2013). The outer membrane restricts the entry of various 
substances from the environment into the cells including the antibiotics with big 
molecular weight such as of penicillin G. On the other hand Gram positive bacteria do 
not have an outer membrane so antibiotics with large molecular weight can easily 
penetrate the porous peptidoglycan layer of the cell wall to access the antibiotic protein 
binding molecules of the bacteria on the cytoplasmic membranes (Seltmann and Holst, 
2013). The key principles of the action of antibiotics on bacteria depends on the 
following; 1) access or entry of the antibiotic molecules into the bacteria, 2) 
concentration of antibiotic molecules in the cytoplasm of the bacteria to levels that is 




altered by the enzymes of the bacteria, 4) the antibiotic molecules should be able to 
bind to the right targets within the bacteria (Kohanski et al., 2010). Antibiotics are 
classified into one or more classes based on their activity and the types of bacteria they 
effectively act upon. They are classified as broad-spectrum if they inhibit the growth 
or kill both Gram-negative and Gram-positive bacteria, otherwise they are narrow 
spectrum if they can only exert their action on either Gram-negative or Gram-positive 
bacteria (De Briyne et al., 2014). As the Gram stain relates to two main types of cell 
wall organisation (presence or absence of outer membrane), then this distinction most 
likely relates to differences in cell permeability. Some examples of broad-spectrum 
antibiotics are given in Table1.2, Figure 1.3 gives a complete summary of potential 














Table 1.2. Examples of antibiotics 
Antibiotic Class Spectrum of 
action 
Mode of action 
Tetracycline Tetracycline Broad and 
bacteriostatic 
It binds to 30s ribosome and 
inhibits tRNA from reading the 
codon on mRNA leading to 
disruption of protein synthesis. 
Penicillin Penicillin Broad and 
bactericidal 
It inhibits transpeptidase and 
disrupts bacteria cell wall 
synthesis.  




It inhibits transpeptidase and 
disrupts bacteria cell wall 
synthesis. 
Ciprofloxacin Fluoroquinolones Broad and 
bactericidal 
it affects DNA gyrase 
(topoisomerase II) and disrupts 
DNA replication and synthesis of 
nucleic acid leading to cell death. 
Sulfamethoxazole Sulphonamides Broad and 
bactericidal 
It inhibits the enzyme 
dihydropteroate synthatase that is 
critical in the synthesis of 
dihydrofolic acid. Folic acid is 
required in the cell survival. 
Streptomycin Aminoglycoside Broad and 
bactericidal 
It works by misreading the 
mRNA translation at 30S 
ribosome to give rise to non-








Figure 1.3. Antibiotic target sites in bacteria. This figure was adapted from Rang and 




1.2.3 Antibiotics use in livestock and humans 
Antibiotics are such an essential product in the treatment of bacterial infectious 
diseases in human and livestock. However, the proper stewardship of antibiotics is 
required for them to remain viable for a longer period (Gillings, 2013). The misuse of 
antibiotics such as when they are used in the treatment of common cold or sinus 
infections in humans (mostly caused by viruses) is not appropriate and may cause such 
antibiotics to become less effective against the life-threatening bacterial infections 
(Shaban et al., 2014). In livestock, antibiotics have been used largely for therapeutic 
purposes. However, they have also been used for metaphylaxis treatment whereby if 
an infectious pathogen is diagnosed in the herd or flock, a short course of antibiotics 
is administered to all the animals in order to prevent the spread of infection (De Briyne 
et al., 2014). In some cases antibiotics are used for prophylaxis i.e. the treatment is 
given to the whole herd for prevention of an infection (De Briyne et al., 2014). Apart 
from the treatment and prevention of diseases, antibiotics have also been used as 
growth promoters, where animals are given sub therapeutic dosages in order to 
eliminate some gut bacteria. The rationale is that when the gut bacteria are reduced 
due to the action of some antibiotics, the feed conversion efficiency of the animals 
increases and thus promotes enhanced growth and good meat quality for a smaller 
amount of feed (Dibner and Richards, 2005). 
Due to the global increase in human population and the demand for food (Livi-Bacci, 
2012), animal production has greatly increased in many countries, consequently, 
leading to an increase in the use of veterinary pharmaceuticals for treatment, growth 
enhancement and prevention of infectious diseases (Sarmah et al., 2006). 
Unfortunately, there is no uniform information from various countries in the world 
with regard to the type of antibiotics being used and the quantities deployed over 
specific periods of time (Meyer, 2004). Latest studies show that there is a global 
increase in antibiotic use and it is associated with a rise in the resistance of bacteria to 
antibiotics (Morris and Masterton, 2002). However, there is still little information 
available that fully explains the relationship between the use of antimicrobials in 




resistant bacterial populations and potential spread in human and livestock 
communities (Morris and Masterton, 2002; Sarmah et al., 2006). 
The above situation applies to Zambia as well where limited information on the use of 
antibiotics in both livestock and humans is available. However, this little available 
information suggests antibiotics in Zambia are mostly used for treatment of infectious 
diseases of livestock and humans (Lukwesa, 2012; Mainda et al., 2015), and there is 
no national database on the use of antibiotics in both humans and animals. 
1.2.4 Quantification of antibiotics used in livestock by 
different countries 
Even in developed countries such as the USA, Canada and the UK, it is still a challenge 
to obtain accurate information on the levels of antibiotic use in animals (Sarmah et al., 
2006). However, the available reports of antibiotic use in specific countries all indicate 
an increase in use, for instance antibiotic use in the USA increased from nearly 91,000 
kg/year in 1950 to 9.3 million kg/year in 1999 (Viola and Devincent, 2006). In order 
to strengthen the monitoring of antibiotic use and collation of information, some 
countries like the UK have drawn up a five year strategic action plan with specific 
goals and guidelines (Davies and Gibbens, 2013). Other countries such as Sweden 
have included other measures such as restriction of antibiotic supplies to specific 
pharmacies so that they can easily monitor and collect information on the sales of 
antibiotics (Sarmah et al., 2006). Similarly, in Norway, the wholesalers and feed 
millers are used as the source of information on the quantities of antibiotics that enter 
the livestock production system (Viola and Devincent, 2006). 
In the UK/European Union (EU), antibiotics are sold as prescriptions only medicines 
(POM); tetracyclines are the most used antibiotics followed by sulphonamides, beta-
lactams, macrolides, aminoglycosides and fluoroquinolones respectively (Sarmah et 
al., 2006). The use of antibiotics as growth promoters was banned in the EU since 




as a mitigation measure to control and limit the rising incidence of antimicrobial 
resistant microorganisms (Regulation Ojeu, 2003). 
In South America, although the data on quantities of antibiotic sales could not be found 
for this review, a small study reported that small dairy farmers in Cajamarca in rural 
Peru used mostly tetracycline, penicillin and trimethoprim/sulfamethoxazole to treat 
infectious diseases on their farms (Redding et al., 2014). 
Generally in sub-Saharan Africa, there are no comprehensive programmes for 
monitoring antibiotic sales and usage particularly in the livestock sector. Few studies 
have been carried out with a view to providing baseline information in setting up 
national monitoring programmes. In South Africa, a survey on antimicrobial usage for 
three year period 2002-2004 was carried out and reported a mean consumption of 
1,538,443 kg of antibiotics with macrolides as the main antibiotics (42.4%), followed 
by tetracyclines (16.7%), sulphonamides (12.4%), penicillins (10.7%), polypeptides 
(6.2%), quinoxalines (5.5%) and others were in small amounts of less than 5% of the 
total (Eagar et al., 2012).  
In Kenya, a total of 14,600 kg of veterinary antimicrobials were deployed in the 
country from 1995 to 1999 of which 56% were tetracyclines and 22% sulphonamides 
combined with trimethoprim (Mitema et al., 2001). Other antibiotics that were 
commonly used were aminoglycosides and beta-lactams. There was no reported use 
of antimicrobials for prophylactic purposes. 
There is little documented information on the use and sales of antibiotics in Zambia 
but veterinary antimicrobials are mostly sold without prescriptions and are easily 
accessed with no comprehensive information on the sales and use in public domain 
(Okeke et al., 2005b). However, advances in this regard have been made and an Act 
of Parliament, the Medicines and Allied Substances Act No. 3 of 2013 of the Laws of 
Zambia was established to regulate and control the manufacture, importation, storage, 




and human use. This regulatory body is now in existence and it known as the Zambia 
Medicines Regulatory Authority (ZAMRA) (http://www.zamra.co/).  
The overall current global consumption of antibiotics in livestock indicates that there 
is more use in intensive farming involving cattle, poultry and swine rather than with 
less intensive smallholders and pastoralists (Grace, 2015). The estimated global 
average annual consumption of antimicrobials was estimated at 45 mg/kg of cattle, 
148 mg/kg for chicken and 172 mg/kg for pigs in 2010. These figures are estimated to 
increase by 67% by 2030 because of the transition of large numbers of farms from 
extensive farming to intensive farming with a perceived subsequent increased need for 
the use of antimicrobials in livestock production to help deal with increases in global 
food demand (Van Boeckel et al., 2015). A global representation of antimicrobial 











Figure 1.4. Worldwide estimated consumption of antibiotics in livestock production. 
The map of the world showing more consumption of antibiotics among the European 





1.2.5 Quantification of antibiotics used in humans by 
different countries 
The global use of antibiotics in humans was reported to have increased by 36% 
between the years 2000 and 2010 (Van Boeckel et al., 2014). As with livestock 
production, similar countries including Brazil, Russia, India, China and South Africa 
have seen a combined 76% overall increase in antibiotic use for treatment of human 
infections (Van Boeckel et al., 2014). The increase was more pronounced with 
‘antibiotics of last resort’ including carbapenems that increased by 45% and 
polymixins by 13%, other increases in the use of antibiotics are depicted in Figure 1.5. 
In Zambia, comprehensive information on the quantities of antibiotics used in 
treatment of human diseases is not available. It is anticipated that with the 
establishment of ZAMRA, this gap will be narrowed. However, in addition to the 
establishment of ZAMRA, there have been other initiatives to increase the presence of 
pharmacies and private medicine vendors to enhance public accessibility to antibiotics 
(Mendelson et al., 2016). Community health workers are being trained to advise and 
administer antibiotics to patients in order to reduce the misuse (Gill et al., 2011). 
However, the misuse of antibiotics in hospitals is increasingly being reported. For 
instance, a study in Lusaka (capital city) at a district human hospital assessed 680 
records of patients and found that 51.4% of cases had a general misuse of drugs of 






Figure 1.5. The global estimated increase of antibiotic use in treatment of human 
infections from 2000 to 2010. The antibiotics are shown based on their classes. The 
highest increase in use was in carbapenems (45%) and polymixins (13%). Substantial 
increases were observed in broad-spectrum penicillins, cephalosporins and 
fluoroquinolones. The antibiotics were measured in Standard units (kg) that were 
defined as a single unit (pill, capsule or ampoule). Adapted from Van Boeckel et al., 
2014. 
1.2.6 Spread of AMR genes among bacteria 
Antibiotic resistance phenotypes are encoded by resistance genes located on the 
bacterial chromosome and/or plasmid DNA (Sørensen et al., 2005). Plasmids are self-
replicating DNA molecules that are found within bacteria and are independent of the 




surviving specific niches; including genes for catabolic pathways, colonisation factors 
and antibiotic resistance (Carattoli, 2009). 
Bacteria acquire antibiotic resistance genes in two main ways, vertical and horizontal 
gene transfer. Vertical transmission is when genes are transmitted from one generation 
to another through cell division (Dantas and Sommer, 2014) and in horizontal 
transmission bacteria acquire resistance genes from external sources through indirect 
or direct contact (Dantas and Sommer 2014). Horizontal transfer is a more important 
mechanism in clinical settings and there are three main ways in which it takes place 
among the bacterial cells. The first is through conjugation, in which genetic elements, 
mainly plasmids, are transferred from one bacteria to another. The process has been 
extensively studied in relation to rolling circle replication and transfer of the plasmid 
copy through an F-pilus, as can occur between E. coli strains (Norman et al., 2009). 
Secondly, bacteria can acquire genetic material horizontally through transformation in 
which the bacteria picks up ‘naked’ DNA with resistance genes left by other bacteria, 
usually following lysis (Tenover, 2006). Thirdly through transduction in which the 
genetic material is introduced into the bacterium by a bacteriophage (Tenover, 2006). 
The bacteriophage is a virus that infects bacteria and a subset can incorporate their 
genetic material or mis-packaged fragments of the donor bacterium on which they last 
propagated into the genome of the target bacterium (Orndorff, 2016). 
When antibiotics are used in livestock or humans, some bacteria with the intrinsic or 
acquired resistance genes are able to withstand the effect of antibiotics and they 
continue to multiply, this is known as antibiotic resistance (Bywater, 2004). This is 
often used interchangeably with a broader term called antimicrobial resistance (AMR), 
which applies to resistance of all the antimicrobials including those used in the 
treatment of fungal, viral and parasite microorganisms (Bywater, 2004). Some bacteria 
evolve to confer resistant to multiple antibiotics in which case they are known as multi-




1.2.7 Mechanisms of AMR in bacteria 
There are four main mechanisms that the bacteria with resistance genes use to confer 
resistance to antibiotics (Schwalbe et al., 2007; Argudín et al., 2014). One mechanism 
is the production of enzymes that cleave antibiotic molecules and therefore inactivate 
them. For instance, some bacteria like E. coli produce enzymes known as the beta-
lactamases which cleave and hydrolyse the beta-lactam ring structure that define beta-
lactam antibiotics like penicillin (such as penicillin G, ampicillin and amoxicillin ), 
cephalosprins (such as cefpodoxime, cefotaxime) and monobactams (such as 
aztreonam) (Dantas and Sommer, 2014). The beta-lactamases are inhibited by the three 
‘classical’ beta-lactamase inhibitors known as clavulanic acid, sulbactam and 
tazobactam and these compounds are in some cases formulated together with the 
antibiotics to aid an extended spectrum of action (extended spectrum antibiotics) 
(Peirano and Pitout, 2010). However, beta- lactamases are unable to hydrolyse, or have 
limited action on, some beta-lactam antibiotics such as cephamycins (such as cefoxitin 
and cefotetan) and the carbapenems (such as imipenem) (refer to section 1.2.10 for a 
detail on beta-lactamases and extended spectrum beta-lactamases) (Peirano and Pitout, 
2010). The second mechanism especially in gram-negative bacteria is as a result of 
mutations in the DNA that leads to lower expression of porins in the outer membrane. 
Consequently, this leads to the reduction in the permeability of the cell wall such that 
very little antibiotic molecules if any are allowed to access the inner part of the cell 
(Dantas and Sommer, 2014). Thirdly, a mutation in the DNA of the bacteria that leads 
to the modification of the natural antibiotic targets such that the antibiotic molecules 
will no longer correctly bind to them (Dantas and Sommer, 2014). Lastly, bacteria can 
use the mechanism of efflux pumps to export the antibiotics from the cytosol to confer 
resistance. This mechanism is induced by bacteria mutants when they over-express the 
chromosomal or plasmid borne efflux pumps encoding genes. Expression is the 
process by which information from a gene is used in the synthesis of a functional 
protein (Argudín et al., 2014). When antibiotic molecules are continuously pumped 
out of bacteria and the concentration is maintained at suboptimal level then they cannot 




1.2.7.1 Specific mechanisms of AMR for selected antibiotics 
Tetracycline resistance in bacteria is encoded by over 40 different tet genes (see 
section 1.2.10). Among the tetracycline resistance genes, tetA, tetB, tetC, and tetD are 
the major genes in clinical settings that are acquired through horizontal gene transfer 
and encode two principle resistance mechanisms; 1) through ribosomal protection 
from action of antibiotics (Thaker et al., 2010), 2) extrusion of antibiotic molecules 
through efflux pumps (Thaker et al., 2010). A third but rare mechanism involves 
tetracycline modifying enzymes, although it has not yet been reported in Zambia. One 
study recently reported the presence of tetX encoding tetracycline encoding 
destructases in Sierra Leone (West Africa) (Leski et al., 2013).  
Aminoglycosides are another class of antibiotics whose members such as neomycin, 
tobramycin, amikacin and streptomycin are widely used in treatment of infections 
caused by aerobic Gram-negative bacteria such as Pseudomonas, E. coli, Enterobacter 
and Klebsiella (Bannerman et al., 2006). Aminoglycosides are also potent against 
Gram-positive bacteria. The mode of action involves an oxygen-dependent entry into 
the bacterial cytoplasm and then binding to the 30S ribosomal subunit thereby 
inhibiting the aminoacyl-tRNA from initiating protein synthesis on the mRNA 
(Ramirez and Tolmasky, 2010). 
A common aminoglycoside resistance mechanism in clinical isolates involves a DNA 
mutation that changes the binding site for the antibiotic on the 30S rRNA preventing 
the interaction so that protein synthesis initiation is no longer blocked (Ramirez and 
Tolmasky, 2010). Another resistance mechanism involves changes to the antibiotic 
structure by the action of the aminoglycoside modifying enzymes (Magnet et al., 
2003). Three different modifying enzymes are known: acetyltransferases (AACs), 
nucleotidyltranferases (ANTs) and phosphotransferases (APHs), and these catalyse the 
modification at –OH or –NH2 of sugar moieties on the antibiotic, Figure 1.6. These 
aminoglycoside modifying enzymes; AACs, ANTs and APHs are encoded by aac, aad 
and aph genes, the last letter denotes the allele e.g aacA and aacB may both be 




Another nomenclature is interchangeably used with the one described above to name 
alleles for resistance to aminoglycosides and it involves three letter identifier of the 
modifying enzyme (e.g AAC) followed by a number with an apostrophe (in 
parenthesis) to denote the position of the carbon site of modification within the 
chemical structure of the antibiotic (e.g (6')), then a roman numeral to denote the 
subclass and a lower class letter to indicate the individual gene. For instance AAC(6' 
)- I indicates acetylation at 6' position and encodes for a resistance profile that is 
common to all AAC(6')-I enzymes such as AAC(6')-Ib, AAC(6')-Ic to AAC(6')-Iaf 
(Ramirez and Tolmasky, 2010). The strA-strB genes are among the common 
aminoglycoside resistance genes in the community and clinical settings (Magnet et al., 
2003). They encode for aminoglycoside-3″-phosphotransferase (APH(3″)-Ib) and 
aminoglycoside-6-phosphotransferase (APH(6')-Id), respectively that confer 
resistance to streptomycin (Chiou and Jones, 1995). Other less common mechanisms 
of aminoglycoside resistance involve the use of efflux pumps and reduced cell wall 
permeability to the antibiotics (Magnet et al., 2001). 
 
Figure 1.6. Representative aminoglycoside molecular structures. The aminoglycoside 




that they introduce on the antibiotics -OH or -HN groups. Adapted from Ramirez and 
Tolmasky, 2010. 
Sulphonamides are broad-spectrum bacteriostatic antibiotics that are used in the 
treatment of both Gram-negative and Gram-positive bacteria (Sköld, 2000). They are 
mostly prepared in combination with trimethoprim. Sulphonamides and trimethoprim 
target the folic acid synthesis pathway of bacteria. The sulphonamides reversibly bind 
and inhibit the dihydropteroate synthetase while trimethoprim binds to dihydrofolate 
reductase (Sköld, 2000). Sulphonamide resistance is caused by plasmid bound sul1, 
sul2 and sul3 genes that encode variants of dihydropteroate synthetase that the 
antibiotic molecule cannot bind to. While resistance to trimethoprim is mediated by 
dfrA gene that encode for resistant variants of dihydrofolate reductase that elude the 
action of trimethoprim (Sköld, 2000). The bacterial folic acid pathway and the targets 
for trimethoprim/sulphonamides are depicted in Figure 1.7. 
 
Figure 1.7. The bacterial folic acid synthesis pathway. The bacteria uses PABA as the 
primary precursor for the folic acid synthesis. The figure shows the two parts of the 
pathway where the sulphonamides act (dihydropteroate synthetase) and the 
trimethoprim action site (dihydrofolate reductase). Tetrahydrofolic acid is used in the 




Penicillins and cephalosporins have been used as first line choice of antibiotics for 
treatment of Gram-negative and Gram-positive bacterial infections in veterinary and 
human medicine. Cephalosporins are particularly important in treatment of urinary 
tract infections (UTI) in human medicine. These antibiotics act on the bacteria by 
binding to transpeptidases and disrupt the formation of peptidoglycan chains as the 
central component of bacterial cell walls. The beta-lactamases TEM, CTX-M and SHV 
types confer resistance by hydrolysing the beta-lactam ring that defines these 
antibiotics. In human medicine, carbapenems have been used as alternative antibiotics 
for treatment of infections caused by ESBL. The rise of carbapenem-resistant 
enterobacteriacae (CRE) in addition of other ESBL such as CMY-2 and OXA has 
made beta-lactamases a public health threat (Abdi et al., 2014; Cornaglia et al., 2011). 
Among the essential antibiotics in human medicine are the fluoroquinolones that are 
used to treat both Gram-negative bacteria and Gram-positive bacteria especially in 
UTIs. The fluoroquinolones work by targeting the topoisomerase II that is essential in 
the replication of DNA and survival of the bacteria. However, resistance are emerging 
that are mediated by such genes as qepA qnrA, and aac(6’)-I that encodes for 
topoisomerases that cannot be targeted by fluoroquinolones.  
1.2.8 Ecological and evolutionary costs of AMR bacteria 
The fitness cost of AMR bacteria is still the subject of debate in microbiology. The 
evolution of AMR in bacteria is influenced by the fitness cost of resistance. Fitness in 
this context is defined as the rate of replication of the bacteria in a particular 
environment and can be measured using assays that compare growth rates of resistant 
and sensitive strains (competitive fitness trials) (Andersson et al., 2007). Resistance 
genes can confer a reduction in fitness, exhibited by either one or all of the following 
factors; reduction in bacterial growth, reduced virulence and/or reduced transmission 
of the organism (Andersson et al., 2007). Therefore bacteria that bear no cost of 
resistance (sensitive bacteria) are expected to outgrow resistant strains at a rate 
proportional to the magnitude of the cost imposed by resistance (Melnyk et al., 2015). 




bacterial functions (Argudín et al., 2014). For instance, resistance to fluoroquinolones 
is caused by the mutation in gyrA that encodes DNA gyrase that facilitates the 
replication of DNA. The resistance to penicillin is as a result of mutation for the gene 
encoding transpeptidase that is responsible for cross linkage of the peptidoglycan layer 
of the bacteria cell wall. These mutational changes are likely to cause variable fitness 
costs for the bacteria (Melnyk et al., 2015). 
The use of antibiotics cause selection pressure for resistance in the bacteria population 
(Gullberg et al., 2011). However, the knowledge of persistence of resistance when the 
selection pressure from the use of antibiotics is removed is limited and debatable. In 
some cases the resistant bacteria continue multiplying and remain abundant (Sundqvist 
et al., 2010), while in other cases the resistant bacteria reduce significantly (Gottesman 
et al., 2009) but mostly does not eliminate resistant strains completely (Andersson and 
Hughes, 2011). This is because some resistance mutations do not have any fitness cost 
and therefore are able to remain in the bacteria population even in absence of antibiotic 
resistance selection pressure. On the other hand some resistance genes such as 
multiple-antibiotic-resistance (Mar) encoding efflux pumps, although present in the 
bacteria cause no fitness cost unless when they are expressed and expression only takes 
place in the presence of antibiotics (Blair et al., 2014). The other possibility is that the 
cost of resistance in bacteria can be compensated through a second mutation at a 
different site (sometimes the same gene) that is able to restore the fitness of the 
bacteria. Lastly, the genetic co-selection of resistance genes with other linked genes 
conferring other phenotypes such as virulence or indeed other resistance genes may 
lead to persistence of a particular resistance in the bacteria population (Baker-Austin 
et al., 2006; Wellington et al., 2013).  
1.2.9 Spread of antimicrobial resistant microbes among 
different hosts and the environment 
It is expected that there is more antibiotic resistant bacteria in the gut in relation to the 




body. In some cases, antibiotic resistant bacteria may circulate systemically and 
contaminate the host.  
Mostly, meat contamination with AMR bacteria can probably take place at slaughter 
from evisceration if defined procedures and hygienic measures are not properly 
applied (mechanical transmission). Humans can get antibiotic resistant bacteria from 
the food of animal origin if they consume improperly prepared food or through 
mechanical transmission when handling animals such as during milking, animal or 
poultry slaughters (Kollef and Fraser, 2001). The antibiotic resistant bacteria also 
spreads to the environment through the excreta of the animals and humans in countries 
where sanitation measures are not properly applied, and then spread from the 
environment to humans and other animals through consumption of contaminated 
water, agriculture products and pastures. The spread of AMR microorganisms in the 
hospital environment is increasingly becoming a public health challenge 
(Wisplinghoff et al., 2004). The risk of nosocomial infections have been reported in 
Zambian hospitals (Mwamungule et al., 2015). A schematic transmission picture of 





Figure 1.8. Transmission of antimicrobial resistance in the community. The complex 
spread of antimicrobial resistance bacteria in the community resulting from the use of 
the antibiotics in humans and animals. The top part of the figure shows antibiotics 
given to both animals and humans. Then the number of resistant bacteria in the 
gastrointestinal tract of both animals and humans increases. The left hand side of the 
figure shows resistant bacteria spreading directly in the community by people 
consuming animal products such as meat and milk. The bottom left of the figure shows 
the indirect spread of resistant bacteria to humans through animal excreta when 
consuming farm products such as vegetables. The right hand side of the figure shows 
the spread of antibiotic resistant bacteria from one person to another through direct 
and indirect contact in the community. The figure shows two distinct cycles, one 




animals (left side), while the right side shows the spread of resistant microbes 
originating from the use of antibiotics in humans. In developing countries such as 
Zambia the spread of resistant microbes in the communities involving the health care 
facilities is more profound than the cycle involving animals due to poor hygiene and 
nosocomial infections (Mwamungule et al., 2015). On the other hand use of antibiotics 
in animals in developing nations is variable and sometimes very low as livestock 
diseases are often left untreated as some farmers cannot afford the cost of antibiotics 
(Mainda et al., 2015). Adapted from Centre for Disease Control and Prevention, 2013. 
1.2.10 Spread of antibiotic resistance genes 
Resistance genes may occur individually or in multiple copies within a single 
bacterium to encode resistance to one or multiple antibiotics (Roberts, 2005). 
Resistance genes are transferred from one bacteria to another through conjugation, 
transduction or transformation (refer to section 1.2.7). Resistance to tetracyclines 
(minocycline, doxycycline, oxytetracycline) is mediated by tet genes (tetA, tetB, tetC, 
tetD, tetE, tetF, tetG, tetH, tetI, tetJ, tetK, tetL, tetM, tetN (withdrawn), tetO, tetP(A), 
tetP(B), tetQ, tetS, tetT, tetU, tetV, tetW, tetX, tetY, tetZ, otrA, otrB, otrC and tcr3(tcrC) 
(Levy et al., 1999). The beta-lactamases confer resistance to beta-lactams antibiotics 
(penicillin, cephalosporin and carbapenems) and are divided into classes A, B, C and 
D (Paterson and Bonomo, 2005). Class A comprises TEM β-Lactamase, SHV β-
Lactamase, CTX-M β-Lactamase and KPC (Klebsiella pneumoniae carbapenems) 
(Abdi et al., 2014; Memariani et al., 2015). The beta-lactamases blaTEM and blaSHV 
have a broad-spectrum to hydrolyse penicillins and cephalosporins (first and second 
generation only), however sometimes the genes encoding these enzymes undergo 
mutation that alters the configuration of amino acids on their active sites such that in 
addition to conferring resistance to first and second generation cephalosporins, they 
now also encode for resistance to all the cephalosporins including the third and fourth 
generation cephalosporins such as cefpodoxime, ceftazidime, cefotaxime and 
ceftriaxone. These variants of beta-lactamases with a broader spectrum of activity are 
known as extended-spectrum beta-lactamases (ESBL) (Nukaga et al., 2003; Paterson 




derived from the broad-spectrum beta-lactamases (TEM-1, TEM-2 and SHV-1) and 
they have an extended activity to hydrolyse all penicillins, cephalosporins and 
monobactams (i.e aztreonam) (Thomson, 2001). However, there are increasing ESBLs 
that are not of TEM or SHV lineages such as CTX-M ESBLs, AmpC β-lactamases 
(e.g CMY-2), KPC carbapenemases in enterobacteriaceae, OXA and Metallo 
carbapenemases that have been reported (Livermore and Woodford, 2006). 
The Class B β-lactamases are mostly the carbapenamases known as metallo β-
lactamases (IMP-type β-lactamases), veron encoded metallo β-lactamases (VIM) and 
(New Delhi metallo β-Lactamase (NDM-1)). The genes encoding most of class B β-
lactamases were confined to specific geographic locations such as Japan, India and the 
South East Asia, but recently these genes have been spreading across the world, 
although little information is available in many African countries (Figure 1.9) (Bush, 
1998; Cornaglia et al., 2011). The Class C β-lactamases are composed of the AmpC 
mediated β-lactamases (both the chromosomal borne and plasmid borne) that encode 
for the ESBLs and other carbapenamases (Jacoby, 2009). The class D β-lactamases 
include plasmid bound OXA β-lactamases which is one of the carbapenamases and 
found largely in Pseudomonas aeruginosa with marked hydrolytic effect against 
oxacillin and cloxacillin. 
The genes encoding resistance to sulphonamides and trimethoprim are often linked 
together and are mediated by sul1 and sul2 genes for sulphonamides and about 20 
variants of dfrA for trimethoprim (Eliopoulos and Huovinen, 2001). The main 
resistance mechanisms for sulphonamides and trimethoprim resistance genes are 
efflux pumps with or without some other permeability barrier alterations (Eliopoulos 
and Huovinen, 2001). Resistance to aminoglycosides is encoded by N-
acetyltransferases (acc), O-andenyltransferases (ant) and O-phosphotransferases 
(aph) genes (Lin et al., 2015). Whereas the resistance to Quinolones is mediated by 





Figure 1.9. Worldwide distribution of New Delhi metallo β-Lactamase (NDM-1) gene. 
This resistance gene was first reported in India (red circle) and then spread to many 
countries in the world. Little information is available from many African countries 
because of inadequate surveillance. This map was adapted from Cornaglia et al. 2011, 
and regenerated for this study in ArcGis 10.2.1, the shape files were downloaded and 
adapted from Diva-GIS website and the satellite image was downloaded from the Bing 
map tool that uses the ArcGIS online. 
1.2.11 Threats from AMR infectious pathogens 
Human and animal infections caused by antibiotic resistant pathogens are a threat to 
spread of infectious diseases because only few classes of antibiotics are available for 
treatment or sometimes there is completely no alternative antibiotics to use in clinical 
settings (World Health Organization, 2001). Consequently, the cost of the treatment 
of infectious diseases involving AMR pathogens are increased and potentially 




outlines are examples of antibiotic resistant infectious pathogens of public health 
concern. 
Infections caused by Extended-Spectrum β-Lactamase (ESBL)-producing 
Enterobacteriaecae. The Enterobacteriaceae are a family of facultative Gram-
negative bacteria of which a subset are associated with community infections and 
nosocomial infections worldwide (Snitkin et al., 2012). Some of the prominent 
members of this family are E. coli, Shigella, Salmonella, Klebsiella, Yersinia pestis, 
Proteus, Serratia and Citrobacter. Resistances are often conferred by plasmid encoded 
β-lactamases, including blaTEM, blaCTX-M and blaSHV. The carbapenems are the 
antibiotic of choice for treatment of infections caused by these pathogens that are 
resistant to β-lactamases (Peirano and Pitout, 2010). However, there has been 
increasing reports of resistance to carbapenems as well (Livermore and Woodford, 
2006). Therefore the resistance to third generation cephalosporins and carbapenems 
now leaves very few antibiotic choices for treatment of ESBL-producing 
Enterobacteriaceae making them a public health concern. Little information is 
available on the prevalence of β-lactamases in Enterobacteriaecae from both human 
and animals in Zambia. However, β-lactamases blaTEM, blaSHV and blaCTX-M have 
been detected in E. coli isolated from the ready to eat chicken meat (Chishimba et al., 
2016) and salmonella isolates from human (Hendriksen et al., 2013). 
Infections caused by the AMR E. coli. The global emergence of E. coli clone 
(sequence type 131 O25:H4) with CTX-M-15 beta-lactamase production in many 
countries around the world is a major public health concern. E. coli serotype O25 has 
been reported to belong to the pathogenic phylogroup B2 and was associated with 
sequence type 131 with MDR IncFII plasmids (Peirano and Pitout, 2010). This clone 
was reported widely in the period between 2000 – 2006 in countries such as France, 
Spain, Canada, Portugal, Switzerland, Lebanon, India, Kuwait, Korea and continued 
spreading to other parts of the world (Coque et al., 2008). In 2011, E. coli serotype 
O104:H4 of sequence type 678 caused a disease outbreak in Germany (3816 cases, 
including 845 haemolytic uremic syndrome cases and 54 deaths as of May 1 - July 4, 




encoded for the resistance of β – lactams antibiotics (Bielaszewska et al., 2011; Frank 
et al., 2011). The magnitude of the outbreak demonstrated the public health concerns 
of the AMR emerging pathogens that can easily spread over a wide geographical area. 
It is not known in Zambia whether some of the infections reported in humans are 
caused by pathogenic E. coli belonging to certain clonal/sequence types within specific 
phylogroups. Most pathogens are not definitively diagnosed and characterised due to 
limited facilities (Mshana et al., 2013a). 
Infections caused by AMR Campylobacter. Campylobacteriosis is a zoonotic food 
borne disease that causes diarrhoea, fever and abdominal cramps in humans (Komba 
et al., 2015). The three main species, C. jejuni, C. coli and C. fetus in humans are 
treated with fluoroquinolones and macrolides such as ciprofloxacin and azithromycin 
respectively. Antibiotic resistance has been increasing in human campylobacteriosis 
infections and is considered linked to use of antibiotics in livestock (Aarestrup and 
Engberg, 2001). Madoroba et al., (2013) reported 2.44% as the prevalence for C. fetus 
in the samples that were collected from cattle of Zambia. The study pointed out that 
the prevalence may be an under estimated because of limited diagnostic facilities in 
the country. 
Infections caused by AMR Salmonella. Salmonellosis caused by Salmonella 
enterica is the cause of Typhoid, e.g S. Typhi and S. Paratyphi A enteric fever and 
non-Typhoidal infections, e.g S. Dublin, S. Heldenberg, S. Typhimurium. Certain 
serovars are associated with foodborne infections such as S. Typhimurium and S. 
Enteritidis (Li et al., 2013). The gradual increase in the prevalence of AMR of both 
Typhoidal and non Typhoidal Salmonella serotypes in many countries in the world is 
a matter of public health concern and has caused some antibiotics like 
chloramphenicol, ampicillin, trimethoprim/sulfamethoxazole to be no longer used for 
treatment of enteric fever leaving fluoroquinolones (ciprofloxacin) as the primary 
antibiotic of choice (Gal-Mor et al., 2014). For instance an increase in the emergence 
of AMR S. Typhimurium Definitive Type (DT) 104 in the United Kingdom from 1979 
to 1996 was reported (Glynn et al., 1998). This study characterised Salmonella isolates 




chloramphenicol, streptomycin, sulphonamides and tetracycline, with the increase in 
the antibiotic resistance prevalence from 0.6% in 1979-1980 to 34% in 1996. A 
Scottish study also reported the complex nature of the AMR infection caused by S. 
Typhimurium DT104 in which they concluded that the resistant strains were not 
always transmitted from animals to humans but there could be other sources such as 
imported foods and the environment that led to human infections with antibiotic 
resistant strains of Salmonella (Mather et al., 2013). In the USA, an outbreak of AMR 
Salmonella Heidelberg was reported from March 2013 to July 2014, with 634 cases 
(Gieraltowski, 2014). In this outbreak, the epidemiology analysis linked the cases in 
humans to the contamination of chickens from particular farms and the pathogen was 
resistant to the wide range of routinely used antibiotics such as tetracycline and 
penicillin, further strengthening the global threats posed by AMR of non-typhoidal 
Salmonella infections.  
In Zambia, extremely drug resistant Salmonella enterica serovar Senftenberg 
involving two epidemiologically independent human cases were reported in 2012 
(Hendriksen et al., 2013). In this study, Salmonella enterica serovar Senftenberg was 
isolated from each patient, one located in Mazabuka in the Southern Province of 
Zambia and the other in Lusaka Province. The two cases were not epidemiologically 
linked and the genomic sequence analysis indicated 93 SNP differences between them. 
However, they were both resistant to amoxicillin, ampicillin, cefepime, cefotaxime, 
cefpodoxime, ceftazidime, ceftiofur, ceftriaxzone, chloramphenicol, ciprofloxacin, 
gentamicin, nalidixan, neomycin, spectomycin, streptomycin, sulfamethoxazole, 
tetracycline, and trimethoprim (Hendriksen et al., 2013). A study by Mwansa et al., 
(2002) reported an increase of antibiotic resistance among the non-typhoid 
salmonellae (p<0.001) isolated from diarrhoea patients at a hospital in Lusaka from 
0% to 34% from 1995 to 1999. Antibiotic resistance of non-typhoid salmonellae has 
also been detected in food animals and food of animal origin (Isogai et al., 2005), no 
comprehensive information is available on the prevalence and resistance profile of 
salmonellosis in animals and humans of Zambia. However, the reported extra multi-
drug resistant pathogens are a major threat to human health as they are capable of 




Infections caused by methicillin resistant Staphylococcus aureus (MRSA). 
Staphylococcus aureus is one of the leading causes of hospital acquired (HA-MRSA), 
community acquired (CA-MRSA) and livestock acquired (LA-MRSA) infections 
worldwide (Chambers and Deleo, 2009). Staphylococcus infections were originally 
treated successfully with penicillin in the 1940s. Soon after S. aureus developed 
resistance due to plasmid-encoded β-lactamases and the methicillin was introduced for 
treatment of S. aureus infections. Methicillin is a semisynthetic derivative of penicillin 
and barely two years after its introduction in the clinical setting, resistance emerged 
mediated by the mecA gene on a genetic mobile element inserted into the chromosome 
of S. aureus; and this is now reported globally (Chatterjee and Otto, 2013). The 
emergence of S. aureus strains that are resistance to methicillin and the related 
antibiotics such as oxacillin, amoxicillin and nafcillin and the cephalosporins is of 
great public health concern. Little information is available for Zambia, however, in a 
study by Neel, (2012), 25.85% (53/205) antibiotic resistance was detected among the 
S. aureus that were isolated from the paper currency notes from the markets in Lusaka. 
This indicated the presence of antibiotic resistant S. aureus in the communities of 
Zambia. 
Infections caused by multidrug-resistant (MDR) tuberculosis (TB). MDR TB is 
defined as TB strains that are resistant to at least isoniazid and rifampicin 
(Organization, 2007; Sharma et al., 2014). Isoniazid, rifampicin, ethambutal, 
streptomycin and pyrazinamide are first line drugs for treatment of TB. They are less 
expensive and less toxic when compared to second line drugs for treatment of TB. 
Some examples of second line drugs or reserved drugs for treatment of TB are 
linezolid, amoxicillin/clavulanate, ofloxacin and kanamycin. There has been reports 
of TB strains that are extensively drug resistant (XDR), literarily resistant to all the 
first and second line drugs of TB treatment. In order to establish the magnitude of this 
problem, the WHO carried a world-wide survey in different laboratories covering the 
period from 2000 to 2004 and tested for antibiotic resistance of 17, 690 TB isolates 
and found that 20% were MDR and 2% were resistant to all second line drugs (Control 
and Prevention, 2006). Additional information on the population based data for USA 




of all the MDR TB cases that were diagnosed in these countries were XDR respectively 
(World Health Organization, 2000; Control and Prevention, 2006). These development 
shows that XDR TB has emerged worldwide and is a serious public health threat that 
is raising concerns of a possible future epidemic of virtually untreatable TB.  
In Zambia, although the information is not comprehensive, latest reports estimated the 
prevalence of MDR TB at 18.9% (172/911) among the cases that were reported in the 
period 2000 to 2011 in the country (Kapata et al., 2013). Earlier on the WHO reported 
the Zambian national incidence data of MDR TB at 8.55 per 100, 000 population in 
the period between 2000 and 2004 (Zager and Mcnerney, 2008).  Other specific reports 
indicate the presence of MDR TB in human hospitals and communities. For instance, 
a prevalence of 22.7% (245/1080) for positive TB cases was detected in a survey 
between 2000 to 2001 involving Zambian prisoners and 23.8% were resistant to at 
least 1 anti-tuberculosis drugs and 9.5% were MDR TB (Habeenzu et al., 2007).  
Infections caused by multidrug-resistant Clostridium difficile. Clostridium difficile 
is a spore forming Gram-positive anaerobic bacillus. It is found in the gut of some 
individuals without causing any clinical infection. When such individuals are given 
broad-spectrum antibiotics such as clindamycin or/and third generation cephalosporin 
(e.g cefpodoxime) that eliminates most of the commensal bacteria and predisposes 
individuals to be susceptible to C. difficile infection (Freeman and Wilcox, 1999). It 
causes a wide range of disease severity in humans from asymptomatic colonization of 
gastro-intestinal tract to severe diarrhoea with a potential of progression into 
pseudomembranous colitis, toxic megacolon, colonic perforations and eventually 
leading to death of the affected individual (Gerding et al., 1995). 
The latest reports are indicating that C. difficile is ahead of S. aureus as the leading 
cause of nosocomial infections in hospitals (Evans et al., 2014). It has been associated 
with epidemics of diarrhoea in hospitals and long term care houses. To make the 
matters worse, infections caused by C. difficile is increasingly reported in the 
communities outside the hospital environmental (Chitnis et al., 2013). Therefore, the 




concerns not only in hospital environment, but in communities as well throughout the 
world. The classical example is the emergence of fluoroquinolone resistant epidemic 
C. difficile strain (027/BI/NAP1), in which two lineages FQR1 and FQR2 of the strains 
emerged and spread from North America to UK, continental Europe and Australia 
where they caused disease outbreaks (He et al., 2013). The information on the 
prevalence of C. difficile in hospitals is not available in Zambia. 
1.2.12 Global call to control the emergence and spread of 
AMR 
There is an urgent call by the International public health bodies such as World Health 
Organisation (WHO), the World Organisation for Animal Health (OIE) and Food 
Agriculture Organisation (FAO) to countries around the world to implement integrated 
antimicrobial use (AMU) and AMR surveillance programmes (World Health 
Organization, 2001). This is to enhance the prudent use of antibiotics and promote the 
development of international food safety standards (World Health Organization, 
2014). In response, many countries have set up specific organisations that are 
responsible for AMR surveillance and reporting of respective national data. Some of 
the notable countries and programmes being implemented are the Canadian Integrated 
Programme for Antimicrobial Resistance Surveillance (CIPARS) that was set up in 
2006 to monitor the prevalence of antimicrobial resistance pathogens in farm animals 
in Canada. For instance CIPARS reported an increase in prevalences of 56-63% of 
AMR Salmonella species and 12-13 % of AMR E. coli from 2006–2008 (Avery et al., 
2014). 
The National Antimicrobial Resistance Monitoring System (NARMS) aggregates and 
reports on AMR pathogens such as Salmonella, Campylobacter, E. coli and 
Enterococci in the USA in collaboration with the Centre for Disease Control and 
Prevention (CDC) and the US Department of Agriculture Agency (USDA) (Gilbert et 
al., 2007). The Japanese Veterinary Antimicrobial Resistance Monitoring System 
(JVARM) monitors and reports on AMR pathogens in Japan, while The European 




Europe (Vernet et al., 2014). In South East Asia, The Asian Network for Surveillance 
of Resistant Pathogens (ANSRP) monitors AMR resistance among the 11 Southeast 
Asian countries predominantly focusing on resistant pneumococcal infections (e.g. 
Streptococcus pneumoniae) (Phongsamart et al., 2014)  
At the moment most of the industrialised countries have working systems to promote 
the prudent use of antibiotics both in humans and livestock as well as to monitor AMR. 
Similar programmes have also been started with the aim of monitoring AMR in 
developing countries particularly in sub-Saharan Africa (Vernet et al., 2014). For 
instance, an expert meeting on the diagnosis and detection of AMR in developing 
nations was held in 2011 in France and there is also a surveillance network among the 
West African countries largely focussing on resistance of malaria parasites, 
coordinated by the Malaria Research Centre at the University of Bamako in Mali 
(Vernet et al., 2014). Another working surveillance programme in Africa is the South 
African National Tuberculosis Drug Resistance Survey that was started in 2012 and is 
aimed at monitoring the resistance of human TB (Schnippel et al., 2015). However, 
AMR surveillance programmes are still missing in most developing countries. 
The other initiatives being instigated to address the emergence and spread of AMR 
are: 1) to lobby the meat companies to help control the use of antibiotics among farms 
by avoiding farms that use antibiotics as growth promoters in livestock production 
(Viola and Devincent, 2006; Davies and Gibbens, 2013); 2) to work with veterinary 
antibiotics suppliers and persuade them to try to switch antibiotics from over the 
counter to prescription and to make it mandatory that veterinarians administer the 
antibiotics (Viola and Devincent, 2006). 
At the global level, AMR is monitored and reported by WHO, OIE, FAO and recently 
regional bodies are being formed to re-enforce this purpose. For instance, the Global 
Health Security Agenda (GHSA) is a cooperative against the threats of AMR formed 
between the USA and Japan with thirty other countries (Gerbin, 2014). There is no 
localised body in Zambia that is spearheading the activities to control and monitor the 




town from the 8th to 15th May 2016, with the aim of developing AMR national action 
plan for Zambia as a requirement by WHO, OIE and FAO for all the member countries. 
1.2.13 Surveillance of AMR in livestock 
In addition to studies on the use of antibiotics, AMR surveillance is being carried out 
in order to establish the prevalence levels and to track the antibiotic resistance 
pathogens in clinical settings (World Health Organization, 2014). In this context 
surveillance is the process by which measures are taken to systematically collect, 
collate, analyse and report on AMR and distribution involving infectious pathogens 
and/or commensal bacteria (Grave et al., 1999; Heffernan et al., 2004).  
A number of surveys, predominantly in developed nations, have been carried out to 
assess the prevalence of AMR in animals and humans and they have shown a lot of 
variation due to differences in the methodologies used (World Health Organization, 
2014). However, most studies have pointed out the threat to public health of the 
emergence of AMR in livestock production systems if levels are not properly 
monitored and controlled (Van Den Bogaard and Stobberingh, 2000). In Europe, the 
Scandinavian countries such as Sweden and Denmark have the lowest levels of 
antibiotic resistant in E. coli, Salmonella and Campylobacter compared to Southern 
European countries such as Spain and Italy (Bywater et al., 2004). Bywater et al (2004) 
reported that the prevalence of antibiotic resistance of E. coli to tetracycline and 
sulfamethoxazole in cattle were 19.6% and 8.5% in Italy, 9.1% and 2% in the UK, 
2.5% and 0.8% in Germany, 0% in France (Bywater et al., 2004). In another study, De 
Jong et al. (2009) also observed lower prevalence of AMR for different types of 
antibiotics in Northern European countries when compared to Southern European 
countries, for instance E. coli that were isolated from cattle were 6% (Germany), 6% 
(France), 20.2% (Italy), 3% (Ireland) and 6% (the UK). Although these studies were 
centred among the European countries, the results could be generalised that the 
variations in AMR may be attributed largely to the differences in the quantities of 
antibiotics used in livestock production by each country or region (Van Boeckel et al., 




the differences in AMR within different farming production systems, generally dairy 
cattle herds tend to harbour more AMR bacteria than beef cattle due to frequent use of 
antibiotics for the treatment of mastitis (Call et al., 2008).  
The prevalence of antibiotic resistance in livestock is more in young stock than in old 
animals (>1year) (Khachatryan et al., 2004). This American study (Khachatryan et al., 
2004) examined the age distribution of dairy cattle and conducted AMR tests using E. 
coli commensals and found that isolates resistant to tetracycline (>4 microgram/ml) 
were more prevalent in less than 3 month old calves (79%) as compared to the lactating 
cows (14%). A similar observation was made in a European study involving seven 
selected countries (Sweden, Denmark, Norway, Austria, Switzerland, Belgium and the 
Netherlands) where the prevalence of antibiotic resistant commensal E. coli isolated 
from veal calves, adult cattle and poultry to a panel of antibiotics (sulphonamides, 
ampicillin, ciprofloxacin, streptomycin, tetracycline, chloramphenicol, gentamicin 
and cefotaxime) was assessed. In this study significant lower prevalences of AMR in 
veal calves compared to the adult cattle for all the antibiotics apart from cefotaxime 
were reported, (Chantziaras et al., 2014).  
In developing countries, nations that use more antibiotics in livestock production such 
as China, South Africa, Brazil, India and Russia (Van Boeckel et al., 2015) are also 
regarded as hotspots for AMR, with other intermediate developing countries such as 
Myanmar, Indonesia, Nigeria, Peru and Vietnam as possible future hotspots (Grace, 
2015). Hotspots in this context are defined as countries with more reports of AMR 
than other developing nations. In hotspot countries the development of AMR is 
considered to be as a result of a rapid growth in intensive livestock production with a 
subsequent increase in antibiotic use (Grace, 2015). The spread of antibiotic resistance 
genes from hotspot areas to other parts of the world has been documented. One such 
example is the spread of the New Delhi metallo β-Lactamase (NDM-1) from India to 
other Asian countries, Europe, North America, Austria and Africa (refer to Figure 1.9). 
Recently, the AmpC plasmid mediated β-Lactamase CMY-2 was detected in 
Salmonella isolated from pigs in China for the first time, this is an indication of both 




to another (Li et al., 2013). The plasmid encoded AmpC β-Lactamase CMY-2 in 
animals was first reported in the USA but now it is reported in many European and 
Asian countries (Folster et al., 2011; Winokur et al., 2000). 
In sub-Saharan African regions, the few available reports suggest increased prevalence 
of antibiotic resistance of commensal and pathogenic bacteria in different livestock 
production systems. In a South African study, 95 E. coli O157 isolates from faecal 
samples of dairy cattle in two dairy herds were observed to have prevalence of 
resistance to a panel of antibiotics as follows: 89.5% chloramphenicol, 94.74% 
ampicillin, 96.84% tetracycline, 94.74% cephalothin, 84.2% streptomycin, 6.3% 
amikacin, 84.2% amoxicillin/clavulanate, 12.6% ciprofloxacin, 8.4% gentamicin 
(Iweriebor et al., 2015). Another report from the same region estimated a range of 
prevalence of antibiotic resistant E. coli in Zambia, Democratic Republic of Congo, 
Mozambique and Tanzania involving various livestock hosts as follows: 80–90% 
ampicillin, 74-83% amoxicillin, 63-67% gentamicin, 36-91% 
trimethoprim/sulfamethoxazole and 4-96% tetracycline (Mshana et al., 2013b). 
There is no established national surveillance system for AMR in Zambia. However, 
the prevalence of AMR is reported to be more in intensive farming systems of poultry 
and swine compared to cattle farming systems (Ngoma et al., 1993). In a Zambian 
study, Ngoma et al., (1993) reported significantly ( P < 0.01) lower AMR in E. coli 
isolated from cattle 6.7% (7/105) than from pigs 39% (41/105). However, the 
prevalence of AMR in livestock and companion animals in Zambia varies for different 
types of antibiotics, for instance, a prevalence of 63.6% and 36.4% of S. aureus 
resistant to penicillin and trimethoprim/sulfamethoxazole respectively was reported in 
companion animals at the veterinary teaching hospital in Lusaka (Youn et al., 2014). 
The prevalence of antibiotic resistant in E. coli that were isolated from pastoral cattle 
were 83.1% (erythromycin), 71.1% (trimethoprim/sulfamethoxazole), 22.9% 
(nitrofurantoin), 8.4% (ampicillin), 3.6% (tetracycline) and 2.41% (gentamicin) 
(Mubita et al., 2008). However, these results also show resistance in erythromycin and 
trimethoprim/sulfamethoxazole, the two antibiotics that were rarely used in the 




of resistance determinants from the environment or humans to pastoral cattle. In view 
of the above, AMR is still a matter of serious public health concern and the predicted 
mortality rates in humans will be compounded by antibiotic resistant infectious 





Figure 1.10. Death attributable to AMR every year by 2050. The circles on different 
continents shows the proportional size of the estimated mortality rates due to AMR 
infectious pathogens. The increased mortality rates will be experienced more in Africa 
and Asia and the least will be in Australia. Adapted from O’Neill, 2014. 
1.2.14 AMR testing of E. coli  
Antimicrobial resistance testing (Figure 1.11 and Figure 1.12 for example) is carried 
out both in clinical medicine and research in order to determine bacteria resistance to 
specific antibiotics as an aid to treatment or research (Olsson-Liljequist et al., 1997). 
The disc diffusion test is regarded as a practical “gold standard test” (defined as a test 
or procedure that is required to establish to a high level of certainty the presence or 
absence of phenotypic resistance for a particular bacteria), but other methods such as 
agar dilution, broth micro dilution and the epsilometer test (E-test) are also used 




consistency of the results, the Clinical and Laboratory Standards Institute (CLSI) 
recommends a standard bacteria culture broth density to test antibiotic resistance with 
the “0.5 McFarland density standard”. This commercially available standard contains 
approximately 1.5 x 108 Colony Forming Unit of bacteria (CFU) and its turbidity can 
then be used to compare the turbidity of the bacterial inoculate used when testing for 
antibiotic resistance.  
 
 
Figure 1.11. Kirby Buer disc diffusion test for antibiotic resistance testing. The disc 
diffusion test model depicting a bacterial colony that is resistant to one antibiotic so 
no zone of growth inhibition is seen around the disc but is susceptible to another 
antibiotic, with a zone of growth inhibition around the antibiotic disc (Hudzicki, 2009). 






Figure 1.12. Kirby Buer disc diffusion test for antibiotic resistance testing. An 
illustration on how to conduct the actual measurement in the laboratory using a ruler 
(millimetres). Adapted from Hudzicki, 2009. 
1.2.15 Next Generation Sequencing (NGS) in the context of 
AMR screening 
The next generation sequencing (NGS) is being applied for diagnostic purposes and is 
being considered for routine use in public health (Köser et al., 2012). However, both 
the complexity of the technology and high costs involved mean it is not yet being used 
routinely in the identification and characterisation of microbes in public health 
laboratories (Köser et al., 2012). Some of the current use involves the identification of 
bacteria species using the 16S rDNA and multi-locus sequence typing (MLST) 
(Söderlund et al., 2014). These methodologies are often used in epidemiological 
studies and involve sequencing and analysis of amplified short PCR DNA fragments 
(Rinttilä et al., 2004). These methodologies have been used to identify point mutations 
in specific genes that are associated with resistance to anti-viral drugs and antibiotics 




However, the recent developments in new sequencing procedures has allowed for full 
sequencing of entire bacterial genomes (whole genome sequencing) (Hu et al., 2013), 
which has the capacity to revolutionise the diagnosis of infectious and non-infectious 
diseases in public health. When applied in the context of antimicrobial resistance, it 
makes it possible to generate refined dissemination genetic maps of the resistomes of 
the microorganisms that are involved (Sommer et al., 2009). Further, NGS enables the 
analysis of bacteria genomes even from the complex mixtures of bacteria such as 
faecal microbial metagenomics samples (Zankari et al., 2012b; Hu et al., 2013; 
Sommer et al., 2009).This has enabled identification of the different bacterial species 
present in clinical samples and the presence and absence of AMR genes in these 
complex environments; it can also be used to diagnose the presence of other diseases 
and conditions in the complex (Hu et al., 2013). Metagenomics has provided a greater 
understanding of the overall effect of the use of antibiotics and the emergence and 
linkage of AMR in humans and animals (Hu et al., 2013). 
Advances due to NGS go beyond pathogen identification in clinical samples but can 
allow resistance and susceptibility determination by analysis of the host’s genome 
sequence (Pareek et al., 2011). These technological advances are becoming more 
useful and visible in the diagnostic laboratories and may lead to treatment of some of 
the current incurable conditions such as cancer (Pareek et al., 2011). It is envisaged 
soon there will be the ability to ‘sequence’ small biological molecules such as poly-
saccharides and fatty acids leading to more advanced diagnostic capabilities. 
In view of the above, several companies such as Illumina, Roche and Ion-Torrent are 
already conducting NGS on a commercial basis and many more new companies are 
expected to get on board in the next decade (Liu et al., 2012). These technologies are 
not yet in use in developing nations including Zambia. However, as these technologies 
get more advanced and many companies get involved, the costs are expected to 
drastically reduce such that the benefit of NGS will be extended and used for public 




1.2.16 Molecular epidemiology studies in public health 
Molecular epidemiology is a branch of biomedical science that focuses on the 
understanding of the potential genetic and environmental risk factors, inferred at 
molecular levels to be associated with the aetiology, distribution and prevention of 
disease within and across populations of organisms or microorganisms (Köser et al., 
2012). This branch of biomedical science combines molecular science techniques and 
conventional epidemiology in order to answer the public health and other genetic 
forensic questions in society. Molecular epidemiology is applied in both non-
infectious and infectious diseases. 
The molecular epidemiology of infectious diseases is the study of evolutionary 
relationships among organisms or genes on the basis of genetic material such as DNA, 
RNA or/and protein sequences (molecular phylogenetic) to characterize the key 
determinants of epidemics (Croucher et al., 2014). In terms of infectious 
diseases/antimicrobial resistance, molecular epidemiology has been applied to 
investigate: 1) the origin of the species, disease outbreaks or epidemics; 2) the 
transmission or spreading patterns of the pathogens; 3) the genetic structure of the 
population of the pathogens (Croucher et al., 2014).  
The study of microorganisms in molecular epidemiology depends on the variation of 
the whole genome sequence of the microorganisms or variation in specific gene 
sequences. The variations of genetic sequences among microorganisms of the same 
species is as a result of spontaneous mutation (change in genetic material), gene 
deletion and/or recombination (exchange of genetic material between genomes) 
(Croucher and Didelot, 2015). When microbial pathogens infect the host, the host 
typically mounts immune responses against the pathogen. As a result, the pathogen is 
subject to selection pressure for change such that the within-host adaptation is often a 
feature of pathogen evolution. Only the pathogens that are able to withstand the 
immune selection pressure of the host are able to be transmitted or spread to other 




the basis on which host-to-host transmission is associated with a loss of genetic 
diversity of the pathogens (clonal spread of the pathogen). 
Pathogens in a disease outbreak with minimal difference in genetic distance are 
considered to have evolved from the same lineage. Application of WGS in molecular 
epidemiology techniques is used to understand the source, spreading patterns and 
population composition of pathogens, i.e. study if the disease outbreak is due to a 
single or multiple lineage of pathogens (Dallman et al., 2015). Specifically the use of 
phylogenetic molecular epidemiology techniques coupled with conventional 
epidemiology is used to trace disease outbreaks (Colijn and Gardy, 2014). 
Phylogenetic analysis is the study of evolutionary relationships among individuals or 
groups of organisms (species or populations) using the common traits that are found 
within their genetic material (DNA, RNA or proteins) (Grad et al., 2012). Phylogenetic 
trees can be built from housekeeping genes as in Multilocus Sequence Types (MLST) 
or from core genome (using concatenated core genes). 
The rationale of phylogenetic analysis is based on the calculation of the evolutionary 
relationships between sequences of interest and mapping the distances on a tree 
(phylogenetic tree) (Croucher and Didelot, 2015). There is a wide-range of software 
applications that are used to build phylogenetic trees from sequence-based 
information. However, the principle procedure is outlined as follows: 1) the alignment 
of sequences in order to identify the regions of similarities and difference (e.g Single 
Nucleotide Polymorphisms (SNPs)) that may be as a result of evolutionary relationship 
between sequences; 2) The calculation of genetic distances between sequences (the 
number of nucleotide differences between sequences divided by the sequence length) 





1.2.17 Different models for construction of phylogenetic trees 
Two different categories of methods are used within commercial software to build 
phylogenetic trees: 1) Distance based matrix methods such as Neighbour Joining (NJ) 
and Unweighted Pair Method with Arithmetic Mean (UPGMA); 2) Character-based 
methods such as Maximum Likelihood (ML) and Maximum Parsimony (Minimum 
evolution tree) (Guindon and Gascuel, 2003; Desper and Gascuel, 2002; Tamura et al., 
2013).  
In the distance based methods, the calculation of distance is based on the number of 
substitutions per site per time period (Croucher et al., 2014). The evolutionary distance 
is calculated based on one of DNA evolutionary models. The neighbours (pairs of 
sequences that have the smallest number of substitutions between them) are joined by 
the common ancestor and placed at the correct positions with the estimated branch 
length. The rationale in the distance based phylogenetic trees is that species with lower 
differences in the given genetic distance matrix must be closer together than those 
species with any other on the matrix (Kaase et al., 2015). 
The distance methods use an assumption that all mutations are neutral and therefore 
happen at a constant random rate (clocklike rate) (Hedges et al., 2015). Although this 
may be true for closely related species, it is not always the case because mutation rate 
is affected by different environmental conditions and this assumption ignores the 
genetic selection issues that vary with time. Further limitations for this model are that 
only matrices with low distance differences between sequences give good results. The 
distance based models produces a single tree at a time, without any provision to 
compare it to other potential trees that can be produced from the same data set being 
analysed, therefore limiting the selection for more robust trees. 
The second category contains the character based models for construction of 
phylogenetic trees that use evolutionary characters such as phenotypic or gene alleles 
to form the branching pattern of evolution or relationships. The principal is that if two 




to each other than to the organism that lacks this character at a particular position as 
long as that character was not present in the last common ancestor of the three 
organisms. 
One such model is ML that builds trees based on mathematical models (Stamatakis, 
2006). This model, like MP methods described below, analyses each position of the 
multiple alignment and calculates the probability that best accounts for a large amount 
of variations of the dataset (sequences) (Croucher and Didelot, 2015). It uses this 
model to analyse the nucleotide substitutions and tries to find the most likely tree (out 
of all the trees of the given dataset). Unlike the distance based models, the character 
based model assumes that each character is independent of its neighbours. It therefore 
uses more complex computer programmes that can be slow and memory intensive. 
Examples of computer  programmes that can be used for construction of ML 
phylogenetic trees are PHYML (Guindon and Gascuel, 2003), mBayes (Ronquist and 
Huelsenbeck, 2003) and RAxML (Stamatakis, 2006), The trees generated by ML can 
be compared by another ML search or by a NJ run, using the nucleotide substitution 
likelihood criterion (Dhar and Minin, 2015). ML models are suitable for analysis of a 
dataset with very weak similarity. The superiority of statistic based models such as 
ML over the distance based models such as NJ trees therefore lies in its consideration 
of all possible trees to identify the best ones with the use of a clear criterion to compare 
them. However, when time is a limitation or for a quick exploration of the data then 
NJ can be considered. 
The other character based model of phylogenetic tree construction is Maximum 
Parsimony. This method builds a tree with the fewest changes required to explain the 
differences observed in the data. It is the model of choice to analyse sequences with 
strong similarity and possessing only small amounts of variation. Like other character 
based methods, MP assumes that each character substitution is independent of its 
neighbours. 
The limitation is that MP is always the shortest possible tree in the dataset, therefore 




limitations are that MP is not guaranteed to produce the true tree with high probability, 
given sufficient data (not statistically consistent). In MP not all substitution sites are 
informative. An informative site has at least 2 characters each appearing at least in 2 
of the sequences of the dataset. The other limitation is that it does not give the length 
of the branches of the phylogenetic tree, it just orders the branches and is not suitable 
for larger data sets. 
The accuracy of the trees is enhanced by setting the software to resample the sequences 
and build the trees (Bootstrap). It is used to estimate the confidence level of the 
phylogenetic hypothesis. Different parts of a phylogenetic tree are further explained in 







Figure 1.13. The model of phylogenetic tree. The parts of a phylogenetic tree showing 
the nodes at the tip of the branches (leaves) and at the point of branch joining (also 
known as internal nodes). Species A and species B are in the same clade (cluster) 
because they have the smallest genetic distance between them. The species C, D and 
E are in the same clade but a separate clade from species A and B. The number 80 is a 
bootstrap number for that node (resampling with replacement). The 100% is the 
maximum statistical support for that node that the branches on the right side clustered 
together than any other combination. The horizontal bars are branches and represent 
evolutionary lineages changing over time. The longer the branch in the horizontal 
dimension, the larger the amount of change. The scale bar at the bottom of the figure 
helps to understand the evolutionary changes in the length of the branches. For 
example the line segment with the number '0.001' shows the length of branch that 
represents an amount of genetic change of 0.001. The units of branch length are in 
nucleotide substitutions per site (the number of nucleotide substitutions divided by the 




the phylogenetic trees apart from merely structure formation of a tree. The root of the 
tree is the origin (the root of the tree) from where all the branches are genetically 
evolving from. Adapted from http://imgarcade.com/1/simple-phylogenetic-tree-of-
plants/. 
1.2.18 Practical examples of infectious disease investigations 
involving molecular epidemiology 
Molecular epidemiology is revolutionising the testing of antibiotic resistance in 
microbiology as the level of resolution and detail can allow inferences about AMR 
evolution and spread. PCR-based methods and WGS based are now widely used to 
identify resistance genes in bacterial isolates (Tenover et al., 1995) and have 
successfully been used to epidemiologically trace disease outbreaks (Croucher and 
Didelot, 2015). The use of WGS allows very fine resolution analysis between strains 
and increases our capacity to understand the detailed epidemiology of an outbreak 
(Köser et al., 2012).  
A practical example of the use of molecular epidemiology with WGS for investigating 
and tracing disease outbreaks was demonstrated in 2011 in Germany for a disease 
outbreak involving E. coli O104:H4 with virulence factors of EHEC and EAEC that 
was caused by contaminated sprouts (Rohde et al., 2011). In that outbreak, analysis of 
WGS of isolates from four early cases showed that the pathogens were genetically 
closely related in relation to the general E. coli species, meaning that those pathogens 
were evolving from the same lineage (clonal spread) (Mellmann et al., 2011). Further 
analysis identified that the disease outbreak was caused by O104:H4 serotype with a 
Stx encoding prophage and the plasmid-encoded resistance to β–lactam antibiotics 
(Rasko et al., 2011). The high resolution analysis by WGS was used to differentiate 
the Germany disease outbreak from an outbreak in France that was concurrently going 
on at the same time (Bielaszewska et al., 2011; Grad et al., 2012). In these German 
and French E. coli outbreaks, Grad et al. (2012) reported 19 SNPs in the WGS of 11 




report a total of 19 SNPs relative to the reference (published genome) was found with 
virtually no genetic diversity among the isolates from the same individual. 
Further, Grad et al., (2012) analysed the 4 genomes from the Germany disease 
outbreak and found that 2 genomes were completely identical to the reference while 
the other 2 genomes had a total of 2 SNPs relative to the same reference that was used 
on the genomes from the French outbreak Figure 1.14 (Grad et al., 2012). This helped 








Figure 1.14. Maximum likelihood phylogeny using 21 SNPs identified in German and 
French E. coli isolates from outbreaks in 2011. The tree is based on 500 bootstraps and 
rooted on 2004 and 2009 historical isolates (Ec04-8351 and Ec09-7901). The isolates 
from the German disease outbreak are C236-11, C227-11, Ec11-3677 and Ec11-3798 
and all other remaining isolates in the figure were from the French outbreak. The 
isolates from a single individual are captioned on the top right corner. The black 
numbers on the internal nodes are the bootstrap support and the red number indicates 




The German outbreak was caused by an emerging pathogen as the O104:H4 serotype 
had not been detected in animals and was rarely associated with haemolytic uremic 
syndrome in humans (Mellmann et al., 2011). Furthermore, Mellmann et al., (2011) 
modelled the possible evolutionary lineages of O104:H4 in that outbreak and 
concluded that the outbreak strain could have acquired and lost some virulence factors 
from a hypothetical EHEC O104:H4 progenitor ancestor as presented in Figure 1.15. 
This is a good example of an emerging infectious pathogen for which the use of high 









Figure 1.15. The allelic profiles of E. coli genome showing the phylogenetic 
relationship of the outbreak strain EHEC O104:H4 (LB226692), the historical EHEC 
strain 01-09591, the EAEC (55989) (coloured dark blue) and the position of the 
hypothetical O104:H4 progenitor. Other pathotypes are included in the tree and the 
numbers between the nodes (allelic profiles) on the connecting lines represent the 







In another study involving the robust use of WGS, a Cholera disease outbreak in Haiti 
in 2010 in the aftermath of the earthquake was investigated and epidemiologically 
linked to have originated from a distance geographic source and was introduced in 
Haiti by human activity (Chin et al., 2011). In that study, Vibrio cholerae isolates from 
the outbreak were whole genome sequenced and subjected to phylogenetic analysis 
with other global collection and found that they were clustered with isolates from 
South East Asia than the ones from South America. Further analysis showed that the 
Haitian Vibrio cholerae isolates clade tightly with isolates from Bangladesh, Figure 
1.16. 
 
Figure 1.16. Phylogenetic analysis showing V. cholerae isolates appear from the 
Haitian outbreak in 2011 in the same clade with the isolates from Bangladesh. This 
figure was reproduced with permission from Chin et al., 2011. Copyright 




1.2.19 Surveillance of Shiga toxin producing E. coli (STEC) 
There are two main types of Shiga toxins that are produced by STEC, namely Shiga 
toxin 1 (Stx1) and Shiga toxin 2 (Stx2) with stx1a, stx1c and stx1d as variants for stx1, 
while stx2a, stx2b, stx2c, stx2d, stx2e and stx2f-g are variants of stx2 (Melton-Celsa 
and O’brien, 2000). Some STEC that possess the locus of enterocyte effacement 
(LEE)-encoded type III secretion system (T3SS) are known as Enterohaemorrhagic E. 
coli (EHEC). The T3SS is a needle like protein structure found in certain Gram-
negative bacteria that is used to aid infection in the host by injection of bacterial 
effector proteins into the host cell (Paton and Paton, 1998). EHEC causes serious and 
sometimes fatal human infections; the common serogroups that have been isolated in 
human infections are O157, O26, O111, O103, O121, O145 and O45 (Pearce et al., 
2006; Friesema et al., 2014). The symptoms in humans range from stomach cramps to 
bloody diarrhoea (haemorrhagic colitis) and haemolytic uremic syndrome (HUS) 
(Kaper et al., 2004). There are about 2,801,000 estimated acute infections caused by 
STEC worldwide annually leading to about 3890 cases of HUS and 230 deaths in 
humans (Majowicz et al. 2014). Ruminants are considered the main reservoir of STEC, 
and so often the human clinical cases are linked to contact with livestock or 
contaminated food products (Zweifel et al., 2013; Karch et al., 2015).  
There have been a number of surveys in various countries involving livestock and 
humans in order to establish the prevalence and genotypes of STEC and to track these 
pathogens in disease outbreaks (Islam et al., 2014). Predominantly the surveys have 
been done in developed countries such as Europe and America where STEC human 
infections are an acknowledged threat to human health (Majowicz et al., 2014; Luna-
Gierke et al., 2014).  
Typical example of STEC surveys include a New Zealand study which determined and 
compared the prevalence and genotype of E. coli O157:H7 in livestock and humans 
involving the Northern and Southern parts of the island. That study reported a 
substantial difference within the country and also a marked variation of the Shiga toxin 




2014). This is evidence of the spread of several serotypes of STEC O157:H7 from 
other geographical areas into New Zealand with subsequent local spreading. This is 
fundamental as it suggests that each geographical region may have a different 
prevalence and genotype of STEC serotypes. In the USA, the cases of human 
infections caused by STEC serotypes are predominantly concentrated in the upper 
midwestern part of the country (http://www2c.cdc.gov/podcasts/createrss.asp?c=280). 
The global geographical distribution of STEC (E. coli O157) was demonstrated to have 
significant differences between regions and there is scant information within Sub-
Sahara Africa as depicted in Figure 1.17 (Islam et al., 2014).  
In Zambia a few STEC studies have been carried out and have reported a wide 
variation of prevalence. One study Kuroda et al., (2013) reported the detection of 
STEC in indigenous pastoral cattle and Kafue lechwe (Kobus leche kafuensis) at the 
livestock/wildlife interface in the areas of the national parks. This study reported the 
prevalence of STEC with stx2 at 55.1% in cattle and 20% in Kafue lechwe (Kuroda et 
al., 2013). In the same geographical area, one study (Mubita et al., 2008) involved the 
isolation of E. coli (n=575) from Kafue lechwe and from pastoral cattle (n= 708) 
estimated the prevalence of STEC O157 to be 18.1% for the isolates from Kafue 





Figure 1.17. Global prevalence of STEC (E. coli O157). The high prevalence of 
>6.52% has been reported in some North American, European, Australia and Japan 
countries. In Africa, South Africa and Nigeria prevalence >6.5% was reported and 
there is no information from other countries. The estimate of the prevalence of E. coli 
O157 is based on the available literature in cattle (Kuroda et al., 2013; Mubita et al., 
2008). This figure was adapted from Islam et al., 2014. 
1.2.20 Statistical modelling for risk factor analysis 
With the increasing problem of antibiotic resistance in human hospitals and different 
livestock production systems, risk factor analysis involving statistical modelling is 
increasingly used to identify putative factors that are associated with the emergence of 
antimicrobial resistance in microorganisms (Broens et al., 2011; Duse et al., 2014).  
The potential risk factors are primarily the use of individual antibiotics on the host of 
microorganisms (Duse et al., 2014). However, logistic regression statistical modelling 
analysis is one such method that is commonly used to identify significant or non-




veterinary settings (Gangcuangco et al., 2015; Hosmer Jr and Lemeshow, 2004). In 
this methodology the response (dependent) variable is the outcome of the test on an 
individual or microorganism (this is often denoted as antibiotic resistance positive (1) 
or negative (0)). It is expected that the response variable is caused or associated by 
certain inputs of independent variables. Statistical models are used to test or explain 
the effects that the independent variables have on the dependent variables (Hosmer Jr 
and Lemeshow, 2004). The variables are often collected during an epidemiological 
study using various methodologies such as questionnaires or through interviews. The 
response variable can be modelled with individual variables (independent variable) to 
assess the effect they have on the response variable.  
The odds ratios scale is used to assess if the independent variable is protective to the 
response variable (odds ratio of < 1, if there is no association between the response 
and the independent variable (odds ratio of 1) or if there is an association (odds ratio 
> 1). Odds ratios are used in statistical modelling with the aid of confidence intervals. 
Regardless of the value of the odds ratio, if the confidence intervals cross 1 then it is 
considered to be no association of the variables being tested (Hosmer Jr et al., 2013) 
So often the response variable is not only affected by a single independent variable but 
a number of variables acting together in a particular environment or system. So further 
modelling is done on all the significant variables from the univariate analysis to test 
their collective effect on the response variable (multivariable analysis) and Akaike 
Information Criterion (AIC) is used to assess the fitness of the model among other 
several methodologies (Feingold et al., 2012). AIC uses numbers to give a relative 
measure of the fit of the models among various variables and the preferred model is 
the one with minimum value (Feingold et al., 2012). For instance in the Netherlands a 
risk factor analysis study Feingold et al., (2012), used univariate and multivariate 
logistic regression models to study whether persons living in areas of high animal 
density were at increased risk for carrying livestock-associated methicillin-resistant S. 
aureus (LA-MRSA) or not. The results from the analysis of this study indicated that 
people living in livestock dense areas had increased odds of nasal carriage of livestock-




E. coli O104:H4 outbreak in Germany in 2011 that was described earlier, logistic 
regression analysis was used to complement the molecular epidemiology of WGS and 
helped to identify the sprouts as the source of the infectious pathogens. In this study, 
26 case subjects with haemolytic-uremic syndrome and 81 controls were enrolled. The 
univariable analysis indicated odds ratio of 5.8; 95%CI: 1.2 – 29 of developing a 
disease for the individuals who consumed sprouts. And the trace back system among 
the restaurants where individuals ate sprouts were 100% linked to the cases (Buchholz 
et al., 2011). In risk factor analysis, identification of variables with significant 
associations with response variable is important as it acts as a basis for decision making 









Chapter 2 : Materials and methods 
2.1 Field based studies 
2.1.1 Pilot study  
The pilot study was first carried out that involved sampling of dairy cattle from the 12 
farms that were conveniently accessible with farmers that were willing to have their 
animals enrolled in the study. During the pilot study it was found that the commonly 
used antibiotics among the dairy herds were tetracycline, penicillin, trimethoprim 
sulphate and gentamicin. Resistance to these antibiotics was then assessed to determine 
the prevalence of AMR in the study model organism (E. coli). In addition, 
ciprofloxacin and cefpodoxime were included to determine resistance to 
fluoroquinolone and a third generation cephalosporin, both of which are essential 
antibiotics that are used in treatment of human infections. A total 81 E. coli isolates 
were obtained and tested for antibiotic resistance. The sampling and laboratory 
methodology is outlined in Appendix 1. Briefly, cattle were first restrained in crush 
pens and then numbered sequentially. The random table numbers were generated and 
assigned to the animals. Then the faecal samples were collected per rectum using a 
gloved hand. In instances where the rectum was empty the animal was stimulated to 
defecate. The faecal samples were put in a refrigerated cool box and transported to the 
laboratory within 48 hours. 
In the laboratory, from each sample, 10 g of faecal matter was put in a pot and 90 mL 
of Buffered Peptone Water (BPW) was added and then incubated at 37oC for 16 to 18 
hours. The lactose and sorbitol MacConkey agars were inoculated with overnight 
enrichment cultures from BPW and incubated at 37oC for 16 to 18 hours and the 
suspected E. coli colonies were then picked and subsequently sub-cultured on trypton 
bile–x-glucuronide (TBX) agar. TBX Agar was used to help confirm the isolation of 
E. coli as they appear blue on these plates as a consequence of β-glucuronidase 




on the each MacConkey plate was picked and plated on the TBX for 16 to 18 hours at 
37oC. The plates which did not yield blue colonies characteristic for E. coli were 
eliminated and another colony was selected from the MacConkey plate. The putative 
E. coli isolates from the TBX agar were further sub-cultured on blood agar in 
preparation for antibiotic resistance testing. The resistance testing was carried out 
using the Kirby-Bauer disc diffusion method (Bauer et al., 1966). Briefly, the 
inoculum was prepared by direct saline suspension of a nutrient broth culture from an 
isolated colony from the non-selective blood agar plates which had been incubated for 
18 to 24 hours. The suspension was adjusted to match the 0.5 McFarland standard 
using saline and vortex mixer. This results in a suspension containing approximately 
1 to 2 x 10⁸ CFU/ml for American Type Culture Collection (ATCC) 25922 E. coli 
which was used as a reference. 
The sterile swab was dipped in the saline inoculum and then streaked on the surface 
of the Mueller-Hinton Agar plate. The antimicrobial discs containing antibiotics of 
both veterinary and human importance (tetracycline, ampicillin, 
sulfamethoxazole/trimethoprim, gentamicin, cefpodoxime, and ciprofloxacin) were 
dispensed onto the surface of the Mueller Hinton Agar plates at least 24 mm apart from 
the centre of each other. The plates were put in an incubator at 35⁰C for 16 to 18 hours.  
The results were obtained by measuring the diameters of the inhibited zones, including 
the diameter of the discs to the nearest whole millimetre using sliding callipers and 
interpretation were done using standard break points (Clinical Laboratory Standards 
Institute). The summary results for the pilot study are presented in Figure 2.1 and were 
used as reference in designing the main study. 
2.1.2 Summary findings from the pilot study 
Tetracycline had the highest resistance among the antibiotics that were tested 21% 
(17/81), followed by sulfamethoxazole at 7% (6/81), ciprofloxacin 6% (5/81), and 
ampicillin 5% (4/81). No resistant E. coli was detected for the two classes of antibiotics 




to the type of antibiotic that was tested is presented in Figure 2.1. These antibiotics 
formed the basis for the AMR assessment in the main study. 
 
Figure 2.1. The summary result of resistance testing from the pilot study. Ampicillin 
(amp), cip (ciprofloxacin), tetracycline (tet), cefpodoxime (cpd), 
trimethoprim/sulfamethoxazole (sxt). 
2.1.3 Main field Study  
The target population of the study was dairy cattle on farms in the central region of 
Zambia, within a 120 km radius from Lusaka district (capital district) and involved a 
total of six administrative districts in central Zambia (Kabwe, Chibombo, Lusaka, 
Chongwe, Kafue and Mazabuka), the workflow is presented in Figure 2.2. The specific 
aspects of the study are also covered in results chapters 3, 4 and 5. A map of the study 
area is shown in Figure 2.3. The dairy farms in the study area are often located in 
groups known as Cooperatives. Each group has a central point known as a Milk 
Collection Centre (MCC) where the members deliver the milk for cooling and onward 
selling to a processing company or for local sales (for example the one in Figure 2.4 
(C)). The MCC also acts as a centre where farmers receive livestock management 
information to improve animal husbandry. The design of the study included all the 
main types and groupings of dairy farms in each district in order to ensure a good 
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Figure 2.2. Workflow and methodologies used in the study. 
Test for E. coli 
O157 
Field Study (ZAMBIA) 
Faecal samples collected from dairy herds. 
Data collection through Questionnaires. 
Microbiology; E. coli isolation (1 per faecal sample), All E. 
coli tested for phenotype antibiotic resistance, DNA 
extracted, bacterial sweep samples collected. 
All samples transported to Roslin Additional E. coli were obtained 
from the hospital in Lusaka  
Wet lab molecular work; Genotyping 
Whole Genome sequencing  
Samples preparation for sequencing 
(DNA re- extraction and quantification) 
Pilot study 
Analysis (focused on antibiotic resistance and Shiga toxins) 
Epidemiological analysis 
(results chapter 3) 
Bioinformatics 
analysis of resistance 
genes (results chapter 4) 
Bioinformatics and molecular analysis of 





Figure 2.3. Map of Zambia depicting the districts where the study area was carried out. 
The following districts were included in the study Kabwe, Chibombo, Chongwe, 
Kafue, Lusaka and Mazabuka. (This map was generated for this study in ArcGIS 




2.1.4 Faecal sampling from cattle 
A list of farms in the area (sampling frame) was prepared with the help of the District 
Veterinary Officers (DVOs) and the management at MCCs. The herds were then 
classified according to farming type; i) small - 1-20 cattle per herd, ii) medium - > 20 
cattle per herd and iii) commercial units; as well as by district; i) Kabwe, ii) Chibombo, 
iii) Lusaka, iv) Kafue, v) Chongwe and vi) Mazabuka). The classification of the 
different farming types took into account the different levels of on farm development 
and the entrepreneurship of the farm. The medium and commercial farms were focused 
on dairy farming as a business activity, whereas the milk from the small-scale farms 
was mostly for home consumption with the surplus sold. Medium-sized farms had well 
defined farm entrepreneurship and management systems but they were less developed 
when compared to the commercial farms. Commercial farmers also took extra care of 
their animals, in order to enhance the milk production. For example, they provided 
sheds to protect the animals from direct sunshine (Figure 2.4 (A)), as high temperatures 
are a cause of stress for the animals. 
Sample size calculation. The findings from the pilot study were used to estimate the 
parameters for calculating the sample size of the main study. A web-based sample size 
calculator using Epitools-Ausvet® (Humphry et al., 2004) was used with the following 
assumptions: sampling 1 animal per farm; 10% of animals have antibiotic resistance 
isolates of E. coli; a perfect test; a 5% level of precision; and 95% level of confidence. 
A sample size of 110 farms was calculated, however, to capture more of the variation 
it was decided to sample a minimum of 3 animals per epidemiological unit (defined as 
a number of animals managed as a group) on each farm; these were randomly selected 
without replacement from a list of animals using random number tables. The herds 
were sampled proportionally to size in each of the three farming types (i.e small, 
medium and commercial scales) and then proportionally to the geographic distribution 
based on the government administrative boundaries to ensure a good geographical 
spread. Seventy-five per cent of herds were small, 20% were medium and 5% 
commercial. Thus a stratified, multistage random sampling of cattle with unequal 




calculating the sample size were the cost of the study, the time frame in which the 
study was to be completed and the distance to the laboratory. 
Faecal samples were collected rectally from the cattle involved in the study. The herds 
were restrained in crush pens (Figure 2.4 (B and D)) and the animals were numbered 
sequentially (i.e., the first animal in the crush pen was numbered as 1, the second one 
as 2 and so on). Random number tables were then used to randomly select the animals 
for sampling. At the end a total of 376 dairy cattle from 104 farms were randomly 
sampled for this study. The additional information on sampling design and procedures 
are in the sampling protocol Appendix 1 and in the results chapter 3.  
In this study design, it is noteworthy that uniform number of animals with minimal 
variations were sampled across the farms without adjustments according to herd sizes 
because of the cost implications. However, this strategy could have caused a bias on 
actual proportions of positive samples for AMR among the studied herds. However, 
this was the most suitable study design that could be used with the budget that was 
available to cover a wide geographical area in order to estimate the prevalence of AMR 
in dairy herds of Zambia. Other possible considerations for the future studies in order 
to increase the robustness of the study are indeed adjusting the collection of samples 
in accordance to the number of animals per unit and/or collection of pooled samples 















Figure 2.4. Pictures highlighting the field study. Data collection at a commercial farm 
from a farm manager using a questionnaire (A). Preparing to collect faecal samples 
from dairy cattle at a commercial farm (B). Officers working for Magoye Smallholder 
Dairy Farmers Cooperative at a Milk Collection Centre after coming from sample 











2.1.5 Data collection using questionnaires 
A questionnaire was designed to collect information from farmers about the use of 
antibiotics on the farms and the animal sampling form was used to collect information 
about the animals that were being sampled. The questionnaire mostly required the 
respondent to answer only “yes” or “no”. Some key information that was solicited 
through the questionnaire was on the drivers for the use of antibiotics, most used 
antibiotics and modes of administration, source of antibiotics, how the farmers stored 
the antibiotics, whether they checked for the expiry dates before use and whether they 
used antibiotics in consultation with veterinarians. The following details were recorded 
for each animal on the sampling form: animal ID, lactation status, breed, sex, age, and 
health status, whether or not it was born on the farm or sourced from another farm and 
whether it had received antibiotic treatment in the twelve months prior to the study 
period. The full questionnaire is presented in Appendix 2 and the animal sampling 
form as Appendix 3. The section below is an outline of the process that was used to 
develop the questionnaire for this study. 
2.1.6 Development of the questionnaire 
The development of the questionnaire was carried out using a systematic approach 
based on the core subject and the following steps were followed: 
Identification of the goal of the research. The goal of this research was identified as 
a survey of the use of antibiotics in dairy cattle in a targeted area of Zambia, assessing 
the existing impact of antibiotic use in terms of AMR in enteric E. coli and to explore 
any relationship with AMR in the human population within the study area. Based on 
this goal, the questionnaire was developed to target the people who were responsible 
for administration of antibiotics to the animals, mostly the managers or the farm 
owners (Daalen et al., 2016). In this case a questionnaire was considered the best 




Choosing the types of questions for the questionnaire. For the purpose of simplicity, 
the type of questions to be included in the questionnaire were to be dichotomous 
(yes/no), multiple choice type of questions consisting of up to five choices from which 
a respondent could choose an answer or the open ended type of question where the 
respondent could freely respond (Payne, 2014). The open ended questions were meant 
to provide data on the ‘why’ questions. The questionnaire was designed to be 
administered and answered within 30 minutes. 
Development of questions. The questions were developed systematically starting 
with the introduction in order to identify the respondents and the farms and then 
progressed into the core questions on antibiotic use and the drivers for this. The last 
part was to gather other information on the management of the farms. In order to solicit 
for the clear, concise and direct answers the questions were designed in the simplest 
form and as brief as possible (Kandrotaite et al., 2013). Only one question was to be 
asked per sentence in order to avoid confusing the respondents. The questions were 
designed without compromising the privacy of the respondents, however, some 
sensitive information such as the age and educational levels were obtained from the 
respondents. The respondents were given an option to choose “not known “or “not 
applicable” in cases where they did not know the answer to the question.  
Decision on the nature of questions and identification of the target group. The 
idea was to restrict the size of the questionnaire, but ensure we could capture all 
necessary data for the study (Kandrotaite et al., 2013). Caution was taken to avoid 
redundant questions. The target group was identified as the people who actually 
manage the dairy herds in the study. During the pilot study it was established that the 
herds were managed either by a person designated as the manager or the farm owner. 
These were the people that were responsible for administration of antibiotics and other 
medications. The questionnaire would be administered to either male or female 
individuals of 18 years old and above in the capacity of manager or farm owner and 





Protection of privacy and explanation of the incentives for the respondents. 
Although it was necessary to identify the respondents and the farms that they managed, 
it was envisaged to destroy the questionnaires at the end of the study and to keep 
electronic records with unique numbers. A brief explanation of the possible benefits 
of the study to the farmers was provided. This study was going to help policy 
formulation for the prudence use of antibiotics. That in turn would help to prevent and 
control the emergence of AMR in infectious pathogens of both animals and humans. 
Introduction part of the questionnaire. The questionnaire was designed to have an 
emblem of the Roslin Institute, University of Edinburgh, the Commonwealth and the 
Government of the Republic of Zambia. This was done to show the respondents the 
different sponsors of the study at the beginning of the interview. In addition, the 
questionnaire would be introduced verbally as the instrument that was used in the study 
on the antibiotic use and AMR in dairy herds of Zambia, as part of my (Geoffrey 
Mainda) doctoral study registered at the University of Edinburgh, in the UK, sponsored 
by the Commonwealth commission. Within the introductory remarks, the respondents 
would be informed that the data was purely for academic purposes. In cases where the 
data would be published, only generalised information would be used and not specific 
responses and farms details. 
Apart from the overall introduction of the questionnaire, each section was introduced 
with a brief explanation on the kind of information that was being solicited.  
Professionalism of the questions. Consent would be obtained from the respondents 
before the administration of the questionnaire. The respondents would be informed 
that even though confidentiality was going to be upheld, other people not necessarily 
involved in the study would see the data, either as raw data or in form of published 
data. However, the questions would be designed in a professional manner (Kandrotaite 
et al., 2013). 
Testing of the questionnaire through a pilot study. The questionnaire was tested 




of the questionnaire the respondents were asked how they found the questions. A note 
was taken where the questions were difficult to understand and the time taken to 
administer the questionnaire. Other useful information was obtained including a list of 
the commonly used antibiotics: tetracycline, penicillin and trimethoprim sulphate. At 
the end of the pilot study the questionnaire was edited to comply with the uncertainties 
that were identified. 
Administration of the questionnaire in the main study. After the pilot study, the 
questionnaire was amended appropriately in readiness for the main field study. The 
administration of the questionnaire would be by face-to-face interview with the 
respondents. This was to ensure that the questionnaire was administered to the right 
demographic group and that the respondents would provide answers to most of the 
questions and the missing data would be minimal (Broom et al., 2016). The four 
research assistants were to be trained at the same time in order to help administer the 
questionnaires to the respondents. 
2.2 Laboratory based studies  
2.2.1 Isolation of E. coli from faecal samples  
The fresh faecal samples were kept cool and transported to the laboratory within 48 
hours. Then 10 g of each faecal sample was suspended in 90 mL of Buffered Peptone 
Water (BPW) and incubated at 37oC for 16 to 18 hours. The enrichments were then 
sub cultured on Lactose MacConkey agar (Oxoid, UK) at 37oC for 16 to 18 hours. The 
pink colonies of 2-3 mm diameter from MacConkey agar plates were taken as 
presumptive E. coli and were sub-cultured on a selective medium, Tryptone Bile-X-
Glucuronide (TBX) agar (Oxoid, UK) at 37oC for 16 to 18 hours. Blue colonies on 
TBX agar were presumptively designated as E. coli. The TBX medium uses a 
chromogenic substrate to indicate E. coli by the presence of β-D-glucuronidase. β-D-
glucuronidase is present in 95% of E. coli strains. However, it is also present in some 
Enterobacteriaceae such as Salmonella, Shigella and Yersinia. Presumptive E. coli 




E. coli isolates were sub-cultured on blood agar (Oxoid, UK) and incubated for 16 to 
18 hours (overnight) at 37oC before they were tested for antibiotic resistance and stored 
in 15% (v/v) Glycerol in tryptone soya broth at -20oC (refer to section 2.2.4 for the 
details on the preservation of E. coli isolates). The detailed E. coli isolation procedure 
is given in the published paper in chapter 3 and the sampling and laboratory protocol 
in Appendix 1. 
As a separate screening test, Sorbitol MacConkey agar (SMAC) was used as a 
selection medium to look for E. coli O157 in samples as this is generally a non-sorbitol 
fermenting E. coli, whereas most other E. coli and Enterobacteriaceae ferment sorbitol. 
The enrichments were spread with a sterile swab onto Sorbitol MacConkey agar 
(SMAC), (Oxoid, UK) and were incubated for 16 to 18 hours (overnight) at 37oC. Any 
colourless colonies were subjected to an antisera agglutination test that was specific 
for E. coli O157.  
2.2.2 Agglutination test for E. coli O157 
This is a rapid test for the detection of serotype E. coli O157 by mixing a bacterial 
suspension with latex particles (Oxoid, UK) coated with specific rabbit antibodies that 
are reactive with the E. coli O157 lipopolysaccharide (LPS) antigen (March and 
Ratnam, 1989). A positive reaction is indicated by agglutination of the suspension and 
the kit includes positive control reagent (with antigen of E. coli O157) that provides 
positive reaction with the test latex (Figure 2.5). A negative control (suspension of E. 
coli O116) reagent is also supplied as well as pre-immune rabbit globulins to confirm 
agglutination is specific to the test antigen. The test was carried out on all E. coli 
isolates that did not ferment Sorbitol MacConkey (Oxoid, UK) (March and Ratnam, 
1986). Briefly, the E. coli isolates were emulsified in a drop of saline on a test card 
(Figure 2.5) and mixed with a drop of test latex-antibody. The slide was then rocked 
for a minute and observed for agglutination. If the mixture of reagents on a slide 
agglutinated then the test was positive, otherwise it was regarded as a negative result. 





Figure 2.5. Serology test kit for E. coli O157. The Test Latex (yellow top) consists of 
the blue latex particles that are coated with specific rabbit antibody to E. coli O157 
LPS. The Control Latex (blue top) consists of blue particles with pre-immune rabbit 
globulins. Positive control suspension cells (red top) consists of a suspension of E. coli 
O157 cells that gives a positive reaction with the Test Latex. Negative control 
suspension (green top) consists of E. coli O116 cells in a buffer. 
2.2.3 Antimicrobial resistance testing of E. coli isolates 
The antibiotic resistance testing for six different classes of antibiotics used the Kirby-
Bauer disc diffusion method (Bauer et al., 1966). The disc diffusion test is a test for 
antibiotic resistance in bacteria where an antibiotic disc is put on a lawn of a bacterial 
isolate cultured on a solid agar media and incubated at 37oC for 16–18 hours. If the 
bacteria are susceptible to the antibiotic, a clear zone with no growth of bacteria forms 
around the disc of the antibiotic to a distance that reflects both antibiotic diffusion into 
the agar and relative sensitivity of the strain. On the other hand, if the bacteria are 





The antibiotics tested for resistance were selected based on the data that were collected 
during the pilot study. Based on the data from the pilot study, tetracyclines, penicillins 
and sulphonamides were the most used antibiotics in dairy herds. Aminoglycosides, 
cephalosporins and fluoroquinolones were regarded as important antibiotics in the 
treatment of human infections. Thus the following antibiotics were used to test for the 
prevalence of antibiotic resistance for the 371 E. coli that were isolated from faecal 
samples of dairy cattle in the study: tetracycline, ampicillin, gentamicin, ciprofloxacin, 
cefpodoxime and trimethoprim/sulfamethoxazole. The detailed antibiotic testing is 
outlined in chapter 3 and Appendix 1. Most of the E. coli isolates that were resistant 
to at least one antibiotic were then confirmed using the minimal inhibitory 
concentration (MIC) E-strip method (Mushtaq et al., 2010). The MIC is one of the 
methods used to test for antibiotic resistance in bacteria and measures the minimum 
concentration of the antibiotic in microgram per millilitre (µg/mL) that is required to 
inhibit the growth of a particular isolate. This method gives more quantitative results, 
whereas the disc diffusion test really only provides information on the presence or 
absence of resistance.  
2.2.4 Preservation of E. coli isolates 
E. coli isolates were frozen with 15% (v/v) Glycerol for later use. The Glycerol broth 
was prepared using 30 g Tryptone Soya Broth (TSB) powder and mixed with 850 mL 
distilled water (i.e. 85% H₂O). After fully dissolving it, 150 mL of Glycerol was added 
and mixed thoroughly. The broth was then dispensed into 20 mL tubes and autoclaved 
at 121°C for 15 min. The bacterial isolates were inoculated and frozen at -20°C in 
Lusaka, Zambia. Following import permission, the isolates were shipped in this 
medium at room temperature to the UK, where they are now stored at -70 oC. 
2.2.5 DNA extraction and quantification 
DNA was extracted from both single bacterial colonies as well as from sweeps of the 
primary enriched cultures. The single colonies were obtained after the E. coli were 




(section 2.2.1). The sweeps were obtained from the non-selective medium when an 
enriched sample was inoculated onto MacConkey agar and then incubated at 37⁰C for 
16 to 18 hours. Each sweep was composed of 1–3 faecal samples. A sterile swab was 
then used to sweep the different types of bacteria that were growing on the non-
selective plate media. DNA was then extracted from this sweep. While the sweeps 
have not yet been sequenced or fully analysed for this thesis, they are now available 
for deep sequencing for future projects to assess the wider diversity of enteric bacteria 
present and detect virulence of AMR genes at the animal level without pre selection 
of just one or more single clonal isolates. 
A single colony or sweep were inoculated into 5 mL of Luria Bertani (LB) broth and 
incubated for 16–18 hours (overnight). One mL of bacterial suspension was subject to 
DNA extraction as per the Wizard Genomic DNA Extraction Kit® or the Qiagen DNA 
Extraction Kit®. Genomic DNA was extracted from a total of 69 sweep samples (60% 
(62/104) of the farms), 371 E. coli isolates from 371 faecal samples of individual 
animals and 79 E. coli isolates from humans.  
The concentration of DNA was assessed and standardised in preparation for Whole 
Genome Sequencing (WGS) as per a laboratory procedure. Briefly, the NanoDrop® 
was calibrated to zero and then 2 µL of DNA was added. The absorbance reading was 
taken in the form of DNA concentration (ng/µL). The integrity of the DNA was also 
visually analysed following agarose gel electrophoresis (refer to section 2.2.8). 
2.2.6 Molecular typing of E. coli isolates 
2.2.6.1 Phylogenotypying of E. coli 
E. coli have been classified into four major phylogroups (A, B1, B2 and D) based on 
the presence and combination of two conserved genes (chuaA and yjaA) and the DNA 
fragment TSPE4.C2 (Clermont et al., 2000). Knowledge of the E. coli phylogroups 
helps to understand the characteristics of E. coli strains as they can differ in ecological 




commensal bacteria, whereas groups B2 and D are more likely to be associated with 
pathogenic E. coli.  
In this study, the bovine strains were phylogenotyped using a published multiplex PCR 
primers with minor modifications (Table 2.1) (Clermont et al., 2000; Doumith et al., 
2012). The amplification was carried out using PCR Express (Thermo Hybaid, UK), 
in 200 µL tubes (Thermo Scientific, UK) with a reaction mixture of 20 µL in each 
tube. Each reaction contained 10 µL of OneTaq®Quickload® 2x MM w/std Buffer, 
0.1 µL of each primer to a working concentration of 10 µM, 0.5 µL of template DNA 
and made up to the final volume with 9.3 µL of molecular grade water (MiliQ-water). 
The PCR conditions were 94⁰C for 4 min; 30 cycles of 94⁰C for 30 seconds, 72⁰C for 
30 seconds; with a final extension of 72⁰C for 5 minutes. The PCR products were 
visualised and images captured using multi imaging software (Fluorchem HD2) 
following electrophoresis in 1.5% w/v agarose gel (Agarose, Melford, UK) and 
staining with Gelred®.  
Table 2.1 Primers for phylogenotyping 
Name Primer sequence (5' - 3') Product size 
(bp) 
gadA Forward GATGAAATGGCGTTGGCGCAAG 373 
Reverse GGCGGAAGTCCCAGACGATATCC 
chuA Forward ATGATCATCGCGGCGTGCTG 281 
Reverse AAACGCGCTCGCGCCTAAT 
yjaA Forward TGTTCGCGATCTTGAAAGCAAACGT 216 
Reverse ACCTGTGACAAACCGCCCTCA 





2.2.6.2 Multiplex PCR for Shiga toxins 
The bovine strains were screened using a published multiplex PCR for Shiga toxin 
genes with minor modifications (Table 2.2) (Paton and Paton, 1998). The amplification 
was carried out using PCR Express (Thermo Hybaid, UK), in 200 µL tubes (Thermo 
Scientific, UK) and contained a reaction mixture of 20 µL in each tube. Each reaction 
contained 10 µL of OneTaq®Quickload® 2x MM w/std Buffer, 0.1 µL of each primer 
to a working concentration of 10 µM, 0.5 µL of template DNA and made up to the 
final volume with 9.3 µL of molecular grade water (MiliQ-water). The PCR conditions 
were; stage I, 1 cycle at 95⁰C for 2 min ; stage II, 30 cycles of 95⁰C for 30 seconds, 
50⁰C for 30 seconds; 72⁰C for 1 minutes; stage III with a final extension of 72⁰C for 
1 minutes and the PCR products were held at 4⁰C. The PCR products were separated 
by electrophoresis in 1.5% w/v agarose gel (Agarose, Melford, UK), stained with 
Gelred® (refer to section 2.6.4), and visualised using multi imaging software 
(Fluorchem HD2). 
Table 2.2 Primers for Shiga toxins PCR 
Name Primer sequence (5' - 3') Product size (bp) 
stx1 Forward ATAAATCGCCATTCGTTGACTAC 180 
Reverse AGAACGCCCACTGAGATCATC 
stx2 Forward GGCACTGTCTGAAACTGCTCC 255 
Reverse TCGCCAGTTATCTGACATTCTG 
rfbO157 Forward CGGACATCCATGTGATATGGAAC 320 
Reverse TTGCCTATGTACAGCTAATCCTTGG 






2.2.7 PCR for genes indicative of enteroaggregative E.coli 
(aggR, aap)  
The E. coli isolates from dairy cattle were all tested by a published multiplex PCR for 
specific alleles associated with enteroaggregative E. coli with minor modifications 
(Table 2.3) (Cerna et al., 2003). The amplification was carried out using PCR Express 
(Thermo Hybaid, UK), in a 200 µL tubes (Thermo Scientific, UK) with a reaction 
mixture of 20 µL in each tube. Each reaction contained 10 µL of OneTaq®Quickload® 
2x MM w/std Buffer, 0.1 µL of each primer to a working concentration of 10 µM, 0.5 
µL of template DNA and made up to the final volume with 9.3 µL of molecular grade 
water (MiliQ-water). The PCR thermo cycler conditions were 50⁰C (2 min, 1 cycle); 
95⁰C (5 min, 1 cycle); 95⁰C, 55⁰C and 72⁰C (45 seconds at each temperature, 40 
cycles); and a final extension step of 10 minutes at 72⁰C. The PCR products were 
analysed as described above. 
Table 2.3 Primers for PCR to detect genes typical of enteroaggregative E. coli 
Name Primer sequence (5' - 3') Product size (bp) 
AA probe Forward CTG GCC AAA GAC TGT ATC AT  629 
Reverse CAA TGT ATA GAA ATC CGC TGT T 
aggR Forward CTA ATT GTA CAA TCG ATG TA 457 
Reverse AGA GTC CAT CTC TTT GAT AAG 
 
2.2.8 Agarose gel electrophoresis 
DNA was loaded into 1% w/v agarose gels (Agarose, Melford, UK) in TAE buffer 
(Tris-acetate-EDTA) (1 g of agarose powder /100mL of TAE buffer). The Gelred® 




Invitrogen) loading buffer and the 1kb or 100 bp size markers (Promega) were used 
on the agarose gel. The samples were separated at 120 V for 60 min in TAE buffer and 
the images were taken using multi imaging software (Fluorchem HD2) using a UV 
gel-documentation system fitted on a Dell® computer. 
2.2.9 Lysate supernatant preparations  
In this study, single colonies were selected from LB agar plates and suspended in 10 
mL of LB broth for 24 h at 37oC non shaking (overnight). 50 µL of overnight culture 
was added to 5 mL (1:100) of fresh LB broth and incubated for 60 min. Then 20 µL 
of 5 µg/mL mitomycin C (MMC) was added to induce prophages followed by 
overnight incubation in tubes that were covered with aluminium foil to reduce 
exposure to light as this inactivates MMC. The cultures were then centrifuged at 14000 
rpm for 5 min. The supernatants were filtered using a Millipore Express®PES 
membrane (0.22 µm filter unit) and collected as supernatant samples to be tested for 
Shiga toxin content and activity. The presence or absence of Shiga toxins was by 
ELISA assay (section 2.6.6). Cytotoxic effects of supernatants on Vero cells were also 
tested (section 2.2.11). Supernatants from non MMC-induced cultures were collected 
in a similar manner for testing.  
2.2.10 Shiga toxin ELISA  
The STEC samples in this study were verified for the presence or absence of the toxins 
using a commercial ELISA kit (RIDASCREEN® Verotoxin ELISA (C2201), R-
Biopharm AG, Darmstad, Germany), in accordance with the manufacturer’s 
instructions. Briefly, the microplate was allowed to stand at room temperature (20-
25oC) for 30 minutes before starting the experiment. The wash buffer provided in the 
kit was aliquoted and diluted in molecular grade water (1:10). The sample supernatants 
were used without any dilutions. The positive control Shiga toxin was provided within 




The micro well strips were put in a frame and 100 µL of the sample, positive control 
or the negative were added to a specific well and incubated for 1 hour at 20-25oC. The 
wells were washed five times with 300 µL of wash buffer. Then 100 µL of conjugate 
was added to each well followed by an incubation period of 30 minutes at 20-25oC. 
The wells were again washed five times with 300 µL of wash buffer followed by the 
addition of the substrate and incubation at 20-25oC for 15 minutes. 
Finally 50 µL of stop reagent was added to the well and photometric measurements 
were at OD590nm in an ELISA plate reader machine (FLUOstar OPTIMA®). 
2.2.11 Vero cells assays 
Vero (green monkey kidney) cells were from laboratory stocks (Laboratory of 
Zoonotic and Animal Pathogens, Roslin). The cells were recovered in 5 mL of RPMI® 
cell medium. About 1 x 105 cells were inoculated in a flask containing 25 mL of 
RPMI® and incubated at 37oC and 5% CO2 until the cells were semi-confluent.  
Briefly, the cells were trypsinised (trypExpress, trypsin 1X) and split following a 
centrifugation of 5 minutes at 1200 revolution per minute (rpm). 100 µL of medium 
containing about 1.5 x 104 Vero cells were seeded on the 96 well plate and incubated 
at 37oC and 5% CO2 for 24 hours (overnight) for the cells to adhere to the walls of the 
plate. Following this incubation media was carefully removed using an Integra 
Vacusafe® and then washed with 100 µL of serum free medium (basic media).  
The supernatants (section 2.2.9) were diluted with basic medium (1:100). Then 100 
µL of the diluted toxin was added to each well and the plate was incubated at 37oC and 
5% CO2 for 72 hours. Both undiluted and diluted (with LB in 1: 100) basic RPMI® 
medium was used as negative controls, while Triton-x 100 (0.2% v/v) was used as a 
positive control. The diluted supernatants were then carefully removed and the wells 
washed with 100 µL PBS. The cells were fixed in the wells with 65 µL of 2% (v/v) 
formalin in PBS after the incubation period of 1 minute. The cells were stained with 
65 µL/well of crystal violet stain and incubated at room temperature for 24 hours 




Images were taken using a scanner (EPSON scan®), then the dye in the 96 well plates 
was released by addition of 10% acetic acid and the absorbance readings taken at 590 
nm in an ELISA plate reader (FLUOstar OPTIMA®). The rationale is that at the time 
of fixing the cells, the cells that are non-viable would retain little stain compared to 
live cells.  
2.2.12 Western blotting for Shiga toxins 
Western blotting (protein immunoblotting) is used for detection of proteins in a 
sample, following separation of protein by gel electrophoresis (Mahmood and Yang, 
2012). In this study Western blotting was used to detect Shiga toxins in STEC isolate 
supernatants as per a laboratory tailored protocol.  
Briefly, the supernatant samples (section 2.2.9) were mixed (1:1) with loading buffer 
and then incubated at 95oC for 5 minutes. The samples were then loaded onto precast 
sodium dodecyl sodium polyacrylamide gel immersed in the running buffer (25mM 
Tris, 192mM glycine, 20% (v/v) methanol pH 8.3) and mounted in the electrophoretic 
apparatus. The gel was run at 150 volts for 60 minutes. The protein molecules were 
separated during this electrophoresis technique. The separated molecules were then 
transferred (blotted) onto nitrocellulose membrane (Hybond ECL) (The gel and the 
nitrocellulose membrane were embedded in 2 filters and a sponge on either side) 
electro-transfer using a submerged system or trans blotted. Following this, 
nitrocellulose membranes were blocked to avoid binding of non-specific proteins in 
1% (w/v) skimmed milk powder (Sigma, Marvel) in phosphate buffered saline (PBS) 
at 4 °C for at least 16 h (overnight). The membranes were washed three times in 0.1% 
(v/v) PBS for 5 minutes intervals at 20°C - 25°C (room temperature), on a rocker. The 
membranes were subsequently immersed in 20 mL of 1% milk (w/v) in PBS (blocking 
buffer) and primary antibodies (mouse monoclonal) added at the dilution of 1:20 
straight into the blocking buffer and incubated for 1 hour at 20 to 25°C (room 
temperature) (Table 2.4). The membranes were then washed again three times in 0.1% 




The membranes were immersed in blocking buffer and 10 µL of secondary antibodies 
(anti mouse) that formed a dilution of 1:200 and incubated for 1 hour on a rocker 
(Table 2.4). The membranes were then washed three times in 0.1% (v/v) PBS for 5 
min intervals at 20°C to 25°C (room temperature) and processed by first immersing 
them in chemi-luminescence (enhanced chemi-luminescence (ECL) solution A 
(2.5mM luminol (Fluka), 400µM p-Coumaric acid (Sigma) in 100mM Tris-HCl pH 
8.5) and ECL solution B (0.2% (v/v) H2O2 in 100mM Tris-HCl pH 8.5) and incubated 
for 5 minutes at 20 to 25°C (room temperature) on a rocker. 
The final blots were then sealed into a radiology cassette and exposed onto chemi-
luminescence film (Amersham, GE Healthcare). The exposed film was automatically 
developed (Kodak). 
Table 2.4. Antibodies used in this study 
Antibodies Details Company Dilution 
Anti Shiga toxin 2 Primary, monoclonal mouse IgG Hycult®biotech 1:1000 
Anti-mouse  Secondary, anti-mouse Cell signalling  1: 2000 
2.2.13 Detection of type 1 fimbriae 
Fimbriae are filament-like structures on the surface of bacteria and are used to attach 
to other bacteria, host cells and/or to form biofilms on surfaces. They can be important 
virulence factors of bacteria (Connell et al., 2000). This method was for detection of 
type 1 fimbriae which adhere to -D mannose residues. A standard phenotypic test for 
type 1 fimbriae is to examine agglutination of yeast cells by the bacteria in the presence 
and absence of added mannose (3% w/v). Isolates to be tested were streaked onto to 
MacConkey agar plates for single colony isolations. The plates were incubated for 16 




mL universal tubes and incubated for 16 -18 hours at 37⁰C on a shaker, 220 rpm. 
Following this incubation, the cultures were diluted (1:100) into 2 mL of LB in 5 mL 
culture tubes and were then incubated statically in pairs, one set was put at 37⁰C for 
24 hours and another set was put at 20⁰C for 48 hours to examine temperature-
dependent expression. Then 0.25 g of yeast was weighed and added to 15 mL of PBS. 
The yeast was mixed gently by vortexing and was stored in the fridge until use. The 
yeast suspension plus mannose was prepared in the same way by first suspending 0.25 
g of yeast in PBS and then added 0.45 g of mannose to the suspension. The equal 
volumes (20 µL) of the bacterial sample and the yeast/mannose suspension were mixed 
in the flat bottom 96 well plate. The mixtures were observed for any agglutination 
(positive reaction) over a dark surface. 
2.3. Bioinformatics and other computer based studies 
2.3.1 Quality control (QC) of sequence data 
The details of bioinformatic methodologies that were used in this study are in the paper 
embedded in chapter 5. Briefly, sequence data were received in fastq file format from 
the Miseq Illumina sequencing platform. A total of 224 genomes of E. coli isolates 
from cattle and 79 genomes of the E. coli isolates from humans were presented as 
paired-end reads with the range of lengths from 32 to 251 bp available for analysis. 
The reads were checked for quality control (QC) using the software FASTQC 
(Bioinformatics, 2011) and when necessary the trimming was done with cutadatp 
(Martin, 2011). 
2.3.2 Assembly of raw sequence reads 
Sequence assembly is a bioinformatics technique that is used to reconstruct genome 
fragments from short read sequencing. Two methods were used to assemble the 
sequence reads: 1) Assembly using a reference genome; 2) Assembly without using a 
reference genome (de novo assembly). In this study, the raw reads were de novo 




the merging and alignment of pieces of overlapping short DNA sequences (reads) 
without a reference genome in order to reconstruct the original genome or contgous 
fragments (contigs) thereof. The algorithm compares each read with every other read. 
The output are fasta format sequence file types that are used in the downstream 
analysis. The whole genome sequences were then annotated using PROKKA software 
in order to produce several different files with different types of genetic information 
that could be used in the downstream analyses (Seemann, 2014). The genome 
annotation is the process of locating and identifying encoding sequences in the genome 
and predicting the function at the encoded products through comparison with available 
database information. 
2.3.3 Identification of resistance genes and sequence types 
from sequence data 
The website for the Centre for Genomic Epidemiology hosts a number of 
bioinformatics tools for characterising bacterial genomes. Some of the tools on this 
website are ‘ResFinder’ for detection of resistance genes and ‘VirulenceFinder’ for 
detection of different types of bacterial virulence factors.  
ResFinder 2.1 is a web-based bioinformatics tool and was used to identify resistance 
genes in the E. coli genomes sequenced in this study. The conditions were set to 
identify the genome as E. coli on an identity threshold of 98% and minimum length of 
60% (Zankari et al., 2012a). One fasta sequence file was uploaded at a time and 
submitted for the detection of resistance genes. In a similar way one fasta file at a time 
was uploaded into the web based Multilocus Sequence Type (MLST) 1.8 scheme. The 
web based software for detection of resistance genes is more suitable to small studies 
with a few genomes. In order to be able to analyse about 300 genomes for this study 
Short Read Sequence Type 2 (SRST2) was used in Linux environment. It uses a similar 
database like the ResFinder but with a high process power (Inouye et al., 2014). 




2.3.4 Detection of Shiga toxin genes from sequence data  
Virulence genes were detected in a similar way as resistance genes, this time using 
VirulenceFinder 1.5, which is a web-based bioinformatics tool that is used to detect 
different virulence determinants in bacteria. The identity threshold for E. coli was set 
to 90% and minimum length of 60% (Zankari et al., 2012a). The main focus for this 
study was detection of Shiga toxin genes for which one fasta sequence was uploaded 
at a time and submitted. In order to allow the processing of large number of sequences, 
BLAST+ was used. BLAST + works in Linux environment and was used in order to 
automate the detection of Shiga toxins within the isolates (Camacho et al., 2009). A 
sequence database was created using BLAST+ for each individual isolate including 
the references, using the fasta files obtained from prior sequence assembly. Reference 
genome sequences were obtained from NCBI in order to serve as controls (Accession 
numbers: Sakai NC_002695, EDL 933 CP 008957, EC4115 NC_011353, TW14359 
NC_013008 and some unpublished sequences from the laboratory of Zoonotic and 
Animal Pathogens). Further details are outlined in chapter 5. (Assistance for use of 
software was provided by Sharif Shaaban, The Roslin Institute) 
A multi-FASTA file (the query file) containing published set of Shiga toxin genes 
nucleotide sequences was created and used to BLAST search against each database 
(Scheutz et al., 2012). In order to dismiss high scoring hits among the highly identical 
Shiga toxin subtypes, filtering was done in order to retain only those with a bit score 
of above 1000, subsequently only the highest score was kept if there were multiple hits 
on the same contiguous sequence (contig).  
2.3.5 Single nucleotide polymorphism (SNP) analysis 
A SNP is a variation in the type of a single nucleotide at a specific position of the 
genome for individuals in a population (Clermont et al., 2015). SNPs can have 
biological consequences for the organisms, for example within a species of bacteria 
similar resistance gene may be present, but resistance phenotypes maybe more 




detailed methodology for the SNP calling and the read alignment are outlined in 
chapter 5. Briefly, the E. coli O157:H7 str. Sakai (RefSeq assembly accession: 
GCF_000008865) was used as reference strain and a combination of the following 
software was used: BWA, SAMtools and SnpEff (Li and Durbin, 2010; Li et al., 2009). 
The consensus sequence for each alignment of the length 5,590,092 bp was produced 
using the majority rule (taking the most common single nucleotide at a particular 
position). The consensus sequence is the sequence for each genome that is produced 
after an alignment of genomes to the reference and determining the presence or 
absence of a particular nucleotide (Cytosine (C), Guanine (G), Thymine (T) and 
Adenine (A)) at a particular position. Consensus sequences for each alignment were 
concatenated into one multifasta file. Multifasta files of concatenated core nucleotides 
for each strain were used in phylogenetic analysis based on the core SNPs present. 
The Shiga toxin gene types (1 or 2) from the isolates together with the reference 
sequences were separately aligned in ClustalW version 2.0, according to the toxin type 
(Larkin et al., 2007). In cases where sequences were in the opposite direction, they 
were re-oriented using the reverse complement tool from the EMBOSS package and 
then the alignment was repeated (Rice et al., 2000). 
2.3.6 Translation of Shiga toxin gene sequences to amino 
acids 
The Shiga toxin sequences were translated using the translation tool from the 
EMBOSS package. The result was a multi-FASTA amino acid file containing the open 
reading frames (ORF) for each Shiga toxin gene sequence. An amino acid sequence 
database was created for each of the multi-FASTA amino acid files (protein sequences 
that were made from the stx genes from Zambian STEC), using BLAST. Two multi-
FASTA amino acid files (query files) were created. One containing reference Shiga 
toxin proteins for subunit A and the other for subunit B. These were BLAST 
searched/against each of the protein databases that were made from the Zambian 
STEC. Using the Linux environment all BLAST hits with a bit score below 20, or a 




kept if multiple hits were present within the same reading frame. Using the coordinates 
of the best scoring hits, amino acid sequences were obtained for all Shiga toxin 
subunits in the genomes analysed. 
In the further analysis subunit sequences (A and B) were concatenated based on their 
respective isolate original numbers. From this point onward analysis were conducted 
based on separate datasets looking at Shiga toxin 1 or Shiga toxin 2. As previously, a 
preliminary alignment was conducted using ClustalW2, and sequences were oriented 
in the same direction based on the results (once more reference protein sequences for 
Shiga toxin were included in the alignments). A second alignment was conducted 
using ClustalW2 and the result was formatted into PHYLIP/Phylip format using the 
same Python script as previously. Two trees were made using RAxML (raxmlHPC-
PTHREADS-SSE3) under GAMMA model of heterogeneity with 1000 bootstrap 
(BS). Trees were viewed in using Figtree software.  
2.3.7 Building of phylogenetic trees 
A phylogenetic tree is a branching diagram that is made from the DNA or protein 
sequences of biological species and it shows how the individuals are related to each 
other (Croucher et al., 2014),  refer to Introduction chapter section 1.2.17. In this study, 
the consensus sequence files for each genome were joined together (concatenated) into 
one file (multifasta file). The differences of the nucleotide bases on this files are known 
as core nucleotides SNPs for each strain and these were used to generate a maximum 
likelihood (ML) tree with the software RAxML under a GAMMA model of 
heterogeneity with 1000 bootstrap (BS) (Stamatakis, 2006). The trees were visualised 
in Figtree and ITOL software. 
The ClustalW2 alignment format was converted to a PHYLIP/Phylip alignment format 
using a pipeline script. The alignments were then entered into RAxML (raxmlHPC-
PTHREADS-SSE3) under GAMMA model of heterogeneity with 1000 bootstrap 
(BS). Trees were then viewed using Figtree software (Assistance with this analysis 




2.3.8 Production of maps  
This study involved field work that covered a wide geographical area, so maps are 
used to illustrate the distribution of the farms and spatial analysis of the prevalences 
of antimicrobial resistance and the Shiga toxin-producing E. coli. All the maps were 
generated in ARCGIS 10.2.1 software ARCGIS® (ESRI, ArcGIS desktop: release 10. 
Environmental Systems Research Institute, CA (2011)). The shape files were 
downloaded from Diva gis (http://www.diva-gis.org/gdata) and drawn in ArcMap 
10.2.1 data view for further specific annotations of the map. The maps involving the 
visualisation of the location of the study farms, farm coordinates were projected in the 
map using display XY function within the package. The coordinates for the farms were 
collected using the Global Positioning System (GPS) device (Garmin etrex 10, UK) 
during the field study.  
2.3.9 Statistical analysis 
This section outlines an overview of the statistical analyses that were carried out in 
this study to investigate the significance differences or associations of various factors. 
The analyses were done in R environment. The detailed statistical analysis in chapter 
3 outlines statistical modelling of antimicrobial resistance of E. coli in relation to 
several livestock production factors. The Fisher’s exact test was also used to assess 
associations between various variables. All the variables were assessed for correlation 
using the Spearman rank’s correlation if they were not normally distributed, otherwise 
the Pearson rank correlation statistic was used. Only one variable was used in cases 
where the two variables were highly correlated with a correlation coefficient of more 
than 0.8. The selection of correlated variables was done after including them in the 
model separately and then the one that improved the model fit would be used. 
 The univariate logistic regression analysis was used with the resistant or not resistant 
(resistPN) as a response variable. The independent variables were all the variables that 
were collected through the questionnaire. The independent variables that were 




model. A standard multi-level logistic regression model was used with antibiotic 
resistance status to one or more antibiotics as a binary outcome. The model was 
developed using the standard Hosmer Lemeshaw (Hosmer Jr and Lemeshow, 2004) 
approach where first potential explanatory variables or risk factors were screened and 
any variables with a p-value <0.25 from the Wald statistic were allowed to pass for 
use in a multivariate multi-level model. The clustering effect of variables within the 
model were tested using farm identity as a random effect in lme4 R statistic package 
(Kuznetsova et al., 2013). In Chapter 4, the significant differences in the carriage of 
antibiotic resistance genes between the E. coli populations that were isolated from 
cattle and human were tested using the Wilcoxon rank sum test. Other statistical and 
spatial analysis techniques are described in their respective results chapters 
(Assistance for statistical analysis was provided by Paul Bessell at Roslin Institute).  
2.3.10 Data management 
The data was generated through the questionnaires and laboratory tests that were 
conducted. The questionnaire questions were transformed into variables that were 
entered in Access (Microsoft 2010) database. Then all the questionnaire data and 
diagnostic results from culture and typing were transferred from paper working copies 
to the database. The data on the sales of antibiotics was collated in Excel (Microsoft 
2010) spread sheets from the antibiotic supplier. The data from the database was either 
read directly in R statistical package or transferred to Excel (Microsoft 2010) spread 
sheet. It was then screened using summary tables and univariate plots for missing and 
unexpected values, and where possible these were resolved by referring back to the 
paper records.  
The methodologies described in this chapter and the data that was generated was then 
analysed and is presented as results chapters 3, 4 and 5 followed by the general 




Chapter 3 : Analysis of antibiotic use and 
AMR 
3.1 Introduction 
Zambia has a diverse livestock farming system practises that is depended on the 
economic status of the individual farmers. The small scale traditional dairy farmers are 
geographically located away from the rail line and as such they have difficulties in 
accessing veterinary services that are predominantly along the line of rail. Their low 
economic status makes it difficult to timely purchase veterinary drugs and to respond 
to emergencies of livestock diseases (Mumba et al., 2013). On the other hand the 
medium scale and the commercial farms have good geographical access to the supplier 
of veterinary drugs and they can also afford to buy the medicines (Mumba et al., 2012). 
The dairy industry in Zambia is faced with a challenge of outbreak of livestock 
diseases (Mulemba, 2009; Simuunza et al., 2011; Mumba and Pandey, 2012). This 
problem is compounded with the presence of weak delivery of veterinary services due 
to inadequate infrastructure and skilled labour like in many other developing nations 
(Grace, 2015). This scenario makes the farmers to seek alternative measures in order 
to serve their animals. Some of the measures involves purchasing of antibiotics and 
treating their animals without involving the veterinary professionals (Redding et al., 
2014). This practise has been cited as one of the risk factors for the emergence of AMR 
in the microorganisms in such animals because of under or over dosing of antibiotics 
by the farmers due to the limited knowledge on their use (Duse et al., 2014). 
Generally, the use of antibiotics in human and veterinary clinical settings is linked to 
the emergence and spread of antibiotic resistant bacteria in many parts of the world 
today (Gillings, 2013). The current available information on antibiotic use and 
emergence of antimicrobial resistance is mainly from industrialised countries. 




many developing nations although the data is not properly collated (Grace, 2015, Van 
Den Bogaard and Stobberingh, 2000).  
Studies on the antibiotic use and AMR in developing nations are also necessary 
because diseases that are caused by pathogens that are resistant to antibiotics in both 
livestock and human infections are difficult to treat and can spread to different parts 
of the world (Hendriksen et al., 2013, Lam, 2013). In sub-Saharan African countries 
antibiotics are either abused or underused as a result of economic or geographical 
access limitations to the main suppliers (Van Boeckel et al., 2014). In view of this, the 
WHO have implored the research community to conduct research in different livestock 
production systems and human health sectors in order to gain a deeper understanding 
of antibiotic use and emergence of antibiotic resistance, the developing nations 
inclusive (World Health Organization, 2001). 
This chapter of the thesis provides the findings on the field study that was done in a 
specific area of central Zambia with the following aims: 
1. To investigate antimicrobial usage and drivers for use in dairy herds. 
2. To determine the prevalence and patterns of antimicrobial resistance of enteric 
E. coli from dairy herds in the study area. 
3. To assess the sales of antimicrobials for livestock use in the study area. 
It is the first results chapter because it gives the background information on the types 
of antibiotics that were being used and the drivers for their use. This chapter also sets 
up the scene on the prevailing AMR in the sentinel E.coli organisms as well as the 
patterns of antibiotic resistance in the study area. The subsequent results chapter 4 uses 
the E. coli isolates data from this chapter and investigates the genotypes of resistances. 
Similarly, results chapter 5 uses the E. coli isolates from this chapter (chapter 3) and 
investigates the presence and absence of specific virulence genotypes. Therefore this 
chapter forms the core focus for this PhD study and forms the basis for other chapters 
in the thesis. 
This study involved many people at different stages. However, as required by the 




of this thesis (Geoffrey Mainda). I designed the original PhD study and used it to get 
funding from the Commonwealth Scholarship Commission. The proposed study was 
then moderated and refocussed by the supervisors David Gally, Mark Stevens and 
Mark Bronsvoort to suit the time frame and the available resources. The study was to 
comprise 1) the field data collection from the dairy farmers using the questionnaire as 
well as collection of faecal samples from cattle of central Zambia, the data on the sales 
for antibiotics were collected from the main supplier in the area as well. 2) Extensive 
laboratory work to be done both in Zambia and Roslin in order to study the resistance 
phenotypes of the study model organism (E. coli). 3) The computational molecular 
study at Roslin would study the resistance and virulence genotypes in all the study E. 
coli organisms. 
In view of the above, I designed and developed a questionnaire for data collection from 
the dairy farmers during the pilot study. I carried out a pilot study in Zambia in which 
the questionnaire and the laboratory study methodologies were tested. The amendment 
to the questionnaire and the study protocols were done with inputs from all the 
supervisors. 
During the pilot study a list of six types of antibiotics to be studied was drawn. These 
were tetracycline, penicillin, sulfamethoxazole, gentamicin, cefpodoxime and 
ciprofloxacin. These antibiotics were widely used in veterinary or human medicine in 
central Zambia and their AMR were investigated in this study. Although this study 
was targeted at a specific small area compared to the whole country, in that region the 
dairy industry was most developed and the results would be of relevance to the whole 
country 
Having improved the study protocols after the pilot study, I then conducted the field 
study in Zambia where I collected 371 samples from 104 farms and administered the 
questionnaire with the help from the 4 veterinary assistants whom I trained during the 
pilot study. The field study was supervised by my supervisors. 
Having done the field study, I conducted microbiology studies and isolated the E. coli 




laboratory at the University of Zambia. I then extracted the DNA from the E. coli 
isolates.  
Then I obtained all the authorities from the Zambian and the UK governments that 
enabled me to transport all the biological research material from Zambia to UK. I 
packaged the pure bacterial culture of isolates in glycerol and shipped to Roslin 
Institute for further laboratory and computational studies. In addition, all the 
questionnaires were shipped to Roslin for analysis.  
At Roslin, I entered all the questionnaire responses into an access database and did the 
analysis with the help from Mark Bronsvoort and Paul Bessell. I then drafted the 
manuscript for the paper in this chapter that was first edited by David Gally, and it was 
then sent to all the co- authors for their approval and inputs.  
The paper presented in this chapter gives the results of the field study and some of the 
results are presented at the end of the paper before the conclusion. 
Below is the full reference for the paper in scientific reports: 
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antimicrobial resistance among Escherichia coli isolated from Zambian dairy cattle 
across different production systems. Scientific reports, 5. 
 
Scientific Reports 5: Article number: 1243910.1038/srep12439; published online: 




Prevalence and patterns of antimicrobial resistance among 
Escherichia coli isolated from Zambian dairy cattle across 
different production systems 
*Geoffrey Mainda1,3, Paul Bessell2, John B. Muma4, Sean P. McAteer1, Margo E. 
Chase-Topping5, James Gibbons6, Mark P. Stevens1, David L. Gally1 and Barend 
M. deC. Bronsvoort1,2  
 
Scientific Reports 5: Article number: 1243910.1038/srep12439; published online: 
July272015; updated: online 2015 Sep 21. doi: 10.1038/srep14162 
 
Divisions of Infection and Immunity1 & Veterinary Clinical Sciences2, The Roslin 
Institute and The Royal (Dick) School of Veterinary Sciences, The University of 
Edinburgh, Easter Bush, Midlothian, EH25 9RG, United Kingdom 
3District Veterinary Office, Ministry of Agriculture and Livestock, P.O. Box 80285, 
Kabwe, Zambia 
4Department of Disease Control, School of Veterinary Medicine, University of 
Zambia, Zambia 
 
5Centre for Immunity, Infection and Evolution, Kings Buildings, University of 
Edinburgh, Charlotte Auerbach Road, Edinburgh, EH9 3FL, United Kingdom 
 
6School of Veterinary Medicine, Veterinary Science Centre, Belfield, Dublin 4, Eire 
 
*Communicating author: Geoffrey Mainda, Division of Infection and Immunity, The 







This study focused on the use of antibiotics on small, medium and commercial-sized 
dairy farms in the central region of Zambia and its relationship to antibiotic resistance 
in Escherichia coli. A stratified random sample of 104 farms was studied, representing 
approximately 20% of all dairy farms in the region. On each farm, faecal samples were 
collected from a random sample of animals and a standardised questionnaire on the 
usage of antibiotics was completed. E. coli isolates were obtained from 98.67% 
(371/376) of the sampled animals and tested for resistance to six classes of antibiotics. 
The estimated prevalence of resistance across the different farming systems was: 
tetracycline (10.61; 95%CI: 7.40-13.82), ampicillin (6.02; 95%CI: 3.31-8.73), 
sulfamethoxazole/ trimethoprim (4.49; 95%CI: 2.42-6.56), cefpodoxime (1.91; 
95%CI: 0.46-3.36), gentamicin (0.89; 95%CI: 0.06-1.84) and ciprofloxacin (0%). 
Univariate analyses indicated certain diseases, exotic breeds, location, farm size and 
certain management practices as risk factors for detection of resistance, whereas 
multivariate analyses showed an association with lumpy skin disease and a protective 
effect for older animals (>25 months). This study has provided novel insights into the 
drivers of antibiotic use and their association with antibiotic resistance in an under-
studied region of Southern Africa. 
INTRODUCTION 
There is little information on the use of antibiotics and antimicrobial resistant bacteria 
on farms in low income countries, where the majority of the livestock are kept on 
smallholdings (Redding et al., 2014). A similar lack of information also exists for the 
commercial sectors in such countries. Knowledge of antibiotic use and the factors 
influencing the decision to use them is important for the management of bacterial 
livestock infectious diseases; the prudent use and good stewardship of antibiotics; 
monitoring of antibiotic residues in food of animal origin and limiting the selection of 
bacterial resistant to antimicrobials (Berge et al., 2003).  
In the United Kingdom (UK)/European Union (EU), antibiotics are sold as 




antimicrobials are readily sold in shops and markets without prescriptions with no 
formal centralised documentation of use (Okeke et al., 2005b). Therefore, further 
information is required on the usage of different antibiotics in the livestock sectors of 
developing countries and levels of resistance need to be ascertained. It is important to 
determine if unrestricted use has led to high levels of resistance to certain antibiotics 
which may have an impact on the efficacy of treatments for local human infections.  
The prevalence of antibiotic resistant bacteria may be an indicator of levels of 
antimicrobial use in livestock. Some studies have been carried out in Zambia 
(Eriksson, 2013) and elsewhere (Yang et al., 2015; Pereira et al., 2014) but these were 
primarily in relation to specific diseases such as mastitis or diarrhoea. There is, 
however, little information on the prevalence of antimicrobial resistance from the 
commensal flora of the wider healthy population and how this may be associated with 
antibiotic use and other farm management practices. 
Dairy farming in Zambia is an important growing livestock industry with support for 
smallholders coming from the government and Non-Governmental Organisations 
(NGOs). In addition, there are larger commercial operations that have very different 
practices and management, but which are also important for the economy. The smaller 
units generally contribute milk daily to co-operative collection centres for onward 
supply to processing or local sales. The primary objective of the present study was to 
determine the association between the prevalence of antibiotic resistant enteric E. coli 
in dairy cattle and the use of veterinary antibiotics (Khachatryan et al., 2004) by dairy 
farmers in Lusaka (capital city) and the surrounding districts in Zambia. In addition, 
we aimed to determine if there is appropriate stewardship of antibiotic use in this sector 
and identify potential ways to improve on usage practices. These results should inform 
the development of new policies and guidelines aimed at improving the rational use of 
antibiotics. The sampling also provides isolates and data which can be analysed for 





Distribution of the study farms 
The sampling effort was proportionally applied with the farm type strata to the districts 
according to the number of dairy farms, such that 46 (44%) farms were sampled in 
Mazabuka district of Southern Province, 32 (31%) farms were sampled in Chongwe, 
Kafue and Lusaka districts of Lusaka Province and 26 (25%) farms in Chibombo and 
Kabwe districts of Central Province, making a total of 104 farms (Table 3.1). The 
location of farms in the study site, the sample sizes on each farm and the proportions 





Table 3.1. Summary of the study sampling frame; including number of herds of each type; the number of herds sampled by farm type & 
district; the number of animals sampled on those farms. 
 Districts 
Farming scale Chibombo Chongwe Kabwe Kafue Lusaka Mazabuka 
 N n s N n s N n s N n s N n s N n s 
Small 56 12 34 59 12 36 22 5 15 29 6 18 0 0 0 217 42 126 
Medium 9 2 6 15 2 9 17 3 9 19 4 12 19 2 15 20 3 9 
Commercial 2 1 9 8 3 18 3 3 18 0 0 0 7 3 27 6 1 15 
Total 67 15 49 82 17 63 42 11 42 48 10 30 26 5 42 243 46 150 





Figure 3.1. Map of Zambia (insert), depicting the location (red rectangle) of the study 
farms in the following Zambian districts; Kabwe, Chibombo, Chongwe, Lusaka, 
Kafue and Mazabuka. The pie charts indicate the relative sample size on each farm 
(ranging from the smallest chart representing 1 animal and the largest representing 18 
animals). The legend shows an example of a pie chart representing 10 sampled animals 
and the red shading equals the proportion of animals that had a resistant isolate. Other 
features on the map include main roads (orange lines) and water areas (blue features). 
The map was generated in ARCGIS 10.2.1 software ARCGIS® (ESRI, ArcGIS 
desktop: release 10. Environmental Systems Research Institute, CA (2011)). The shape 
file was downloaded from Diva gis (http://www.diva-gis.org/gdata) and drawn in 
Arcmap 10.2.1 data view. The coordinates for the farms were projected in the map and 




Prevalence of antimicrobial resistance  
The population based design adjusted animal-level prevalence estimates of 
antimicrobial resistance (AMR) E. coli (defined as resistant to at least one antibiotic) 
by farm type and overall are given in Table 3.2. The raw proportions (apparent 
prevalence) suggest a much higher prevalence in the commercial dairy farms (26.4%) 
compared to the small (12.7%) or medium scale farms (15.0%) (results not shown). 
However when the analysis took account of the study design, there was no significant 
differences in true resistance prevalences across farm scales as judged by the overlap 
of the 95% CI’s (Table 3.2). 
Table 3.2. Prevalence of antibiotic resistant E. coli by farm scale.  
Farming No. resistant 
animals/total 
Population based design adjusted 
prevalence 
Small 29/226 13.7 (7.4-22.6) 
Medium 9/59 13.0 (5.6-24.2) 
Commercial 23/86 11.7 (2.5-30.0) 
Overall 61/371 12.3 (4.7-19.8) 
The results were further broken down and the population based design adjusted 
prevalence estimates for each antibiotic resistance type by farm type are plotted in 
Figure 3.2. Resistance to tetracycline (Tet) was the most prevalent (overall 11.2%; 
95%CI: 4.2 - 18.3) among the 6 antibiotics screened, with little difference between the 
farm types. Resistance to ampicillin (Amp) was the second most prevalent (6.5%; 95% 
CI: 2.1 - 10.9), followed by sulfamethoxazole/trimethoprim (Sxt) and the prevalence 
of resistance to other three antibiotics, cefpodoxime (Cpd), ciprofloxacin (Cip) and 





Figure 3.2. Prevalence of antimicrobial resistant E. coli to each antibiotic tested in 
relation to farming scale. Confidence intervals (95%) are depicted by the whiskers. 
Phenotypic antimicrobial resistance patterns of E. coli isolates in the study 
sample  
Sixteen antibiogram patterns of resistance were detected in this study (Figure 3.3). The 
most prominent one was for the isolates that were resistant to Tet (n=7).  The second 
was for isolates that were resistance to a combination of TetAmp (n=4). The third was 
resistance to SxtTet (n=2). Pattern number four (n=1) was noteworthy as it was 
resistant to all the antibiotics apart from Cpd. The dendrogram shows the clustering of 
antibiogram patterns for all the resistant isolates in Figure 3. Resistance patterns based 





Figure 3.3. Patterns of antimicrobial resistance phenotypes for E. coli strains isolated 
in the study. The bottom matrix border shows the different types of antibiotics that 
were tested in the study, Cpd: cefpodoxime 10mg; Cip: ciprofloxacin 5mg; Amp: 
ampicillin 10mg; Sxt: sulfamethaxazole/trimethoprim 25mg; Tet: tetracycline 30mg 
and Gen: gentamicin 10mg. The colour indicates the susceptibility gradient with red 
indicating resistant and green indicating susceptible. The right margin indicates the 
antibiogram patterns of phenotypic resistance detected from 1 to 16 (cl1 to cl16) and 
the numbers of isolates in each resistance pattern from 1 to 10 (size_1 to size_10). The 
top margin of the dendrogram indicates the relationship among the antibiotics in terms 
of their susceptibility testing profiles. The dendrogram on the left margin indicates the 
clusters of antibiogram patterns in the study. 
Cattle diseases and usage of antibiotics  
From the survey, cattle diseases were the main drivers for using antibiotics on the 
farms. The most common disease at farm level was mastitis with a prevalence of 
100.0% (95%CI: 95.0 - 100.0) among the commercial, 77% (95%CI: 61.9 - 91.2) 




was mostly treated with an intra-mammary infusion (Mastiject®: tetracycline 
hydrochloride 200 mg, neomycin base 250 mg, bacitracin 2000 I.U, prednisolone 10 
mg) with a disease episode treatment (DET) mean of 3.00 doses (95%CI: 2.17 - 3.83) 
per case in the commercial, 2.64 doses (95%CI: 1.60 - 3.67) for the medium scale 
farming and 0.61 doses (95%CI: 0.61 - 1.13) for the small farms.  
Diarrhoea was the second most common disease in all three different farming scales 
with a prevalence of 77.8% (95%CI: 56.1 - 99.4) among the commercial, 64.8 (95%CI: 
46.1 - 83.6) in the medium scale and 19.6% (95%CI: 11.7 - 27.5) among the small 
scale farms. The most commonly used treatments for diarrhoea were the injectable 
sulfa-based antibiotics such as sulfadimidine, sulfazine and trimethoprim sulphate 
with the DET mean of 3.00 injections (95%CI: 1.80 - 4.20) per case among the 
commercial farms, followed by 1.63 injections (95%CI: 0.35 - 2.86) among the 
medium scale and 0.22 injections (95%CI: 0.07 - 0.36) in the small scale farms. Other 
diseases were present at various levels in the different farm sizes (as shown in 
Supplementary Tables S1 and S2). It was found that intramuscular tetracycline was 
used as a specific treatment for theileriosis in combination with antiprotozoal. 
Penicillin with or without streptomycin was almost solely used for treatment of lumpy 
skin disease in combination with anti-inflammatory drugs. However, the two main 
antibiotics, tetracyclines and penicillins, were occasionally used in various 
combinations interchangeably across all the diseases.  
Multi-level logistic regression model for antibiotic resistance at the animal level 
A univariate analysis of animal and farm level factors was carried out and all the 
factors with a p-value of less than or equal to 0.25 were passed forward for further 
analysis in a multivariate model. The final list of factors is listed in Table 3.3 with 
associated odds ratios and confidence intervals. The factors included: animals that 
were bred on the farm; treatment with tetracycline; treatment with any antibiotic; 
medium and commercial farms (big farms); Friesian and Jersey breeds (exotic breeds); 
presence of calves on the farm; lumpy skin disease (LSD); diarrhoea; foot rot; and the 




Table 3.3. Univariate analysis for risk factors associated with detection of antibiotic 
resistant E. coli. 
Factor Unit Odds Ratio (95%CI) P 
Cattle bred on-farm Yes 2.13 (0.98–5.33) 0.077 
Tetracycline treatment Yes 0.41 (0.10–1.20) 0.154 
Any antibiotic treatment Yes 0.63 (0.28–1.30) 0.235 
Commercial Yes 2.04 (0.77–5.41) 0.103 
Exotic herds Yes 2.89 (1.51–5.55) <0.001 
Cows* Number 1.48 (1.04–2.07) 0.025 
Calves* Number 1.78 (1.15–2.74) 0.008 
Age >25months 0.24 (0.13–0.44) <0.001 
Lumpy Skin Disease Presence 2.14 (1.13–4.03) 0.019 
Diarrhoea Presence 1.62 (0.78–3.33) 0.192 
Lactating Yes 0.75 (0.41–1.33) 0.048 
Contact with other herds Yes 0.67 (0.35 -1.22) 0.206 
Foot rot Presence 2.12 (1.17–3.79) 0.012 
Lusaka district Yes 5.84 (1.63–20.9) 0.006 
*Figures were log10 transformed. 
Breed of cattle was associated with an increased risk. Herds composed of only Jersey 
and Friesian cattle were assigned with a new variable known as ‘Exotic herds’, as they 
are not indigenous cattle breeds. These herds were found to have an increased risk (OR 
= 2.89; 95%CI: 1.51 - 5.55) of antimicrobial resistance (Table 3.3). These animals may 
be more susceptible to local diseases, in addition to the fact that metabolically they 
have to divert more energy to production and may be more prone to diseases due to 




The final model following forward and backward approaches included just an 
association with lumpy skin disease and the cattle age of more than 25 months. Farms 
that reported having had lumpy skin disease were more likely to have cattle that were 
positive for antimicrobial resistance (OR = 2.25; 95%CI: 1.03 - 4.91) (Table 3.4) even 
after adjusting for age which was associated with a protective effect with older age 
groups.  
Table 3.4. Multi-level logistic regression model for risk factors associated with 
detection of antibiotic resistant E. coli. 
Risk factor Estimate (95%CI) P 
Lumpy skin disease 2.254 (1.034 - 4.908) 0.014 
Cattle ( > 25 months) 0.314 (0.139 - 0.707) 0.001 
Antibiotic sales 
The pattern of resistance detected reflected the relative levels of sales of antibiotics, 
with the majority use of the tetracycline class matching the high prevalence of 
resistance found. A total of 41,280.87 kg of active ingredient of antibiotics was 
dispensed from the major supplier during the period under review (January 2013 – 
February 2014). Of the total, 63.6% were parenteral antibiotic and 36.4% were oral 
ones. Tetracyclines were the most sold class of antibiotics during the period reviewed 
for both parenteral and oral sales and contributed 68% and 59% respectively (by 
weight). Penicillins were the second most abundant class of antibiotics sold by weight 
accounting for 27.2% of parenteral and 9.6% of oral sales. These were followed by the 





Spatial clustering of the resistant E. coli isolates 
There was no significant cluster of antimicrobial resistant E. coli detected in the study 
area using SATSCAN. 
DISCUSSION 
The aim of this study was to gain information on the use of antibiotics in small, 
medium and commercial dairy farms in central region of Zambia and subsequently 
determine the levels of antibiotic resistance to the commonly used veterinary 
antibiotics. The study made use of both questionnaires and resistance profile data from 
E. coli isolated from cattle. This allowed investigation of both drivers of antibiotic use 
and risk factors associated with the prevalence of resistance. 
There was an apparent high prevalence of antimicrobial resistant E. coli in commercial 
farms when compared to the medium and small scale farms. Several of the large 
commercial farms were less willing to allow access and there was substantial variation 
in the proportion of resistant isolates detected on the commercial units (Table 3.2). As 
such the adjusted prevalence of antimicrobial resistance did not significantly differ 
across the three farm types, although practices in the commercial sector vary 
substantially. The commercial farms have predominantly pure breeds such as Holstein 
Friesian and Jersey, referred to as ‘exotic breeds’ in this study. The main local breeds 
are Tonga, Baila and Angoni (Zulu, 2008); these have been crossed with the Holstein 
Friesian and Jersey breeds to improve milk production traits. These cross breeds were 
predominantly found among the small and medium scale farms. With the significant 
association between exotic breeds and isolation of resistant E. coli, future work is 
required to determine if local breeds are more resistant to specific diseases and 
therefore less antibiotics are used.  
In this study, there was a specific correlation of antimicrobial resistant E. coli and the 
records of having lumpy skin disease on the farms. Lumpy skin disease was the only 




highly infectious disease and as the skin lesions sometimes get secondary infections, 
farmers tend to use high doses of antibiotic treatments, mainly penicillin and/or 
oxytetracycline in affected animals and sometimes antibiotics in healthy animals with 
an apparent belief that they could be preventing the spread of this viral disease. In 
summary, farms that reported lumpy skin disease were more likely to have cattle with 
antimicrobial resistant E. coli in the gut than those which did not have the disease 
(Table 3.4).  
A protective effect of older cattle (> 25 months) for carriage of AMR isolates was also 
identified from the multivariate analysis and could be as a result of less treatment of 
this group of animals when compared to young animals (< 25 months) which are more 
prone to diarrhoea and respiratory diseases resulting in more use of antibiotics. This 
observation is in line with other studies that indicated that AMR is more prevalent in 
younger cattle than in the older ones (Khachatryan et al., 2004).  
There were more sales of tetracycline than any other antibiotics at the main supply 
depot in Lusaka and this was also reflected in the responses from the farmers and the 
level of resistances detected in E. coli. Although tetracycline was used as a treatment 
for all diseases, it is important to note that it is used prophylactically and 
therapeutically alone or in combination with an antiprotozoal such as buparvaquone to 
prevent and treat Theileria infection. Theileria parasite growth is inhibited by 
tetracycline. Theileriosis occurs sporadically throughout the year with outbreaks 
mostly associated with the rainy seasons (December to February) and during the dry 
months (May to July) (Simuunza et al., 2011; Billiouw et al., 2002) and is a major 
disease resulting in high mortality of cattle in the study area. This survey was 
conducted in the off-season and so was not co-incident with Theileriosis, and this may 
explain why treatment for Theileria was not identified as a risk factor for carriage of 
antibiotic resistant E. coli in the final model. 
The lack of correlation with mastitis, the most common disease, may reflect the direct 




are concentrated in the udder, thereby providing limited opportunity for resistance to 
be selected for in commensal intestinal E. coli.  
In general, the prevalences of antibiotic resistance in this study were lower when 
compared to antimicrobial resistance reports from other parts of Africa (Okeke et al., 
2005a) and other continents (Duse et al., 2014; Gibbons et al., 2014). The prevalences 
will differ due to sampling study design and estimation method or if true may be 
attributable to a wide range of factors including economic prosperity and affordability 
as we found that some of the reported diseases were left untreated, possibly due to the 
cost of purchasing antibiotics. Most of the farmers (91%) purchased the antibiotics 
from established small or big veterinary drugs shops. The fact that most of the 
antibiotics used in the study area were sourced from well-established suppliers, and 
thus likely to be of proven provenance, is important as this reduces the potential risk 
of antimicrobial resistance emerging from the use of poorly formulated products. 
However, a substantial number of responders (35%) indicated that prescriptions were 
not asked for by the retailers which does indicate the lack of a strong inspectorate 
system around the sale of antibiotics in Zambia despite having laws and regulations in 
place. 
Sixteen distinct AMR patterns were observed based on the six antibiotics tested. Some 
groupings were more common than others, indicating co-selection of resistance alleles 
(Figure 3.3). Future work will examine the genetic basis of resistance in these strains 
and establish whether particular alleles are associated, for example on plasmids. 
Sequencing will also allow fine mapping of the distribution of antibiotic resistance 
alleles in the region and if sequence data can be obtained from human isolates, then 
insight the possible transmission of alleles between humans and cattle can be 
established.  
Overall, the study has produced a general picture of the use of antimicrobials in the 
dairy sector in the region of Zambia studied. More access to commercial units would 
have been desirable and the very wide confidence intervals for the commercial farms 




mixed breeds and not pure imported breeds might provide a basis to more sustainable 
dairy farming in these settings. Future work will address resistance allele distribution 
in cattle and human isolates in the study area.  
MATERIALS AND METHODS 
Study design and sampling 
The target population was dairy cattle on farms in the central region of Zambia, within 
a 120km radius from Lusaka district, covering parts of Lusaka, Central and Southern 
Provinces. A sampling frame of all known dairy herds was developed from records 
held by the District Veterinary Officers (DVOs) and the management of the Milk 
Collection Centres (MCC). Based on local knowledge and the census data from the 
sampling frame, herds were stratified into small (1 - 20 cattle), medium (> 20 cattle) 
and commercial units. Medium and commercial farms were subjectively classified 
based on levels of production mechanisation and clear commercially orientated 
activities such as milk packaging or/and processing, use of paper records or electronic 
data bases. Medium-sized farms had well defined farm entrepreneurship and 
management systems but less developed when compared to commercial farms.  
Parameter estimates used to calculate the sample size of the study were derived from 
the analysis of 81 samples, collected from 12 farms during a pilot study in June and 
July 2013. The prevalence of antibiotic resistance at the animal level in the pilot study 
was 10%, the intraclass correlation coefficient (ρ) showed more variability between 
farms (ρ = 0.027) when compared to the within farms (ρ = 0.112). Sample size was 
calculated using Epitools-Ausvet® (Humphry et al., 2004) with the following 
assumptions: sampling 1 animal per farm; 10% of animals have antibiotic resistance 
isolates of E. coli; a perfect test; a 5% level of precision; and 95% level of confidence. 
A total of 110 farms was desired, however, to capture more of the variation it was 
decided to sample 3 animals per epidemiological unit (defined as a number of animals 
managed as a group) on each farm; these were randomly selected without replacement 




proportionally by the numbers in each of the three categories in the sampling frame 
and then proportionally to the geographic distribution based on the government 
administrative boundaries to ensure a good geographical spread. Seventy-five per cent 
of herds were small, 20% were medium and 5% commercial. The target sample size 
was then 83, 17 and 4, respectively. However, as the number of commercial farms was 
very small in the sample and they were more accessible, it was decided to aim to 
sample all 26. Thus a stratified, multistage random sampling of cattle with unequal 
probabilities was generated (Table 3.1). 
Farm data collection 
Two types of questionnaires were designed and used to collect data at both the 
individual animal and farm levels. For individual cattle the following information was 
collected; animal ID, lactation status, breed, sex, age, health status, whether or not it 
was born on the farm or sourced from another farm and whether it had received 
antibiotic treatment in the twelve months preceding the study period. At the farm level, 
information was obtained on farm management and the use of antibiotics. 
Four research assistants were trained by the principal investigator to help in 
questionnaire administration and faecal sample collection.  
Faecal sample collection and E. coli isolation 
Faecal samples were collected per rectum using a gloved hand. A fresh glove was used 
for each animal. Each glove was inverted and sealed immediately after the collection 
of faecal material. In instances where the rectum was empty, the animal was stimulated 
to defecate. Faecal samples were kept on ice in a portable refrigerator (ADDIS®, South 
Africa) connected to the vehicle and transported to the laboratory in Lusaka within 48 
hours of collection. The samples were enriched in Buffered Peptone Water in order to 
help recover E. coli.  From each faecal sample, 10 g was mixed with 90 mL of Buffered 
Peptone Water (BPW) (Oxoid, UK) and incubated overnight statically at 37oC. The 




UK) and these were incubated for 16 to 18 hours (overnight) at 37oC. One colony from 
each plate suspected to be E. coli, based on appearance, was picked and streaked onto 
Tryptone Bile-X-Glucuronide (TBX) agar plates (Oxoid, UK) and incubated for 16 to 
18 hours at 37oC. Blue colony colouration as a result of glucuronidase production was 
taken as an indication that the colony was E. coli. It was noted from subsequent 
phylogenotyping (Clermont et al., 2013) of the 371 isolates by PCR, that only 10 (3%) 
could not be typed indicating that >95% of the isolates studied were E. coli (data not 
shown). All faecal sampling and animal handling of the farm animals was carried out 
in accordance with the approved guidelines issued by The Roslin Institute Animal 
Welfare and Ethical Review Body which approved this study. 
Antimicrobial Susceptibility Testing (AST) 
The AST was carried out using the Kirby-Bauer disc diffusion method (Bauer et al., 
1966). For each isolate, one colony from the TBX plate was streaked onto a non-
selective blood agar plate. One colony from the blood agar plate was used to inoculate 
10mL of nutrient broth and statically incubated for 18 - 24 hours (overnight). About 
600µL - 1000µL from each suspension of overnight nutrient broth culture was adjusted 
with 5mL of sterile saline to match the visual opacity with that of 0.5 a McFarland 
standard, containing approximately 1 - 2 x 10⁸ colony forming units (CFU)/mL of the 
E. coli strain American Type Culture Collection (ATCC) 25922. The saline suspension 
was spread onto the surface of a Mueller-Hinton Agar plate with a sterile swab (Oxoid, 
UK). The antimicrobial discs (Oxoid, UK) containing antibiotics of both veterinary 
and human importance (tetracycline 30mg, ampicillin 10mg, 
sulfamethoxazole/trimethoprim 25mg, gentamicin 10mg, cefpodoxime 10mg, and 
ciprofloxacin 5mg) were dispensed onto the surface of the Mueller Hinton Agar plates 
at least 24 mm apart from the centre of each other using a Multi-disc dispenser (Oxoid, 
UK). The plates were incubated at 37oC for 16 - 18 hours. The diameters of the 
inhibited zones were measured; including the diameter of the discs to the nearest whole 





The minimal inhibitory concentration (MIC) for all six antibiotics for the majority of 
the resistant E. coli isolates was assessed using an E-strip method (Mushtaq et al., 
2010) for resistance confirmatory purposes. The inoculum was spread onto Mueller 
Hinton Agar plates (Oxoid, UK) as above. The specific E - strip containing the 
antibiotic of interest was placed on the plate and incubated for 16 - 18 hours before 
visually taking the readings. E. coli strain ATCC 25922 was used for reference in all 
the culture assays.  
Data management 
Questionnaire data and all diagnostic results from culture and typing were transferred 
from paper working copies to an Access (Microsoft 2010) database. The data on the 
sales of antibiotics were collated in Excel (Microsoft 2010) from the antibiotic 
supplier. The data was screened using summary tables and univariate plots for missing 
and unexpected values, and where possible these were resolved by referring back to 
the paper records.  
Statistical analysis 
Population based prevalences were estimated using the survey package (Lumley, 
2004) in R software environment version 3.1.1 (http://cran.r-project.org/). In order to 
account for the sampling method that was used of unequal probability to size, statistical 
weights were used in the analysis. From the final dataset individual herd weightings 
were generated based on the total number of herds in a given district of a particular 
category divided by the final number actually sampled. For example in Chibombo 
(Chb) 56 smallholdings were present of which 12 were sampled so the weighting at 
the herd level was 56/12. In a similar way, individual animal weightings were 
calculated from the total number of animals present on the farm divided by the sample 
size taken on that farm. The final animal weight was then the product of the herd and 
animal level weightings and is applied to data such as prevalence of resistance to allow 
comparisons across farms and districts. These weightings were used in the creation of 




A standard multi-level logistic regression model was developed with antibiotic 
resistance status to one or more antibiotics as a binary outcome. The model was 
developed using the standard Hosmer Lemeshaw (Hosmer Jr and Lemeshow, 2004) 
approach where first potential explanatory variables or risk factors were screened and 
any variables with a p-value <0.25 from the Wald statistic were allowed to pass for 
use in a multivariate multi-level model. The model was built using the lme4 package 
in R (Kuznetsova et al., 2013). Both forward and backward approaches were explored 
with variables being entered or removed based on their Wald statistic p-value. As 
variables were added or removed they were tested using a likelihood ratio test of the 
change in deviance and variables that were significant at the 5% level were retained. 
Collinearity of all potential explanatory variables was checked using the Pearson rank 
correlation statistic.  
Diagnostics were performed and plots of residuals were examined, confirming the 
goodness-of-fit of the model. Odds ratios (OR) and their associated 95% confidence 
intervals were estimated in the final logistic model for factors statistically significantly 
associated with the presence of antibiotic resistant E. coli in individual cattle.  
The distribution of resistant E. coli on farms was examined to determine if they 
occurred randomly or if there was some clustering. SATSCAN® was used to search 
the significant clusters of antimicrobial resistant E. coli. We used Bernoulli algorithm 
model, involving geometry of the study area, the probability distribution of the events 
and different shapes and sizes of the window to scan through possible cluster in the 
sample (Kulldorff, M. Satscan user guide. StatScan, Boston, USA (2006)). The 
locations of farms were mapped using ARCGIS® (ESRI, ArcGIS desktop: release 10. 
Environmental Systems Research Institute, CA (2011)). 
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Table S1. Means percentages of number of farms with standard error of mean (SEM) on the presence/absence of specific 
diseases/syndromes and number of farms which did not provide information (Unknown). 
  Presence Absence  
Category (n= Total farms) Disease/Syndrome Farm numbers (%) SEM (%) Farm numbers (%) SEM Unknown   
Small (n=77) 
Mastitis 47 5 53 5 2 
Diarrhoea 40 4 80 4 1 
Lumpy Skin Disease 25 44 73 44 2 
Post parturient 10 3 90 3 3 
Tick-borne 15 38 86 37 3 
Foot rot 11 3 89 3 3 
Respiratory 10 3 90 3 3 
Digestive 5 2 95 2 3 




Table S2. Means percentages of number of farms with standard error of mean (SEM) on the presence/absence of specific 
diseases/syndromes and number of farms which did not provide information (Unknown). 
  Presence Absence  
Category (n= Total farms) Disease/Syndrome Farm numbers (%) SEM (%) Farm numbers (%) SEM Unknown   
Medium (n=16) 
Mastitis 77 7 23 7 1 
Diarrhoea 64 10 35 10 1 
Lumpy Skin Disease 45 15 55 15 1 
Post parturient 38 15 62 15 1 
Tick-borne 11 7 89 6 1 
Foot rot 25 14 75 14 1 
Respiratory 37 8 63 8 1 
Digestive 45 15 55 15 1 
Others 55 10 55 10 1 




 Diarrhoea 78 11 22 11 3 
 Lumpy Skin Disease 25 12 75 12 3 
 Post parturient 63 14 38 14 3 
Commercial (n=11) Tick-borne 26 12 76 12 3 
 Foot rot 67 13 33 13 3 
 Respiratory 38 14 63 14 3 
 Digestive 62 14 38 14 3 





Table S3. Parenteral antibiotic sales (2013/2014) 
Route of administration/Class Quantity(kg) Percentage (%) 
Tetracycline 17,840.20 68.00 
Penicillin 7,139.00 27.21 
Sulphonamide 739.90 2.82 
Aminoglycoside 337.00 1.28 
Tylosin 98.00 0.37 
Floroquinolones 80.30 0.31 




Table S4. Oral antibiotic sales (2013/2014) 
Route of administration/Class Quantity(kg) Percentage (%) 
Tetracycline 9,177.22 58.66 
Sulphonamide 2,790.40 17.84 
Penicillin 1,508.00 9.64 
Nitrofurans 695.225 4.44 
Fluroquinolone 439 2.81 
Polymyxin 266 1.70 
Pleuromutilin 89 0.57 












3.2 Analysis for antibiotic use and their drivers 
The questionnaire described in this thesis was used to collect different information 
including the type of antibiotics that were mostly used by the farmers in the study area 
and the reasons why they used those antibiotics. The farmers were asked to state what 
they considered was the most used antibiotic on their farms. A total of 47% of the 
farmers from different farms responded that tetracycline was the most used and the 
other 46% responded that they used penicillin than any other antibiotic on their farms. 
Meanwhile less than 7% of the farmers either used other antibiotics apart from 
tetracycline and penicillin or did not use any form of antibiotics at all to treat their 
animals, Figure 3.4 shows the percentage of farms that used particular antibiotics. 
 
Figure 3.4. Analysis on the use of antibiotics. The most commonly used antibiotics in 
the study area were tetracycline and penicillin. Other notable antibiotics that were used 






An analysis on the questionnaire concerning the drivers by the farmers to use 
antibiotics in the study area revealed that antibiotics where purely used for therapeutics 
or prophylaxis treatment of livestock diseases. The use of antibiotics was driven by 
the treatment of various infectious diseases with Mastitis (49 % of the farms), 
Diarrhoea diseases (26% of the farms), Lumpy Skin Disease (25% of the farms). The 
percentage of farms with respective diseases that drove the use of antibiotics during 
the study period are depicted in Figure 3.5.  
 
 
Figure 3.5. Livestock diseases or conditions that prompted the farmers to use 
antibiotics in the study area. The notable five diseases on which the antibiotics were 





















There is a real global concern of emergence of bacterial resistance to all classes of 
antibiotics that is increasing at a faster rate. The AMR in the communities has been 
linked to significant adverse economic and social impacts and this highlights the 
pressing need for both the stewardship of current active compounds and the need for 
alternatives. While data apportioning the level of culpability of AMR emergence in 
human pathogen through use in agriculture sector is still relatively scarce. It is evident 
that the levels of antibiotic use in food animals needs to be monitored and regulated. 
In Zambia, there is currently no national surveillance system for antibiotic use or 
AMR. The little available information is from isolated studies that were done using 
different methodologies and focussed on few farms in small geographical areas. 
Although this study does not cover the entire country, but it covers a large part of the 
country where dairy industry is most developed. Therefore the findings from this study 
would provide the baseline information that is required for implementation of 
antibiotic use and AMR surveillance in Zambian dairy herds.  
The use of antibiotics in the study area was driven by the treatment of various livestock 
diseases. The common diseases that were treated are mastitis, diarrhoea and respiratory 
diseases. Mastitis was mostly treated with an intramammary infusion cream 
(Mastiject®) that is made up with a combination of antibiotics including tetracycline, 
neomycin, bacitracin and an anti-inflammatory such as prednisolone. Tetracycline was 
also used for therapeutic and prophylactic treatment of Theileriosis. Theileriosis is one 
of the major livestock diseases in Zambia with serious economic consequences 
because it is associated with high mortality in cattle (Simuunza et al., 2011). Although 
no reports or cases were found among the study farms, it’s because the disease is 
seasonal and the study was done during the off period. However, this could have 
contributed to the number of farmers that perceived tetracycline as the most used type 




In that study area the choice of antibiotics was probably determined not only by the 
availability but also the cost. It is noteworthy that even though the third and fourth 
generation cephalosporin are more efficacious and broad spectrum, they were not used 
by the farmers in the study area. However, the cephalosporin (Baytril®) was in stock 
at the main antibiotic supplier in Lusaka. Possibly the farmers opted to use much 
cheaper form of antibiotics such as tetracycline and pencillin than the cephalosporins. 
At the main antibiotic supplier, there was the presence of a veterinarian who provided 
prescriptions to clients before they could buy the antibiotics. This was a good set up 
because clients were guided on the choice of antibiotics in relation to the type of 
livestock disease they were treating. However, the small antibiotic shops in the farming 
community did not require a client to have a prescription for them to buy antibiotics. 
This indicated an existence of a weak system on the dispensing of antibiotics in the 
country. And this study has highlighted this gap on which policy may be formulated 
to harmonise and standardise the dispensing of veterinary antibiotics in Zambia. 
There is need to set up a robust surveillance system for antibiotic use in Zambia that 
can provide a clear and comparable data with other countries in the region or indeed 
at a global scale. In order for this data to be comprehensive a national database census 
of livestock, the number of animals slaughtered for meat and the milk that is produced 
per year are required to be documented. A system could then calculate the amount of 
antibiotics in kilograms that are used in different production systems. This surveillance 
system is currently used in European countries and it is giving reliable and comparable 
figures (Davies and Gibbens, 2013). In the case of Zambia where most of the 
antibiotics are imported. The surveillance could target to account for all the imported 
antibiotics at the ports of entry, few manufacturers that are present in the country, the 
distributors and the farmers.  
Once the antibiotic surveillance system is put in place, it would be practical to monitor 
the use and trends. And it would make it easy to implement herd health programmes 
that are meant to reduce the use of antibiotics such as vaccinations of the common 




From the set of six types of antibiotics that were tested for AMR, tetracycline had the 
most prevalent (10.61; 95%CI: 7.40-13.82), followed by ampicillin (6.02; 95%CI: 
3.31-8.73), sulfamethoxazole/trimethoprim (4.49; 95%CI: 2.42-6.56) and 
cefpodoxime, gentamicin and ciprofloxacin had low AMR prevalences of less than 
2%. The AMR profiles that were obtained in this study were in line with the findings 
on the sales of antibiotics, in which case tetracycline, penicillin and sulfa-based 
antibiotics were the most sold antibiotics. The findings were also in line with the views 
from the farmers, of what they considered were the most used antibiotics on their 
farms. However, there is still a possibility of the antibiotic resistant microbes spreading 
from other sources. It is recommended that future studies can holistically investigate 
the reservoir of resistance genes in the environment and different animal production 
systems. There is evidence that antibiotics in livestock are more used in intensive 
production systems of poultry and piggery than in semi intensive and pastoral 
production systems of cattle (Ngoma et al., 1993; Grace, 2015). 
A further analysis was done in order to explore and investigate associations of factors 
and the AMR. A number of factors were significantly associated with the detection of 
AMR in the study organism based on the univariate analysis. The exotic breeds 
(Friesian and Jerseys) were significantly associated with AMR E. coli isolated from 
cattle (OR 2.8995%CI: 1.51-5.55, p <0.001). Further studies are required to investigate 
and support this assertion. This could have been attributed to the fact that the local 
breeds are more adapted to the environment and are more resistant to the tropical 
diseases subsequently received less antibiotic treatments compared to the exotic 
breeds. The other factors that were associated with the AMR were the cows and the 
calves. This could have been attributed to the fact that dairy herds are mostly made up 
of cows and calves because bull calves are culled and removed from the herds.  
Other associations were livestock diseases such as Lumpy Skin Disease and Foot rot, 
this finding requires further investigation and if proved then strengthening preventive 
measures will curb the emergence of AMR in dairy herds. Lusaka district was 
associated with AMR E. coli, but this could be attributed to the fact that there were 




could be that farmers in Lusaka easily accessed and used more antibiotics because that 
is where the main supplier depot is located. 
The overall AMR in the study area was 12.3; 95%CI: 4.7-19.8. Other small studies in 
Zambia have reported higher prevalence of AMR in pastoral cattle (Mubita et al., 
2015; Kuroda et al., 2013). However, this is an indication that AMR is a growing 
concern in Zambia spreading over a wider geographical area. And the prevalence from 
this study will form the basis for future reference on the dynamics of AMR since the 
study was done on a bigger geographical area covering a radius of 120 km from 
Lusaka. We didn’t find any significant differences of the AMR prevalence among the 
farming types. This was an indication of similar level of antibiotic use and the 
evolution of resistance across the farm types.  
The pattern of AMR is of clinical importance because it gives an indication of how 
many types of antibiotic are being selected in one organism. The bacteria uses different 
mechanisms of resistance that is impossible to tell based of phenotype testing. 
However, the resistance patterns gives an indication of the possible mechanism for a 
specific pattern of resistance showed by a set of microorganisms. Although this study 
only tested for the six types of antibiotics the resistance patterns that were obtained are 
of clinical importance because they show the nature of AMR that is evolving in the 
bacteria population. There were sixteen patterns of antibiogram in all the antibiotic 
resistant E. coli isolates. However, it is important to keep in mind that these patterns 
are only based on the antibiotics that were used in this study and the model organism 
(E. coli). This pattern may change if the test are done for instance using a different 
bacteria model or by direct detection of AMR genes by PCR from DNA extracted from 
faeces. Future studies may use more than six types of antibiotics in order to obtain a 
more refined AMR patterns among the isolates. 
Despite having done this study, a number of areas in the methodologies were noted 
that needs to be improved in future studies. Below is an account of some of the 




Study farms. It is possible that some of the farms were omitted from the study because 
there is no existing data base on the farms in the study area or indeed in the country.  
Data collection on the use of antibiotics. A questionnaire was used to collect 
information about the use of antibiotics. This could have been a source of bias as some 
small scale farmers do not keep updated written records on the treatment of their 
animals (assessment of record keeping was not part of this study). It is likely that some 
information that was collected on the use of antibiotics was missed or inaccurate. 
Isolation of E. coli and resistance testing. The isolation of single colonies of E. coli 
from faecal samples was carried out after an enrichment in BPW. This could have 
given a selection advantage to some strains of bacteria over others thus creating a 
possible bias. The other possible bias is on the selection of single colonies (1 E. coli 
isolate per faecal sample). Clearly this does not adequately represent the true AMR 
status of E. coli in the gut of the sampled animals, however this allowed a consistent 
estimation of prevalences and comparison of results across different farming systems. 
Six types of antibiotics used in the study. These number of antibiotics are not 
conclusive, because there are a number of antibiotics that are being used in veterinary 
and human medicine in the study area that were not tested for. Future studies may use 
more types of antibiotics to test for the possible resistances as well as to study the 
resistance patterns.  
The next chapter (Chapter 4) of this thesis is the analysis of the resistance genotypes 
of all the E. coli that were isolated from dairy cattle in this study. The rationale is to 
study the genetic basis of the phenotype resistances that has been reported in the 
current chapter. In addition, genetic analysis will be done on the E. coli isolates that 
were isolated from human diarrhoea patients at a hospital in Lusaka in order to gain 










Chapter 4 : Analysis of AMR genotypes in 
E. coli isolates from dairy cattle and humans in 
the study area  
4.1 Introduction and aims 
The original aim of this study was to examine the use of antibiotics in different types 
of dairy farming in central Zambia and to investigate the different drivers for their use. 
The previous chapter (Chapter 3), analysed this initial objective and found that 
tetracycline, penicillin and sulfamethoxazole/trimethoprim were the most dispensed 
and used type of antibiotics. The use of antibiotics were largely for treatment of various 
livestock diseases. Further analysis in chapter 3 was done to determine the AMR 
phenotypes in the study organism E. coli. The rationale was to assess the AMR that is 
prevailing in the sentinel organism and then hypotheses on overall AMR in the enteric 
microorganisms of dairy herds. In chapter 3, the prevalence of AMR were in line with 
the type of antibiotics that were mostly sold and used in the study area. 
Having completed the analysis in chapter 3, a good collection of E. coli isolates from 
dairy cattle were available for further molecular studies in order to gain more 
knowledge on the emergence and spread of AMR in the study area. The isolates were 
whole genome sequenced and resistance genes in the genomes were studied. In order 
to investigate the resistance genes in humans and to compare with those in cattle, 
additional E. coli isolates that were isolated from human diarrhoea patients from a 
hospital in Lusaka (within the study area) were also sequenced and added in the 
analysis. This allowed the comparative analysis of the common, unique resistance 
genes and their distribution between the E. coli population from cattle and human 
hosts. These resistance genes emerge as a result of different antibiotic selection 
pressures that are experienced by a bacterial population in the study area (De Jong et 
al., 2009). Consequently, a bacterial population with high levels of resistance is much 
more likely to transfer resistance genes within the population and to other populations 
when compared to a population with lower burden of AMR (Gillings, 2013; Guenther 




also provide information on how different livestock systems impact on the evolution 
of resistance genes in both commensal and pathogenic microorganisms (Goodyear, 
2002). Also it may be possible to determine which livestock production systems might 
contribute to AMR that is found in human infections within the same area.  
Therefore, the following were the objectives for this chapter. 
1. To whole genome sequence (WGS) and analyse a subset of the bovine E. coli 
strains (n=186) and the human E. coli isolates (n=77) 
2. To analyse the resistance genotypes of the E. coli from cattle in relation to the 
AMR phenotypes of the isolates 
3. To extract resistance gene profiles from WGS data and analyse the different 
resistance gene patterns, gene relationships, gene variants and their 
















4.2 Materials and Methods 
4.2.1 Whole genome sequencing and analysis 
In this study, all E. coli isolates from cattle that were resistant to at least 1 type of 
antibiotic were purposely selected for sequencing. Another selection criteria was all 
the E. coli isolates that tested positive for Shiga toxin (stx) encoding genes (Chapter 
5). Because of the high costs of sequencing, it was not possible to sequence all the 
isolates, however, other isolates were randomly selected to make up the number that 
could be sequenced in accordance with the amount of money that was available. The 
numbers of E. coli isolates that were included in analysis for this chapter and their a 
priori information for selection are presented in Table 4.1. 
Table 4.1 Selection of E. coli isolates for genotype analysis 














1 Cattle 61 41 125 189 186 
2 Human *- 0 77 79 77 
Table 4.1.Selection of E. coli isolates for genotype analysis. The isolates were obtained 
from cattle and human hosts. From the total collection of isolates from cattle 61 were 
resistant to at least an antibiotic, 41 others were positive for stx. The two sets were 
included in the lot for sequencing together with the 125 that were selected at random. 
A total of 189 isolates of cattle origin were sequenced. After the quality assessment 
some isolates were eliminated from analysis and in the end only 186 whole genome 
sequences were available for analysis. For the isolates of human origin, data was not 
available for phenotype antibiotic resistance (*) and none (0) were positive for stx. A 




The DNA was extracted from the E. coli isolates using the Quiagen DNA extraction 
kit as per manufacture instruction. The DNA was then quantified using the Nano drop 
and sent to Edinburgh Genomics at the Roslin Institute, University of Edinburgh 
(http://genomics.ed.ac.uk/) for sequencing. The company used Miseq Illumina 
sequencing platform. A total of 186 genomes of E. coli isolates from cattle and 77 
genomes of E. coli from humans were available for this analysis. The reads were 
checked for quality control (QC) using the software FASTQC (Bioinformatics, 2011) 
and when necessary the trimming was done in Cutadatp software (Martin, 2011). The 
raw reads sequences were de novo assembled using SpaDES software (Bankevich et 
al., 2012). The de novo method is the merging and alignment of pieces of overlapping 
short DNA sequences (reads) without a reference genome in order to reconstruct the 
original genome or contiguous fragments (contigs). The de novo assemblies’ produces 
scaffold of genomes in fasta formats. These scaffolds are not completely closed but 
they have got gaps in low coverage areas and areas with repetitive nucleotides. The 
open gaps in the whole genome sequences are a matter of concern because they may 
contain novel or important genetic information that is cannot be captured in the 
downstream analysis of the genomes. Although there are algorithm softwares used to 
close the genomes such as Gap filler, the genomes in this study were not closed before 
the analysis.  
The whole genomes in this study were then analysed for the presence and absence 
resistance genes. The resistance genes were detected using the Short Read Sequence 
Type 2 (SRST2) software in a Linux environment. It uses the web based data base to 
query the resistance genes in each of study genomes (Inouye et al., 2014). (Assistance 
in bioinformatics to use the software was provided by Emily Richardson, The Roslin 
institute). 
4.2.2 Statistics 
Statistical analysis were performed using R 3.2.2 (R Core Team. R:. A language and 
environment for statistical computing. 2013. www.r-project.org/). The distribution of 




exploration of the distribution of genes were done using histograms and boxplots. The 
differences in the resistance gene carriage between the E. coli from cattle and those 
from humans were tested with Wilcoxon rank sum test. The associations of resistance 
to a particular antibiotic and the underlying resistance genes were tested using Fisher’s 
exact test. The relationships of different resistance gene variants were analysed in 
Linux environment using RaxML with 1000 bootstrap and the results are presented in 
phylogenetic tress. The statistical significant was considered at p < 0.05. 
4.3 Results 
4.3.1 Analysis of AMR genotypes of E. coli from cattle  
The E. coli isolates from cattle were first separately analysed for the presence and 
absence of resistance genes. Resistance genes were detected in 28% (52/186) of the 
genomes. Among these genomes with resistance genes 51 of them were from the set 
that was resistant to at least 1 antibiotic that were tested (refer to Appendix 4). There 
was a perfect much of the resistance phenotypes and the presence of at least one 
resistance gene in the genome 85% (51/61). Several resistance genes were detected, 
however, the 5 most common type of genes were those encoding resistance to 
streptomycin, sulphonamides, tetracycline and the beta lactamases blaTEM. The 
frequency and the percentages of those genes in all the genomes of E. coli from cattle 
are presented in Table 4.2. 
Table 4.2 Five common resistance genes in the genomes of E. coli from cattle (n =186) 
Gene Number of genomes Percentage (%) in all 
genomes 
strA 36 19 
strB 35 19 
sul2 32 17 
tetA 30 16 





The next analysis was to show the distribution of the resistance genes in all the 
genomes. This analysis was done using histograms. The majority of the genomes of E. 
coli from cattle contain less than 5 genes. However, there was wide variation in the 
distribution of resistance genes per genome (mean: 1.29; median: 0; range: 0–12 
genes). The distribution of resistance genes in the genomes are presented in Figure 4.1. 
 
Figure 4.1. Distribution of resistance genes among the genomes of E. coli isolates from 
cattle (n=186). The x-axis is the number of resistance genes in a genome and the y- 
axis (count) is the number of genomes. Most of the genomes had less than five 
resistance genes with only a few genomes with seven or more genes. 
Having studied the distribution of resistance genes in the genomes, it was found that 
some genomes had multiple copies of resistance genes. This is so because some 
resistance genes are co selected in the bacteria and occur on the same or different 
plasmids. The analysis of these genes reveals resistance patterns that are of both 
clinical and epidemiological importance. Resistance genotype patterns provides 




mobile genetic elements such as plasmids often harbour more than one resistance gene. 
It also helps to investigate the emergence of AMR isolates with multiple resistance 
genes. Therefore resistance pattern analysis is an important molecular epidemiological 
subject (Aslam et al., 2012). In the genomes of E. coli isolates from cattle 33 resistance 
genotypes patterns were determined. The common patterns that were observed in at 
least 2 genomes are presented in Table 4.3. The complete patterns of all resistance 
genes and phenotypes for this data set of E. coli genomes from cattle are presented 
Appendix 4. 
Table 4.3. Patterns of resistance genes in genomes of E. coli from cattle 







After studying the resistance genes and the patterns of the genes in the genomes, an 
analysis was done to examine associations between resistance phenotypes and the 
underlying resistance genotypes. In this analysis, resistance to ampicillin was 
associated with blaTEM-1 allele (Fisher’s test, p < 0.001), resistance to tetracycline was 
significantly associated with genotypes tetA and tetB (Fisher’s exact test, p < 0.001) 
for each genotype as maybe expected. The resistance to 
trimethoprim/sulfamethoxazole was associated with all the three sulphonamides 
encoding genes sul1, sul2 and sul3 (Fisher’s test, p < 0.001) in each case and the three 
individual trimethoprim resistance gene variants dfrA5, dfrA7 and dfrA8 (Fisher’s test, 
p < 0.001) and aac(3’)-II was the only aminoglycoside resistance encoding gene that 
was associated with the gentamicin resistance phenotype. The resistance of different 
antibiotics in the isolates and the underlying resistance genes are presented together 




4.3.2 Analysis of phylogroups and genotype variants of AMR 
E. coli isolates from cattle 
The analysis of phylogroups of E. coli population gives an indication of their niche 
background and also separates them according to their pathogenicity. This is because 
E. coli pathotypes are more likely to be associated with phylogroups B2 and D while 
commensal E. coli are more likely to be grouped in phylogroups A and B1 (Clermont 
et al., 2000). However, recently more subgroups have been proposed (C, E, F, cl) to 
delineate different E. coli based on fine genetic differences from the original 
phylogroups (Clermont et al., 2015). In this study all the genomes of E. coli from cattle 
with resistance genes were assigned to phylogroups. The majority of the genomes 
belonged to the commensal phylogroups B1 (56%, 29/52), C (23%, 12/52) and A 
(19%, 10/52). Only a few genomes belonged to the pathogenic phylogroups; D (2%, 
1/52) and B2 (2%, 1/52). Therefore the phylogroup analysis indicates that this bacteria 
population is largely predicted to be commensal E. coli (phylogroup B1, A and C) as 
expected because most of the isolates were from apparently healthy cattle.  
The analysis of resistance gene variants were done in order to fully document the 
resistance profiles in the E. coli isolates. The majority of the genomes (72%, 134/186) 
had no resistance genes, which was an indication that the resistance genes in this 
population of E. coli were not common. However, different resistance gene variants 
that encode for beta lactamases (15%, 27/186), tetracycline (27%, 50/186), 
sulphonamides/trimethoprim (31% 58/186), aminoglycosides (45%, 84/186) and 









Table 4.4. Frequency of resistance gene variants in E. coli isolated from cattle (n=186) 
Class Gene  No. of isolates % 
Beta-lactamase 
blaTEM-1 25 13 
blaTEM-117 1 1 
blaTEM-135 1 1 
subtotal   27 15 
Tetracyclines 
tetA 30 16 
tetB 18 10 
tetC 2 1 
subtotal   50 27 
Sulphonamides 
/trimethoprim 
sul1 5 3 
sul2 32 17 
sul3 2 1 
dfrA1 1 1 
dfrA5 5 3 
dfrA7 5 3 
dfrA8 4 2 
 dfrA10 1 1 
 dfrA12 1 1 
 dfrA14 1 1 
 dfrA15 1 1 
subtotal   58 31 
Aminoglycosides 
aac(3)-IId 2 1 
aadA1 4 2 
aadA5 2 1 
aadA7 1 1 
aph(3')-Ia 4 2 
aph(3')-Ic 1 1 
strA1 11 6 
strA4 25 13 
strB1 36 19 
subtotal   84 45 
Others 
catA1 2 1 
cml 2 1 
cmlA 2 1 
lnuF 1 1 
Subtotal   7 4 
With no resistance genes  134 72 




4.3.3 Analysis of AMR genotypes of E. coli isolates from 
humans 
We were fortunate in this research programme to have access to E. coli isolated from 
people residing in the same geographical area of the study. Ideally, E. coli isolates 
would have been isolated from people on the study farms but this could have meant a 
lengthy procedure of obtaining ethical approval that was not possible during the 
specified period of the study. These E. coli isolates from humans were obtained from 
another study (supervised by Prof. Muma) that was going on over a similar time frame 
2014/2015 at the University Teaching Hospital in Lusaka with similar E. coli isolation 
methodologies. The isolates were all obtained from patients presenting with diarrhoea, 
but epidemiological data including AMR phenotype and the type of antibiotics 
potentially supplied (if any) to patients was not obtained. The location of Lusaka in 
the study area is depicted in Figure 4.2. From this data set 77 genomes were available 
for resistance gene analysis and resistance genes were detected in (88%, 68/77) of 
them. Similarly to the E. coli genomes from cattle host, different types of analysis were 
done including resistance gene distribution, resistance gene patterns, analysis of 
resistance gene variants and assignment of genomes with resistance genes to different 
phylogroups. Several resistance genes encoding different types of antibiotics were 
detected. The five most common genotypes were those encoding resistance to 
trimethoprim, sulphonamides, streptomycin and beta lactamases blaTEM. The type of 
genes and the frequency of their occurrence in the genomes and the overall percentage 
in all the genomes are presented in Table 4.5. 
Table 4.5 Top 5 resistance genes in E. coli genomes from humans (n=77) 
Gene Number of genomes % on all genomes 
dfrA 52 68 
sul2 51 66 
strB 49 64 
strA 48 62 





Figure 4.2 Map of Zambia showing the location of Lusaka. The E. coli isolates from 
humans were collected from diarrheic patients presented at the University Teaching 








In line with the analysis that was done with the E. coli genomes from cattle, the 
analysis of distribution of resistance genes were done using the histogram. The 
distribution of the resistance genes in the genomes indicated that most of the genomes 
had resistance gene copies between 5 and 10 as presented in Figure 4.3.The mean 
distribution of resistance genes per genome was 5.9, with the median of 6 and a range 
of 0 - 17 genes.  
 
Figure 4.3. Distribution of resistance genes in the genomes of E. coli isolated from 
humans (n=77). The first bar indicates the 6 genomes with the single genes in the 
genomes, but there are few genomes with less than 3 copies of resistance genes. The 






The resistance gene pattern analysis was also done for this population of E. coli from 
humans. There were 59 unique resistance genotype patterns with only 7 patterns 
occurring each in 2 genomes, the rest of the patterns occurred 1 per genome. The 
resistance gene patterns that were determined in at least 2 genomes are presented in 
Table 4.6. A complete detail of the unique resistance patterns in the genomes of all the 
human E. coli isolates is presented in Appendix 5. 
Table 4.6. Patterns of resistance genes in genomes of E. coli from humans 
Number of genomes Pattern of resistance genes per genome 
2 tetB 
2 dfrA5-strA4-strB1-sul2 
2 blaTEM-1 -dfrA14-mphA-strA4-strB1-sul2 
2 blaTEM-1 -dfrA5-strA4-strB1-sul2-tetA 







In addition to the wide range of patterns of resistance genes, several resistance gene 
variants were detected in the genomes of E. coli from the human host. This was an 
indication of the presence of diverse resistance gene pool in this E. coli population. 
Among the notable resistance gene variants of clinical importance were those encoding 
beta-lactamases such as the blaTEM-1, blaCTX-M-15 and the blaOXA-30. The complete list 
of all the gene variants that were detected in this E. coli population are presented in 
Tables 4.7. 
This analysis indicates that resistance genes were more frequent in the E. coli isolates 
from this specific human population compared to the E. coli population we studied 
from cattle. It is appreciated that this does represent a specific patient group but the 
AMR gene types and frequencies are still important to determine and compare with 




Additionally, the genomes of E. coli from humans were also assigned to phylogroups. 
While cattle isolates mostly belonged to the phylogroups consistent with commensal 
E. coli (phylogroups B1 and A), the genomes of isolates from human origin were 
almost equally assigned to all the phylogroups, an indication that more of the isolates 
could have pathogenic traits especially those in groups B2 and D, consistent with the 
condition of the host (diarrhoea patients) of the isolates as depicted in Figure 4.4. The 
details of the distribution of the genomes of E. coli from human and cattle in the 
different phylogroups in relation to those in which resistance genes were detected is 










Figure 4.4. Distribution of E. coli isolates from cattle and humans among the 
phylogroups. The isolates of cattle origin are mostly belonging to phylogroup B1 
(commensal group). The figure is also showing almost the uniform distribution of the 
isolates from humans among the phylogroups A, B1, B2, C and D. This is an indication 
that these isolates were not predominantly commensal but have a diverse niche 







Table 4.7. Frequency of resistance gene variants in E. coli isolated from humans 
(n=77) 
Class Gene variant No. of isolates % 
beta-lactamase 
blaCMY-4 1 1 
blaCMY-41 1 1 
blaCMY-47 1 1 
blaCTX-M-14 1 1 
blaCTX-M-15 14 18 
blaCTX-M-27 2 3 
blaCTX-M-55 1 1 
blaDHA-1 1 1 
blaLEN12 1 1 
blaNDM-1 1 1 
blaOKP-B 1 1 
blaOXA-2 1 1 
blaOXA-10 1 1 
blaOXA-30 10 13 
blaSHV-38 1 1 
blaTEM-1 43 56 
Subtotal   81 105 
tetracycline 
tetA 25 32 
tetB 17 22 
tetD 1 1 
Subtotal   43 56 
sulphonamides/trimethoprim 
sul1 22 29 
sul2 51 66 
dfrA1 6 8 
dfrA5 10 13 
dfrA7 6 8 
dfrA8 5 6 
dfrA12 7 9 
dfrA14 9 12 
dfrA15 3 4 
dfrA17 6 8 
Subtotal   125 162 
aminoglycosides 
aac(3)-II 13 17 
aac(6’)-Ib-cr-1 10 13 
aadA 29 38 
aph(3)-I 1 1 
strA1 4 5 
strA4 44 57 
strB1 49 64 
Subtotal   150 195 





Table 4.7. Frequency of resistance gene variants in E. coli isolated from humans 
(continued from previous page). 
Class Gene No. of isolates % 
quinolones 
aac(6')-Ib-cr-1 10 13 
oqxA 1 1 
oqxB 1 1 
qepA 4 5 
 qnrB 3 4 
 qnrS 2 3 
Subtotal   21 27 
Others 
cat 15 19 
cml 1 1 
ereA 1 1 
ermB 1 1 
floR 1 1 
fosA 2 3 
mphA 18 23 
mphE 1 1 
msrE 1 1 
Subtotal   41 53 














Table 4.8. Phylogroups of the E. coli isolates from humans (n=77) and cattle (n=186) 











A 18 10 (5) 16 12 (16) 
B1 114 29(16) 14 10 (13) 
B2 10 1 (1) 12 12 (16) 
C 17 11 (6) 14 16 (18) 
D 18 1 ((1) 12 11(14) 
cl 5 0 (0) 1 1 (1) 
E 1 0 (0) 0 0 (0) 
F 0 0 (0) 2 2 (3) 
Unassigned 3 0(0) 4 4 (5) 
Table 4.8. The genomes of E. coli isolates from cattle and humans were assigned to 
different phylogroups (first column). The second column is the total genomes per 
phylogroup and the third column is the number of genomes with resistance genes, the 
figure in brackets is the percentage of the genomes with resistance genes for that 
phylogroup in relation to all the genomes  n=186 ). The fourth column is the total 
number of genomes for a particular phylogroup among the isolates of human origin. 
The fifth column is the number of genomes with resistance genes in a particular 
phylogroup and the number in brackets is their percentage in relation to the total 
genomes (n=77). 
4.3.4 Resistance genotypes of E. coli isolates from cattle in 
relation to E. coli from humans 
The E. coli isolates from human and cattle hosts showed marked differences in the 
overall resistance gene carriage in the WGS: 28% (52/186) for cattle E. coli isolates 
and 88% (68/77) for those from humans. There was a significance difference in the 
median of resistance genotypes between the 2 E. coli populations (Wilcox rank sum 
test, p < 0.001) as presented in Figure 4.5. This observation is made with caution 
because the human sample was relatively small and the E. coli isolates were collected 





The distribution of resistance genes in the genomes of E. coli from cattle and those 
from humans showed distinct differences on histogram analysis. The distribution was 
normal for the genomes from human isolates with most of the genes occurring between 
5 and 10 copies per genome. Whereas the genes in the genomes of E. coli from cattle, 
were sparsely distributed and skewed to the left with most of the genes occurring in 
less than 5 copies. The histograms showing the density of resistance genes among the 
genomes are presented in Figure 4.6. 
Another analysis was done to clearly visualise individual genomes in relation to the 
number of gene copies present. This individual genome differences in the carriage of 
resistance genotypes and the relationships among gene variants were analysed using 
phylogenetics. The genomes from human E. coli isolates tended to cluster together 
away from those of cattle origin. The differences in the carriage of resistance genes 
and how they related to each other phylogenetically can be visualised in the 


















Figure 4.5. The Box plots showing the carriage of resistance genes in the E. coli 
genomes from cattle hosts (red) (n=186) compared to isolates from human hosts (blue) 
(n=77). The median of resistance genes from the cattle isolates was 0 and the range 
was (0 – 12). The median for those from human hosts was 6 and the range was from 
(0 – 17). There was a significant difference (Wilcox rank sum test, p < 0.001) between 











Figure 4.6. Density plot for distribution of resistance genes. The density plots for the 
distribution of resistance genes in the genomes of E. coli from cattle (left plot) and 
those from humans (right plot). The resistance genes are densely distributed in the 





Figure 4.7. Maximum Likelihood Core SNP based tree of E. coli genomes from 
humans (blue labels, n= 77) and cattle (red labels, n=186) showing resistance gene 
carriage. The black bars are a quantitative indication of the number of AMR genes in 
the genomes. The bars are based on the scale range of AMR genes between 0 - 17 per 
genome. This visualisation method clearly shows that the majority of the human strains 





4.3.5 Analysis of variants for selected resistance gene families 
Some of the most critical resistance genes in clinical medicine are those encoding beta 
lactamases and quinolones. Therefore, the last analysis was focused on the resistance 
genotypes for beta-lactamases and quinolones. Out of the E. coli genomes with 
resistance genotypes, (15%, 27/186) of cattle origin had blaTEM encoding beta 
lactamase as the only type that were detected (please refer to Table 4.4 for various 
gene variants). The blaTEM  resistance gene variants are reported to be widespread in 
community and clinical settings, they confers narrow spectrum resistance to beta-
lactam antibiotics (Vernet et al., 2014).  
In E. coli genomes of human origin, beta-lactamases were detected in (68%, 52/77) of 
the genomes with resistance genes (refer to Table 4.7 for various gene varinats). A 
total of 9 types of beta-lactamase encoding genes were detected with the blaTEM as the 
most frequent, other including new and rare genes are blaCMY, blaCTX-M, blaDHA, blaLEN, 
blaNDM, blaOKP, blaOXA and blaSHV (refer to Table 4.7). 
The resistance gene variants in the genomes of E. coli from humans were further 
analysed in the phylogenetic tree to determine their relationship with those isolated 
from cattle. This is a useful molecular epidemiology technique that can provide 
information about the possible exchange of AMR pathogens and genes between 
humans and cattle (refer to section 1.2.16). The variants of blaTEM-1 from cattle and 
human hosts were identical and clustered together on the same clade, an indication of 
common occurrence and possible exchange of these genes among the commensal 
bacteria in the study area. The phylogenetic tree of beta-lactamases is presented in 
Figure 4.8. Quinolones resistance genes were only detected in E. coli from humans 
and four resistance gene variants were noted including aac(6’)-Ib-cr-1 as the most 





Figure 4.8. Maximum likelihood core SNP based tree indicating genetic relationships 
between beta-lactamase genes identified in the study: black labels for the variants from 
cattle isolates and red labels for most variants from human hosts, except blaNDM-1 that 
is labelled in blue and blaDHA-1 is labelled in green. The reference genomes were 
downloaded from NCBI and are labelled in cyan. The tree is midpoint rooted. The 
blaTEM-1 genes from cattle and human were identical and clustered on the same clade 
together on the top circle of the tree. Other beta-lactamases that were only found in 






The study of resistance genotypes in microorganisms helps to understand how the 
resistance genes are emerging and spreading in a specific area (Woolhouse et al., 
2015). If we know the type of genes that are emerging in a particular environment then 
specific measures can be devised to control the spread. In addition we can also study 
the epidemiology of particular resistance genes in humans and animals for the same 
purpose of instituting preventive and control measures (Van Den Bogaard and 
Stobberingh, 2000). 
The study of resistance genotypes in microorganisms is difficult in developing 
countries such as Zambia because of limited facilities for molecular biology studies 
(Vernet et al., 2014). Therefore, the alternative and practical approach is to use 
traditional methodologies such as the disk diffusion test that was used in the initial 
study for screening of AMR in the E. coli population from both cattle and humans. In 
view of this, studies that attempt to use phenotype approach to screen for AMR and 
predict the possible genotypes in the test organism are valuable for developing 
countries, but advanced molecular studies involving PCR and whole genome 
sequencing are now desired for better results (Buckley et al., 2015; Croucher and 
Didelot, 2015). Indeed some studies have used the resistance phenotype data in order 
to predict the underlying resistance mechanisms (Zhao, 2015). However, this area still 
needs more research. 
In this study, analysis of genotypes and phenotypes of E. coli isolates from cattle was 
done. Out of the total of 60 isolates that were resistant to at least 1 antibiotic, 51 of 
them had at least 1 resistance gene variant to make a perfect match of up to 85%. 
Conversely, it provides confidence that relatively accurate predictions about genotype 
resistances can be made based on phenotypes in the absence of molecular tools such 
as WGS and PCR analyses. These findings can be used as a basis for building 




In this study, resistance genes and several gene variants encoding different types of 
antibiotics were detected (refer to Table 4.4 and Table 4.7). But more diverse 
resistance gene variants were detected in E. coli from humans than those from cattle. 
For instance only 3 gene variants encoding beta lactamases were detected in cattle 
whereas 16 of them were detected in E. coli from humans. The presence of resistance 
genes is influenced by the type of antibiotics that are being used in the animals or 
humans but also the horizontal gene transfer of genes from the environment and other 
reservoirs may be a contributing factor (Tadesse et al., 2012; O’neill, 2014).  
In this study it was found that tetracyclines and penicillin were the most common used 
antibiotics among the farms in the study area (refer to chapter 3, Figure 3.4), so the 
presence of resistance genes encoding these antibiotics were expected. However, the 
specific type of gene variants were not expected because there is little documented 
research on the prevalence of resistance genes in Zambia. The other possible sources 
of resistance genes are not known in the study area. Consequently, the resistance to 
tetracycline in the E. coli from both human and cattle were mostly encoded by tetA 
and tetB genes. The resistance to penicillin were encoded by the blaTEM-1 in the E. coli 
of cattle origin and there was no data on the use of antibiotics in the human host. It is 
therefore possible that other beta lactams antibiotics were used in humans such as the 
cephalosporin of different generations. Other common variant of resistance genes in 
human and cattle were sul1 and sul2 that encode for resistance to sulphonamides in 
both cattle and humans E. coli isolates. Although sulphonamides are uncommonly 
used in human medicine, they are still widely used in livestock production in 
combination with trimethoprim (Amaechi, 2014). However, several gene variant of 
dfrA encoding resistance to trimethoprim were detected in both human and the cattle 
isolates. Seven of these gene variants (dfrA1, dfrA5, dfrA7, dfrA8, dfrA12, dfrA14, 
dfrA15) were detected in both hosts with dfrA10 only detected in cattle and dfrA17 in 
isolates of human origin. The strA1, strA4 and strB1 were also common resistance 
gene variants encoding resistance to streptomycin in the isolates of both cattle and 




Although common genes were detected, there were also differences of gene variants 
that were detected among the genomes. For instance, there were more beta lactamase 
encoding genes variants in isolates of human origin than those from cattle. Other 
differences were for resistance genes that encodes for quinolones and were only 
detected in isolates of human origin and none of them were found in the E. coli from 
cattle. 
The presence of similar and unique resistance genes in these 2 independent E.coli 
populations from cattle and humans in the same study area is a complex scenario and 
creates a number of hypothesis. The possible explanation is that there were similar 
antibiotic selection pressure going on in cattle and humans resulting in the emergence 
of similar resistance genes in some cases. However, the beta lactamase encoding genes 
and other unique genes that were only found in the genomes of E. coli from humans 
may indicate the use of certain antibiotics such as cephalosporin, fluoroquinolones and 
amphenicols on a sub population of humans where no exchange of genes with 
microorganisms in cattle took place. However, the presence of several variants of rare 
resistance genes such as blaCMY, blaCTX-M, blaNDM, blaDHA and blaOXA in some 
genomes of E. coli from humans may also be an indication of the spreading of these 
genes from different parts of the country or indeed from other countries (Fang et al., 
2008). We recommend that a future study may focus to understand the different types 
of resistance gene variants in microorganism isolates from humans residing or working 
on specific farms. 
The other possibility is that since antibiotics such as tetracycline, penicillin and 
sulphonamides are not often used in human medicine because of the rampant resistance 
in microorganisms to these antibiotics (Eliopoulos and Roberts, 2003), the presence of 
encoding genes in E. coli from humans similar to those found in cattle may indicate a 
possible exchange of such genes among the microorganisms of which the direction of 
exchange is a subject of further research. 
From several resistance gene variants that were detected in the study organisms, it was 




the resistance to particular antibiotics. The association tests could not be done in the 
E. coli of human origin because there was no phenotypic data available. However, key 
findings were made in E. coli isolates from cattle. The blaTEM-1 encoding beta-
lactamase was significantly associated with resistance to ampicillin confirming the 
findings from the use of antibiotics. This was expected because it was the most 
frequent beta-lactamase encoding gene variant detected in E. coli from cattle. All the 
tet genes tetA, tetB and tetC were significantly associated with tetracycline resistance. 
This is in agreement with other studies that have reported tetA and tetB as the common 
determinant of tetracycline resistance in E. coli from faecal samples of cattle (Shin et 
al., 2015). 
The resistance to sulfamethoxazole/trimethoprim was associated with all the three 
genotypes for sulphonamides (sul1, sul2 and sul3) in each case and only three gene 
variants dfrA5, dfrA7 and dfrA8 out of the total 8 variants that were significantly 
associated with trimethoprim. The aminoglycoside modifying enzyme 
acetyltransferase encoding gene (aac(3’)-II) had a significant association with 
gentamicin phenotype resistance. These genes could be targeted in future molecular 
epidemiology studies to further understand their evolution and spread. 
Although the AMR selection pressure in humans and dairy cattle was not studied and 
compared, there was significantly more number of resistance genes in the E. coli from 
human hosts than the ones from cattle hosts (Wilcox rank sum test, p < 0.001). This 
translated into having more resistance gene patterns among the E. coli isolates from 
humans. Only two patterns of resistance genotypes were observed in common between 
the two populations (tetB and blaTEM-1-tetA patterns) (refer to Appendices 4 and 5). 
This probably is still an indication that the two E. coli populations have undergone 
through separate AMR selection pressures and that some antibiotics were only used in 
humans and not in the dairy herds. As already alluded to, it may also indicate that some 
resistance genes in human population could be spreading from other sources within or 




The detection of several beta-lactamases encoding genes in human E. coli population 
means the surveillance for beta-lactamases should be enhanced in both livestock and 
humans. Hendriksen et al., (2013) reported multiple antibiotic resistance encoding 
genes including cat1, blaTEM-1, dfrA7, sul1, sul2, strA and strB in human Salmonellosis 
in Zambia. However,  epidemiology of the carbapenemases such as blaNDM-1 that has 
been detected in this study is not well described in Zambia and in the African region 
as a whole (Manenzhe et al., 2014). The blaNDM-1 carbapenemase encoding gene has 
been reported to spread very fast and confer resistance to essential antibiotics 
(carbapenems) that are used to treat infections in humans that are caused by ESBL 
Gram-negative bacteria (Yong et al., 2009; Lowman et al., 2011). The surveillance for 
the three gene families encoding fluoroquinolones resistance (qnr, qepA and aac(6’)-
Ib-cr) should also be enhanced. It will also be necessary to carry out further 
comprehensive AMR studies in human focusing on ESBLs and fluoroquinolones.  
Although the study generated novel results, the following shortfalls in the 
methodologies were noted: 
Sequencing of a subset of E. coli from cattle. The selection of the E. coli from cattle 
were partly purposely selected and this creates bias because other isolates were initially 
not given equal chances to be selected. In addition, our results possibly were negatively 
affected because not all the isolates were sequenced even though a random selection 
was used in the last set of the isolates after removing all those that were resistant to 
antibiotics and those that were Shiga toxin encoding genes positive. 
Whole genome sequences and analysis. Some valuable data were lost during the 
processing of whole genomes. The FastQC program was used to assess the quality of 
the genomes and those that were of low quality were removed from downstream 
processing (Bioinformatics, 2011). Additionally during processing, the deno vo 
assemblies produces gapped scaffolds sequences with the potential of having novel 
and valuable information in the gaps (Boetzer and Pirovano, 2012). In order to 
maximise accessing of the information contained in the genomes, it is a precaution 




Pirovano, 2012). However, this was not done in this study and it is possible that some 
information such as new resistance genes were missed. For instance in this study we 
specifically looked and did not find a new gene mcr-1 that encodes for mechanism 
responsible for resistance to colistin (Liu et al., 2016). Since we did not close the 
genomes we cannot definitely rule out its presence.  
Having analysed the resistance to antibiotics and their genetic basis of the E. coli 
populations from cattle and human hosts in the present chapter (Chapter 4) and the 
previous one (Chapter 3), the data set will be subjected to analysis of virulence factors. 
The analysis will be focused to determine the presence of Shiga toxin producing E. 
coli (STEC) in our E. coli collection. This is because STEC have been a public health 
concern in many industrialised countries and they have caused big food borne disease 
outbreaks that accompanies morbidities and mortalities in humans. Livestock 
especially cattle are the primary reservoir of STEC and humans gets infected through 
consumption of contaminated food. In Zambia, few studies have reported the presence 
of STEC in livestock but there is no comprehensive information on the prevalence and 
it is not known whether those STEC are causing any human infections. So Chapter 5 
will try to provide some information on these knowledge gaps by analysing the 
collection of E. coli from both cattle and humans in this study. Potentially the findings 









Chapter 5 : Analysis of STEC in the study 
area 
5.1 Introduction and aims 
In sub-Saharan Africa, there is limited information about the epidemiology of STEC 
in livestock systems and the impact of STEC on human health is not known (Farrokh 
et al., 2013; Islam et al., 2014). Shiga toxins (Stx) are a family of closely related toxins, 
in terms of function and structure, produced by Shigella dysenteriae type 1 strains and 
a subset of E. coli strains termed Shiga toxin producing E. coli (STEC) (Melton-Celsa 
and O’brien, 2000) (refer to the introduction chapter, section 1.1.4 for the description 
of different E. coli pathotypes)(Paton and Paton, 1998). Two immunologically distinct 
Stx variants have been identified, Stx1 and Stx2, which are further divided into 
subtypes; stx1a, stx1c and stx1d and subtypes stx2a, stx2b, stx2c, stx2d, stx2e, stxf, 
stx2g, respectively(Krüger et al., 2011; Fagan et al., 1999). Both Stx1 and/or Stx2 
containing STEC can cause disease in humans. However, Stx2 producing isolates 
causes more severe disease than the isolates that produce Stx1 (Boerlin et al., 1999). 
In vitro studies established that purified Stx2 was 1000 fold more toxic on human renal 
endothelial cells than stx1 (Louise and Obrig, 1995). The pathogenicity of Stx2 
producing E. coli depends on the various levels of toxin production. A study using 
phylogenetic analysis of WGS of 123 Stx2 isolates and 12 reference genomes reported 
that Stx2a phage subtype was a critical factor that determined the virulence of Stx2 
positive STEC isolates (Ogura et al., 2015). 
Both Stx1 and Stx2 toxins are classic AB5 toxins comprised of a single catalytic A-
subunit, encoded by stxA, attached to a B subunit pentamer, encoded by stxB (Herold 
et al., 2004). The AB5 toxins are a family of protein toxin complexes that are secreted 
by certain pathogenic bacteria including STEC and V. cholerae, they share common 
structure and mechanisms of entering the target cell (Boerlin et al., 1999). The stxA 




horizontally by E. coli after viral infection (transduction) and subsequent lysogeny 
(Herold et al., 2004). 
In case of human infection with Shiga toxins, the B subunit first attaches to 
globotriaosylceramide (Gb3) receptor (Gb3/CD77) and by endocytosis enters the 
cytoplasm of the target cell and then enters the transport pathway of the cell through 
the Golgi apparatus to the ribosomes on the endoplasmic reticulum of the cell (Croxen 
et al., 2013). Then through a catalytic reaction of toxin subunit A as an RNA-
glycosidase, it removes (cleaves) an adenine from the 28S ribosomal RNA in order to 
inhibit protein synthesis and eventually cause target cell death (Pruimboom-Brees et 
al., 2000). 
In addition to Stx, Enterohaemorrhagic E. coli (EHEC), a subgroup of STEC, express 
a type III secretion system (T3SS) that is important for bacteria pathogenesis. T3SS is 
encoded by a T3SS gene cassette that is located on the locus of enterocyte effacement 
(LEE) pathogenicity island. The region has five main operons and these encode a basal 
secretion apparatus, (mainly esc designation genes) and a translocon (encoded by 
espADB) which requires expression of sepL for production. The pathogenesis of LEE-
positive STEC depends on translocation into cells of a variety of effector proteins that 
manipulate host cell function. The main functions described are attachment and innate 
response modulation. Intimin is a LEE-encoded outer-membrane protein that interacts 
with the translocated intimin receptor (Tir) on the host cell surface (Kaper et al., 2004). 
Once intimin on the bacterial surface attaches to Tir on the host cell there is initiation 
of signalling changes in the host cell involving cystoskeleton re-arrangement driven 
by Arp2/3 complex. This can lead to the formation of attachment and effacement (A/E) 
lesions (Kaper et al., 2004). A/E lesions involve degenerated gut microvilli and 
densely clustered cytoskeleton proteins that appears like a pedestal to form a stand for 
the colonising bacteria (Paton and Paton, 1998). Ruminants (cattle, sheep, and goats) 
are the primary reservoir of STEC. Human infections of STEC are therefore incidental 
and occur through direct contact with infected animals or indirectly by consumption 
of contaminated food or/and water (Gyles, 2007). E. coli O157 has been the main 




America since 1982 when it was first discovered in North-west USA (Wells et al., 
1991; Islam et al., 2014). However, there are another six key serogroups (O26, O111, 
O103, O121, O145 and O45) of non-O157 STEC that can be associated with human 
infections in Europe, Australia and North America (Pearce et al., 2006; Friesema et 
al., 2014). Other serogroups have also been identified but very rarely.  
As a part of the whole study, the E. coli collection from chapters 3 and 4 that were 
analysed for AMR will now be analysed for Shiga toxin producing E. coli. As alluded 
to in chapter 3, I designed the original PhD study and carried out all the field sampling 
under the supervision of my supervisors. In this chapter, specifically, I carried out all 
the laboratory work in particular the PCR assays to screen all the 371 E. coli isolates 
for Shiga toxin encoding genes. Additionally, all the isolates were also screened for 
the phylogroups. Thereafter, all the isolates positive for Shiga toxin encoding genes 
were prepared for sequencing (refer to Chapter 4, Table 4.1). This included DNA 
extraction as well as quantification and standardisation using electro fluorescent gels 
and Nano drop readings. DNA samples were sent for sequencing to Edinburgh 
Genomics, University of Edinburgh (http://genomics.ed.ac.uk/). 
I also carried out Vero cell assays in the laboratory to test the cytotoxicity of extracts 
from stx positive isolates. The work involved culturing the bacteria and preparing 
lysates containing in containment level 3 (CAT 3) laboratory conditions as the majority 
of the strains were stx+. The Vero cell assays involved culturing of green monkey 
kidney cells (Vero cells) and testing the killing effect (toxicity) of the isolate extracts 
on them. During the laboratory work I was supervised by the Assistant Research 
Scientist (Sean McAteer) with the work overseen by my supervisors David Gally and 
Mark Stevens. 
This chapter also includes the risk analysis that performed to assess the presence of 
STEC in different farming types. The statistical modelling was done in R environment 
and I was supervised by the Research Fellow (Paul Bessell) and my supervisors (Mark 




Further work in this chapter involved the in silico analysis of the sequence data 
(bioinformatics). Therefore, after the sequencing was carried out, I received the data 
from Edinburgh Genomics and downloaded it to the storage space for the Gally group 
on the Roslin server. The in silico analysis involved a lot of data manipulation in the 
Linux environment, as such all the analysis were carried out with the help of 
bioinformaticians at the Roslin Institute, mainly within the Gally group (Nadejda 
Lupolova and Sharif Shaaban); I was also helped in the bioinformatics by Emily 
Richardson from Ross Fitzgerald’s group within the Roslin Institute. The 
bioinformatics was overseen by David Gally and Tim Dallman (Public Health 
England). 
Sequence read quality assessment used FastQC and then sequences were assembled 
using SPADES. The in silico analysis to detect the presence and absence of stx1 and 
stx2 and the subtyping were done using BLAST. Phylogenetic analysis was used to 
construct the relationship trees of the E. coli isolates from Zambia which included 
some E. coli from around the world and different host species for context. The addition 
of these comparative E. coli sequences lead to the inclusion of multiple co-authors on 
the manuscript for provision of this material and/or information. 
The final part of my work in this chapter was to draft the manuscript and Nadejda 
Lupolova (Gally group) added some data on some of the bioinformatics approaches 
that were used in the analysis. The manuscript was first edited by David Gally and then 
sent to all the co-authors for their inputs. The now published paper in Scientific 
Reports is included in this chapter with the following aims.  
1. To assess the zoonotic potential of STEC from Zambian dairy cattle and humans.  
2. To determine the phylogenetic relationship of STEC isolates from Zambia with 
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This study assessed the prevalence and zoonotic potential of Shiga toxin-producing 
Escherichia coli (STEC) sampled from 104 dairy units in the central Zambia and 
compared these with isolates from patients presenting with diarrhoea in the same 
region. A subset of 297 E. coli strains were sequenced allowing in silico analyses of 
phylo- and sero-groups. The majority of the bovine strains clustered in the B1 
‘commensal’ phylogroup (67%) and included a diverse array of serogroups. 11% 
(41/371) of the isolates from Zambian dairy cattle contained Shiga toxin genes (stx) 
while none (0/73) of the human isolates were positive. While the toxicity of a subset 
of these isolates was demonstrated, none of the randomly selected STEC belong to key 
serogroups associated with human disease and none encoded a type 3 secretion system 
synonymous with typical enterohaemorrhagic strains. Positive selection for E. coli 
O157:H7 across the farms identified only one positive isolate again indicating this 
serotype is rare in these animals. In summary, while Stx-encoding E. coli strains are 
common in this dairy population, the majority of these strains are unlikely to cause 
disease in humans. However, the threat remains of the emergence of strains virulent to 
humans from this reservoir. 
INTRODUCTION 
Shiga toxigenic E. coli (STEC) are emerging pathogens of public health concern 
worldwide, including in Europe, North and South America and Asia 1,2. Ruminants, in 
particular cattle, have been identified as the predominant reservoir of STEC3,4, 
indicating that the bacteriophage-encoded Shiga toxins (Stx) are likely to confer an 
advantage to E. coli in these host animals. In Africa there is little information on the 
epidemiology of STEC in livestock systems and their impact on human health1. It is 
evident that only a subset of STEC are a serious threat to human health, these 
enterohaemorrhagic E. coli (EHEC) are associated with specific serogroups in 
particular the seven that have been defined as adulterants in beef production in the 
USA, O157, O26, O111, O45, O145, O103, O121 5,6. Similar serotypes, especially 
O157 & O26 are also an issue in Europe. Typical EHEC strains can be further 




colonisation of the gastrointestinal tract7. EHEC infections in humans are associated 
with diarrhoea and bloody diarrhoea, with the more serious sequelae of kidney and 
brain damage due to activity of Stx on the microvasculature in these organs4,8. 
The cost of whole genome sequencing (WGS) has drastically reduced and it is now 
possible to sequence large numbers of isolates and use bioinformatics approaches to 
extract strain relatedness and gene carriage data. For E. coli, strains have classically 
been assigned into phylogroups that provide a good correlation with commensal versus 
pathogenic strains 9. The phylogroups are based on particular combinations of specific 
genes and can be assigned from the WGS. Whole genome core SNP analysis to define 
strain relatedness is now commonly used and provides greater resolution than MLST10. 
In addition the serogroup, the O-chain of LPS, can also be inferred from their genetic 
determinants using WGS. The WGS of any strain collection is therefore a valuable 
resource allowing relatively rapid comparison of phylogeny and pathogenic potential.  
Both small holding and large-scale dairy farming is important to the economic survival 
of communities in many developing nations, including Zambia11, 12. As such, it is 
important to understand if practices on these units and their products may represent a 
threat to human health and where such risks exist suggest possible mitigation 
measures. A study has recently been carried out to sample E. coli strains from cattle 
across small, medium and large-scale (commercial) dairy farms in central Zambia, 
with the primary aim of understanding antibiotic use and antimicrobial resistance 
patterns in this sector13. 
These isolates have now been further analysed in the present study for stx prevalence 
and any association with the farming system. In addition, E. coli isolates from patients 
with diarrhoea were also screened and sequenced to determine evidence of relationship 





Detection of Shiga toxin alleles (stx1 and stx2) in isolates from Zambian dairy 
cattle and humans 
Eleven percent (41/371) of the bovine E. coli isolates were positive for the presence of 
Shiga toxin genes as defined by detection of appropriately sized PCR amplification 
products using an established stx multiplex assay (Paton and Paton, 1998). Based on 
this, both stx1 and stx2 were detected in 54% (22/41) of the STEC, while 37% (15/41) 
had stx2 only and 10% (4/41) had stx1 only. Using this data, the overall adjusted 
prevalence of STEC across the different farming scales for the central Zambian study 
area can be estimated at 6% (95%CI: 2.5-10.2). The adjusted prevalence per farming 
scale was higher in medium-scale 17.1% (95%CI: 5.9-28.2) and small-scale 10.6% 
(95%CI: 6.6-14.5) farms when compared to the commercial farms 2.8% (95%CI: 0.3-
6.0). Based on these ranges, there is a significant difference in estimated prevalence 
between the small and commercial scales. Logistic regression indicates that medium- 
and small-scale farming are significant risk factors for Shiga toxin producing E. coli 
(STEC) with commercial as a reference (Table 5.1). Out of the 79 E. coli isolates from 
human patients with diarrhoea, no Shiga toxin genes were detected.  
Table 5.1. Farming type STEC risk analysis 
Farm type Estimate 95%CI P 
Commercial 1 - - 
Medium 7.05 1.76-28.28 0.007 
Small 4.05 1.20 – 13.64 0.002 
As an additional investigation, the enrichment cultures for all the animals (n=371) 
were streaked onto sorbitol MacConkey agar plates and any non-sorbitol fermenting 
colonies tested for O157 agglutination. Only one animal yielded a positive strain (ZB-





In order to understand the genetic backgrounds of the STEC strains isolated in this 
study, including their potential threat to human health, their relationship to other 
human disease-associated EHEC were tested by phylogenetic methods.  The WGS of 
297 of the Zambian isolates (224 bovine and 73 human) were determined. This 
included 41 STEC, 37 of the 41 defined as stx+ by PCR from main study, three STEC 
strains from a pilot study and the single positively selected E. coli O157 strain. These 
were compared with other 262 E. coli sequences from human, cattle, avian and canine 
hosts; one hundred and twenty nine strains in this second collection were human 
clinical STEC isolates (see Supplementary Table 1). 
Alignment to a reference genome (E. coli O157:H7 str. Sakai, RefSeq assembly 
accession: GCF_000008865) resulted in 715,632 core positions with 68,327 single 
nucleotide polymorphism (SNPs) across all 559 sequences. A maximum likelihood 
phylogeny revealed the population structure of the E. coli strains (Figure 5.1).  
While there was no clear clustering of the strains based on geographical location or 
host, there was, as anticipated, good correlation with established E. coli phylogroups, 
with only minor discordance. All possible phylogroups and cryptic clades were 
identified, however the majority of the E. coli strains (97%) were distributed across 
only 5 phylogroups (Figure 5.1). 
The Zambian bovine strains (n=224) predominately associated with the B1 
‘commensal’ cluster (67%) with the remainder present as: A (9%); B2 (4%); C (8%); 
D (9%); other (3%). By contrast, the Zambian human strains (n=73) had equivalent 
representation across the 5 main phylogroups: A (22%); B1 (19%); B2 (16%); C 
(22%); D (16%); other (5%). The Zambian cattle STEC strains were also 













Figure 5.1. Phylogenetic context of Zambian isolates. The tree (divided in two 
previous pages for the purpose of clarity in the thesis) depicts the phylogenetic 
relationship of E. coli isolates from Zambia (bovine - red and human - blue) with other 
E. coli isolates (grey). The ML tree is based on core SNPs as described in Materials 
and Methods. The tree is un-rooted and grey circles on branches represent bootstrap 
values higher than 80. Vertical columns demonstrate: (1) Diversity of the sequence 
types (ST) based on MLST analysis where each colour represents a different ST; (2) 
Diversity of O-serogroups for which each colour represents a different group; (3) 
Phylogroups: A-yellow, B1-red, B2-blue, C-green, D-turquoise, E-pink, F-grey, 
cryptic clades-light green. The phylogroups are consistent with core SNP clustering 
with some minor discordance. White spaces on all columns indicate sequences that 
were untypable (Acknowledgement to Nadejda Lupolova for the help to produce this 
figure). 
Serotyping 
The majority of EHEC strains that are a threat to human health are associated with 7 
specific serogroups. A bioinformatic approach was used to serotype the sequenced 
strains. H typing was possible for 550/559 strains and O-typing for 483/559 
(summarized in Supplementary Tables 3 & 4). Failure to detect specific genes in some 
of the strains was most likely due to assembly issues with short read sequences.  
With the exception of the positively selected E. coli O157 strain, none of the Zambian 
bovine STEC strains (0/40) was assigned to any of these seven serogroups. In fact, 
only 3 strains across the whole set of cattle isolates could be assigned within these 
serogroups (ZB-244; serogroup O45 and ZB-2213N0112; serogroup O111 and ZB-






Figure 5.2. Phylogenetic relationship between STEC. The same ML core SNP tree as 
in Figure 5.1 plotted in a circular manner to depict relationships between Shiga toxin 
encoding strains. The strain designations are Zambian bovine (red), Zambian human 
(blue), other E. coli (grey). For the Zambian strains, the coloured bars indicate the 
presence of Stx: stx2 (purple) and stx1 (green). Black blocks around the tree indicate 
non-Zambian E. coli encoding stx (1 or 2). Orange blocks highlight the presence of 
intimin (eae) and sepL indicating the possession of a type 3 secretion system. It is 
apparent that with the exception of one positively selected EHEC O157 (ZB-
2213N0194), that the Zambian cattle STEC do not encode this system. The on the top 




occurring in close proximity with clinical E. coli O157 from UK. ( Acknowledgements 
to Nadejda Lopulova for the help in producing this figure). 
Overall, the Zambian strains (cattle and human) exhibited an extensive array of 
serogroups (Figure 5.1 and Supplementary Table 4) and H:O combinations were 
unique for each strain with little clustering or association with established human 
clinical isolates (Figure 5.2). 
Toxicity analysis of stx+ strains  
To determine if the genotypically positive stx strains were able to express Stx, eighteen 
of the bovine STEC were examined for Vero cell cytotoxicity with and without 
mitomycin C (MMC) induction. 89% (16/18) of the MMC-induced STEC strains had 
a cytotoxic effect on Vero cells (Figure 5.3). These samples were verified as Stx 
positive using a commercial ELISA (Figure 5.3), with only one strain (4) exhibiting 
toxicity on Vero cells without any detection of Stx by ELISA. 
Shiga toxin subtyping  
Forty one STEC positive strains were included in the WGS analysis (Figure 5.2) and 
from this stx alleles could be further subtyped using a published BLAST-based 
methodology28 (Supplementary Table 5 ). It was evident that the most cytotoxic strains 
(Figure 5.3) were those encoding Stx2a often in combination with Stx1a, in line with 
studies of cytotoxicity and pathology induced by enterohemorrhagic strains with 





Figure 5.3. Shiga toxin activity and subtyping. The top panel graph indicates the 
cytotoxic effect of selected STEC strain supernatants on Vero cells. Increased cell 
survival results in higher values. 0.2% Triton X-100 was used as a positive control; 
RPMI + LB and RPMI alone were used as negative controls. Values below the black 
dotted line indicate a cytotoxic effect on the cells. 89% (16/18) of the STEC 
supernatants tested demonstrated a cytotoxic effect. Supernatants were prepared as 
described in Materials and Methods. Stx subtypes are shown in the lower panel along 
with ELISA results for detection of Stx. Isolates with both stx1a and stx2a are 
associated with higher toxicity. Sample number ZB-4 contains stx2a and exhibited 
cytotoxicity on Vero cells but was negative by ELISA. 
Stx association with type 3 secretion and enteroaggregative virulence factors 
Typical enterohemorrhagic E. coli strains are defined by the co-association of stx genes 
with a type 3 secretion system (T3SS) (Kaper et al., 2004). In the present study, the 




BLAST analysis, 3.6 % (8/224) and 2.7% (2/73) of the Zambian bovine and human 
isolates may encode a T3SS respectively (Figure 5.2). Excluding the positively 
selected O157 strain, neither intimin (eae) nor sepL were detected in the bovine STEC. 
Other non-STEC but intimin positive strains were present within the Zambian strain 
analysed and some were in close proximity to clinical human STEC strains (Figure 
5.2). The cattle strains were also checked for the presence of the enteroaggregative E. 
coli (EAEC) adherence factors AggR and AA probe by PCR but all were negative 
indicating that these dairy cattle are not a common reservoir of enteroaggregative E. 
coli as associated with the atypical EHEC O104 outbreak in Northern Germany in 
2011. 
DISCUSSION 
Shiga toxins (Stx) can pose a serious threat to human health, and human infections are 
usually restricted to a subset of serogroups that can express Stx and a type 3 secretion 
system (T3SS) or other adherence mechanisms that can facilitate colonisation of the 
human gastrointestinal tract. In this study, E. coli isolates were obtained from cattle 
associated with dairy production in a region of central Zambia. A total of 371 isolates, 
each from an individual animal, covering 104 farms were tested for the presence of stx 
by PCR. Of these, 41 (11%) were positive. This gives an estimated prevalence (taking 
into account sampling and the study design effect) of 6% (95%CI: 2.5-10.2). To our 
knowledge, this is one of the first surveys to systematically analyse the proportion of 
random E. coli from a farm animal source that are positive for stx as other studies 
usually use positive selection methods from animals. Our survey does indicate that 
STEC are common in these dairy cattle. It was also evident that the small and medium 
sized production units had a higher prevalence of STEC than the commercial units 
sampled. This is of interest as it does indicate that management practices potentially 
influence the selection of STEC. On-going work will investigate these differences 
including the influence of breed which can differ between the farming scales13 and/or 
diet which can change EHEC O157 prevalence33. 
Our study also examined 73 E. coli strains from human patients with diarrhoea 




numbers were relatively low, stx was not detected, indicating that STEC are unlikely 
to be common in the local human population. The overall phylogenetic analyses of the 
strains into phylogroups was as anticipated, with the majority of the Zambian bovine 
strains being present in the B1 group associated more with commensal strains, 
although this cluster contains non-O157 EHEC serotypes causing infections in humans 
that likely originate from cattle. A greater proportion of the human Zambian isolates 
clustered within the phylogroups associated with human disease, reflecting that the 
strains were collected from patients with diarrhoea and in some cases the strain may 
be the aetiological agent. 
Based on bioinformatic analyses of WGS, there was marked diversity of serotypes in 
the cattle and human sample populations (Figure 5.1 and Supplementary Table 3 & 4 
online). None of the randomly selected bovine STEC was allocated to a serogroup 
commonly associated with human EHEC infections. Furthermore, none of these 
bovine STEC encoded a T3SS based on detection of intimin (eae) and SepL alleles 
(Figure 5.2). An additional study to positively select for E. coli O157 isolates from the 
faecal pat enrichments only identified one positive sample from a farm. Taken 
together, this study indicates that while STEC are common in the Zambian dairy cattle 
these strains would not be classified as EHEC and are unlikely to be associated with 
serious human disease.  
While it is encouraging that EHEC strains were extremely rare, many of the 
supernatants from the STEC strains were cytotoxic and appropriate backgrounds for 
EHEC emergence are present. As such, we should remain vigilant in case Stx-encoding 
prophages from this reservoir do emerge in other strain backgrounds that have a higher 
capacity to cause disease in the human host. Continuing work on factors driving the 
maintenance of STEC strains in the bovine host will hopefully clarify approaches to 





Bovine and human isolates from Zambia 
Bovine E. coli isolates (n=371) were collected as part of a previously published study 
investigating antimicrobial resistance13. Faecal sampling and animal handling of the 
farm animals was carried out in accordance with the approved guidelines issued by 
The Roslin Institute Animal Welfare and Ethical Review Body which approved this 
study13. A total of 376 dairy cattle from 104 farms representing about 20% of the dairy 
herds in the study area were randomly sampled and an E. coli was isolated from each 
of the 371 animals based on growth characteristics on both MacConkey agar and Bile-
X-Glucuronide (TBX) plates (Oxoid, UK). Subsequent phylotyping indicated that 
97% (361/371) could be allocated to established E. coli phylogroups14. In addition, a 
further 81 E. coli isolates from cattle in the same study region had been collected as 
part of a pilot study for the above. The E. coli isolates from patients presenting with 
diarrhoea were collected at Lusaka hospital between 4th December 2014 and 7th 
January 2015 as part of another project managed by Prof. JB. Muma and generously 
supplied for sequencing. Informed consent was obtained from all subjects. Further 
strain and sequence details are provided in the Supplementary Table 1. 
DNA extraction 
Bacteria were cultured in LB broth overnight at 37 oC. One mL of bacterial suspension 
was subject to DNA extraction as per the Wizard Genomic DNA Extraction Kit® for 
the first batch of isolates (n=136) and the Qiagen® DNA extraction kit for the second 
batch of isolates (n=192).  
PCR detection of virulence determinants  
The bovine strains were screened by a published multiplex PCR for Shiga toxin genes 
and intimin15. The strains were also screened with a multiplex PCR for aggR and AA 
probe genes as markers for enteroaggregative E. coli16. The PCR products were 




electrophoresis in 1.5% w/v agarose gel (Agarose, Melford, UK) and staining with 
Gelred®.  
Verocytotoxicity assays 
Established method17,18, with these minor variations: Single colonies were selected 
from LB agar plates and suspended in 10 ml of LB broth for 24 h (overnight). 50 µl of 
overnight culture was added to 5 ml (1:100) of fresh LB broth and incubated for 60 
min. Then 20 µl of 5 µg/ml mitomycin C (MMC) was added followed by overnight 
incubation. 
Supernatant samples were screened for the presence or absence of Stx using a 
commercial ELISA kit (RIDASCREEN® Verotoxin ELISA (C2201), R-Biopharm 
AG, Darmstad, Germany) according to the manufacturer’s instructions. 
Statistical analysis 
The adjustment of prevalence estimates per farming scale and the risk factor analysis 
were carried out using logistic regression in ‘survey package’19 in R software 
environment version 3.1.1 (http://cran.r-project.org/), p < 0.05 values were taken as 
statistically significant. The statistical analyses and more information on the definition 
of the different level farming systems were as described previously13.  
E. coli whole genome sequence analyses 
To better understand how the Zambian E. coli strains dataset compared with other E. 
coli, the Zambian strain genomic sequences were analysed with a larger strain 
collection that consisted of 559 E. coli genomes, including clinical and commensal 
isolates from 4 different broad categories of animal and human hosts (Supplementary 
Table 1). New short read sequence files have been uploaded to European Nucleotide 
Archive under the study accession number: PRJEB11782, PRJEB11950, 




due to poor read and/or assembly quality, resulting in 297 Zambian genome sequences 
(224 bovine and 73 human) available for analysis.   
Sequencing analysis 
All reads were generated by Illumina 1.9 paired-end read sequencing with read lengths 
from 36 to 251 bp. FASTQC 20 was used for quality assessment and where necessary 
trimming was done with cutadapt 21.  Short reads were aligned to a reference E. coli 
O157:H7 str. Sakai (RefSeq assembly accession: GCF_000008865) by combining 
BWA22, SAMtools and SnpEff23 in a custom-made python script. The consensus 
sequence for each alignment of 5,590,092 bp was produced using the majority rule. 
Consensus sequences for each alignment were concatenated into one multifasta file 
that were then parsed to find core positions. Multifasta files of concatenated core 
nucleotides for each strain were used for recombination analysis with GUBBINS24. 
The recombinatorial regions were removed from the final alignment. The final 
alignment was then used to construct a Maximum Likelihood (ML) tree with 
RAxML25 under a GAMMA model of heterogeneity with 100 bootstrap replicates 
(BS). The trees were visualised with ITOL26. 
An established phylotyping scheme27 was used as a starting point to develop a 
programme that assigned each strain to one of the 4 possible phylogroups (A, B1, B2, 
and D) based on the presence or absence of one of 3 genes chuA, yjaA, arpA and one 
genetic fragment TspE4.C2. To further distinguish between groups and assign strains 
to an additional 4 phylogroups (C, E, F or cryptic clades), it was necessary to check 
for the presence of a fifth gene trpA and for the presence of specific alleles for the 
above genes. arpA alleles were used to distinguish between phylogroups D and E based 
on specific primer sequences described in27.  
To establish gene presence or absence a database that includes all sequences from the 
collection were built with BLAST+28. Query gene's sequences of intimin, sepL, chuA, 
yjaA, arpA, trpA, genetic fragment TspE4.C2  were downloaded from the NCBI 




toxin sequences identified in 29 also were downloaded from the NCBI website. Gene's 
presence were established based on E-value = 0 and similarity match at > 90% 
coverage of the query sequence.  For Shiga toxins blast results were filtered based on 
bit score above 1000, if multiple contigs were involved only the highest result was 
kept. 
Serogroups were identified based on presence of one or several alleles from the 
following genes: for O-typing - wzx, wzy wzm and wzt; for H-typing the flagellin genes 
fliC, flkA, fllA, flmA and flnA. Databases were provided by Dr Flemming Scheutz and 
colleges 29. Multi locus sequence type were identified using SRST2 software30. 
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39 This study, two collections of avian isolates. 
(i) Disease associated isolates from the UK, 
Italy and Germany, courtesy of Zoetis Animal 
Health (ii) E. coli strains from the GIT of 
healthy birds (UK). Sequences released to 








6 Isolates from diseased birds in Germany and 
Italy, courtesy of 













     
Isolates from cattle fecal sampling in central 
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A subset of E. coli O157 strains isolated from 
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Canine Canine (UK) 
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18 Multi-drug resistant strains isolated from dogs 
at the Edinburgh 
University Veterinary School (3) Sequences 








19 A s bset of strains associated with 
community-acquired canine UTI (3) 
Sequences release to public 31 January 2016 
http://www.ebi.ac.uk/ena/data/view/PRJEB11
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Isolated from patients exhibiting symptoms of 
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NCBI: 
 
H10407, REL606, HS, IAI1, E24377A, 
55989, SE11, TW14359- O157, Sakai, 
Godstone, SMS, IAI39, CE10, 42, UMNO26, 
E2348- 
69, SE15, JJ1886, NA114, 536, S88, 
IHE3034, PMV, UTI89, UM146, LF82, 857C, 
83972, CFT073, W3110, MG1655 
     
 
 
 Supplementary Table 2. Gene Identifiers 
Gene GI Position 
arpA 556503834 4222487-4220301 
chuA 15829254 4391446-4389464 
trpA 556503834 1317222-1316416 
TspE4.C2 7330942 Not applicable 
yjaA 556503834 4213234-4213617 
SepL NC_002695.1 4593776 - 4594831 



















Supplementary Table 3: Most frequent H-types defined from whole genome 
sequence analysis 
Collection (all including Zambian) Zambian only 
H type (44 types 
identified) 
Number of strains 
 
550 
H type (42 types 
identified) 
Number of strains 
 
297 
H7 242 H21 38 
H4 47 H8 26 
H21 47 H7 25 
H8 31 H4 22 
H10 23 H10 16 
 
Supplementary Table 4: Most frequent O types assigned from whole genome 
analysis 
Collection (all including Zambian) Zambian only 
O type (129 types 
identified) 
Number of strains 
 
483 
O type (102 types 
identified) 
Number of strains 
 
235 
O157 57 O8 17 
O8 20 O25 9 
O6 16 O102 9 
O25 13 O6 6 





Supplementary Table 5: Shiga toxin subtypes of bovine Zambian STEC 
Shiga toxin Subtype Number of isolates % 
stx1 only sxt1a 4 9.76 
stx2 only stx2a 3 7.32 
stx2b 1 2.44 
stx2d 7 17.07 
stx2e 1 2.44 
stx2c 2 4.88 
Stx1 and stx2 stx1a, stx2d 9 21.95 
stx1a,stx2a 10 24.39 
stx1a,stx2g 1 2.44 
stx1c, stx2b 1 2.44 











5.2. Analysis of sweeps taken from bacterial cultures for stx2 
and rfbO157 encoding genes 
Apart from the isolation of individual E. coli from the faecal samples of cattle, the 
sweeps of bacteria cultures were also taken from the culture plates and screened using 
mPCR for the presence and absence of rfbO157 and stx2 genes. This was done in order 
to increase the chance of detecting these genes as an additional assay to the analysis of 
individual isolates that was being used in the study. A convenient sample of 69 samples 
were used for this analysis. A total of 30 % (21/69) of the samples were positive for 
the presence of rfbO157 genes, while 92% (63/69) of the samples were positive for the 
presence of stx2 genes further confirming that Shiga toxin encoding genes were 
common among the study farms in line with the other results presented earlier in this 
chapter indicating that STEC was a common finding in Zambian dairy cattle and that 
E. coli O157 was present but rare as presented in Figure 5.4. 
 
Figure 5.4. The analysis of rfbO157 and stx2 genes in the bacteria culture sweeps type 
of samples. The results for the presence and absence of rfbO157 (left pie chart) and 




21/69) of the samples, while the right pie chart is showing that (92%, 63/69) was 
positive for stx2 gene. 
5.3. Spatial analysis of STEC in the study area 
Spatial analysis has been used in public health studies in order to determine whether 
the cases (positives) are clustered, dispersed or randomly occurring (Kao et al., 2016). 
The spatial distribution of cases helps to find out the associated or causative risk factors 
that may be accompanied with their occurrence. In this study, the spatial 
autocorrelation analysis of STEC distribution was done in ArcMap 10.2.1 package 
using Global Moran’s Index statistic in order to investigate whether they clustered 
geographically or there is any spatial autocorrelation of cases within the study areas. 
Global Moran’s Index is an indicator used to calculate a global spatial autocorrelation 
analysis within GIS ArcMap package (Anselin, 1995).  
Briefly, as described in Kao et al., (2016), the algorithms gives the Global Moran’s 
Index (I) between -1 and 1. When I is larger than 0, it implies that the neighbouring 
units (farms in this case) have similarly high values (or cases). If I is less than 0, it 
means there is a big difference among the neighbouring units. When I approaches 0 it 
means the correlations among the neighbouring spatial units are low (meaning that 
there is a random distribution of high and low cases). The algorithms converts 
statistical values into Z-score and the spatial distribution is significant when it is larger 
than 1.96 (or at 0.05 significant level). When the Z-score is between -1.96 and 1.96 
the spatial distribution is insignificant. And when the Z-score is smaller than -1.96 it 
means there is a significant negative spatial correlation.  
In this study, the Global Moran’s Index was 0.034, that is slightly larger than zero an 
indication of a positive spatial autocorrelation, but the P-value was 0.458 meaning that 
it was not significant. The Z-score was 0.74 falling in between -1.96 and 1.96 an 
indication that there was no spatial clustering of cases. Based on these results no 
further spatial analysis was done. The geographical distribution of STEC in the study 





Figure 5.5. Map of Zambia to show the geographical distribution of STEC in the study 
area. The pie charts indicate the relative sample size on each farm (ranging from the 
smallest chart representing 1 animal and the largest representing 18 animals). The 
legend shows an example of a pie chart representing 10 sampled animals and the red 
shading equals the proportion of animals that had STEC. The map was generated in 
ARCGIS 10.2.1 software ARCGIS® (ESRI, ArcGIS desktop: release 10. 
Environmental Systems Research Institute, CA (2011)). The shape file was 
downloaded from Diva gis (http://www.diva-gis.org/gdata) and drawn in ArcMap 
10.2.1 data view. The coordinates for the farms were projected in the map and pie 





The results in this chapter have shown that STEC is common in Zambian dairy cattle. 
This conclusion was drawn from the finding that 11% (41/371) of randomly isolated 
individual E. coli from sampled cattle were positive for stx. This observation was 
consolidated by the finding that 92% (63/69) of sweeps were positive for stx2. This 
indicates that the majority of animals will have STEC in their faecal flora and agrees 
with the finding that STEC can be isolated in most farms throughout the world 
(Hancock et al., 2001). Studies show very wide ranges of STEC prevalence and in part 
this is related to the fact that very different methodologies have been used (Farrokh et 
al., 2013). A total of 193 different STEC serotypes have been reported in dairy cattle 
worldwide and 24 of these have been isolated in human infection of E. coli that have 
progressed into haemolytic uremic syndrome (Hussein and Sakuma, 2005; Farrokh et 
al., 2013). This emphasizes the complexity of assessing the zoonotic threat from STEC 
in different farming systems. Several studies just focus on E. coli O157 as this is an 
important STEC serogroup associated with serious human infection (Cobbaut et al., 
2009; Ellis-Iversen et al., 2008; Söderlund et al., 2014) and it was interesting that this 
serogroup was very rare in my study. In fact, only one E. coli O157 isolate 0.3% 
(1/371) was recovered. This is at the minimum end of ranges found in other studies in 
cattle, for example 0% to 7.2% (Makela et al., 2012) or 0.2 – 48.8% (Hussein and 
Sakuma, 2005; Islam et al., 2014). Similar observations were made in a Brazilian study 
in which STEC was detected in 71% (140/197) of E. coli isolates from dairy and beef 
cattle with only 1.5% (3/197) isolates belonging to serogroup O157: H7 (Cerqueira et 
al., 1999). However, sporadic studies in some countries have reported much higher 
prevalences, well above the global average (Cobbaut et al., 2009), which may also be 
related to variation in sampling methodologies.  
An indication of the significance of sampling/analysis method comes from my own 
study in which 30% (21/69) of the sweep samples were positive for rfbO157 that 
defines the O157 serogroup. This would indicate that E. coli O157 may be present at 
low levels in many herds or that the strains are not the classical sorbitol non-fermenting 




enrichment (the method used in my study, Materials and Methods, Chapter 2). But 
clearly this PCR-based assessment provided a much higher estimate than achieved by 
the culturing and testing from a selective agar. 
An important finding of the study was that farming scale/system had an impact on the 
occurrence of STEC in our study area. The risk was significant in the medium-sized 
farming scale OR 7.05; 95%CI: 1.76-28.28, p =0.007 and small scale OR 4.05 95%CI: 
1.20-13.64, p=0.002 compared with commercial farms as a reference. Other risk 
factors for STEC that have been reported by various studies are geographical area 
(Lejeune et al., 2006), housing (Ellis-Iversen et al., 2008), diet (Jacob et al., 2009), 
presence of cows and sheep (Chase-Topping et al., 2008), stress (Rostagno, 2009) and 
herd size (Eriksson et al., 2005). At present it is unclear what may account for the 
apparent higher levels of STEC on the medium and smaller scale dairy farms but this 
may well reflect management practices including feeding regimens or may be related 
to cattle breeds on the farms. 
In the current study, STEC surveillance was only carried out in dairy cattle and other 
possible sources such as sheep and goats were not sampled. This could have resulted 
in the missing valuable information as some studies have reported that sheep and goats 
also carry STEC as commensals (Farrokh et al., 2013) and most of the smallholder 
farmers keep their cattle together with other small ruminants such as goats and sheep. 
In support of this, two studies from Spain reported a high prevalence (47.7 %) for 
STEC in Goats (Cortés et al., 2005) and a prevalence of 68% in Sheep (Rey et al., 
2003). Additional work would be required to study the full ecology of STEC in the 
different scale of dairy farm environments to determine reservoirs and risk factors for 
STEC in production animals. 
A shortfall of most of the prevalence studies of STEC in different parts of the world 
including those that have been done in Zambia is that they were based on the detection 
of Shiga toxin encoding genes (stx) only, without the demonstration of viable Stx+ 
bacteria (Mubita et al., 2015; Kuroda et al., 2013; Zweifel et al., 2013). The problem 




toxin encoding genes and may not pose a risk to humans (Kaper et al., 2004). 
Furthermore, the Shiga toxin genes may be in phages and not necessarily associated 
with any bacterium (Schmidt, 2001), so the detection of these genes only, may not be 
associated with a health risk (Makela et al., 2012). However, it can be argued that the 
surveillance of Shiga toxin genes is still very useful as the genes can enter bacteria 
through transduction or transformation resulting in a pathogenic genotype (Herold et 
al., 2004). Moreover, such recombination always threatens emergence of novel STEC 
such as the EHEC-EAEC combination that resulted in the atypical EHEC O104 disease 
outbreak in German in 2011 (Scheutz et al., 2011). In my study, although stx was 
initially detected, I went further by isolating the positive isolates and analysing a subset 
for toxicity. The toxins were extracted from isolates under Biosecurity Level 3 
containment conditions and the cytotoxic effect of extracts tested on Vero cells in order 
to provide clear evidence that the Shiga toxin genes were not only present but were 
being expressed and capable of killing cells. By extrapolation these strains could 
potentially cause serious pathology in humans provided that the isolates had other 
virulence factors necessary to colonise the human host. 89% (16/18) of the isolates 
tested had a cytotoxic effect on Vero cells. 
While E. coli isolates positive for stx were common in cattle in the study area (11%, 
41/371), it was noteworthy that none of the 73 E. coli isolates from humans that 
presented at the Lusaka teaching hospital with diarrhoea were positive for stx. This 
indicates that the common detection of STEC in dairy cattle does not translate through 
to the human population in the same study area. My work indicates that STEC may 
not be a significant human issue in Zambia despite the high prevalence of STEC in 
dairy cattle. Molecular analysis of the Zambian STEC from cattle showed the absence 
of eae and sepL as a proxy for a T3SS (Kaper et al., 2004). This is why the majority 
of cattle STEC isolates are not a threat to human health, as despite the presence of stx, 
the strains do not encode the secretion system that characterises typical EHEC strains 
in humans. This reduced pathogenic potential of the cattle STEC was further supported 
by the absence (or very low incidence) of key EHEC serogroups such as O157, O26, 




The phylogenetic analysis of the WGS clustered the E. coli under study into the main 
phylogroups of E. coli, with the majority of the strains (66.5%, 149/224) clustering 
in phylogroup B1, this was expected as most of the isolates from cattle were likely to 
be commensals (Clermont et al., 2013). The human isolates spread across the 
phylogroups A, B2, C and D, indicating that although they were negative for Shiga 
toxin genes, there is a potential of these E. coli especially those in phylogroup B2 and 
D to have other virulence factors (not analysed for this thesis). The phylogenetic 
analysis in wider context with UK clinical isolates showed that some STEC from 
Zambian cattle could cluster with human STEC from the UK (refer to Figure 5.2 of 
the embedded paper), indicating some genetic relatedness of these strains. 
This study has revealed the fine molecular characterisation of STEC in the dairy herds 
of Zambia. Although the majority of the detected STEC do not belong to the typical 
serogroups of EHEC causing food borne infections in different parts of the world, I 
have demonstrated that the STEC in dairy herds of Zambia have a potential to evolve 
into pathotypes. Therefore, surveillance of STEC in livestock and food of animal 
original should be prioritised in Zambia. 
Having presented the results for this study in Chapters 3, 4 and 5, the next chapter is 
going to generally discuss the results including methodologies and the philosophical 
account of the evolution and spread of antimicrobial resistant microbes and AMR 







Chapter 6 : General discussion 
6.1 Study Summary 
The main achievement of this study is the completion of a comprehensive structured 
epidemiological survey of antibiotic use and AMR prevalence in the Zambian dairy 
sector. The research was conducted in a large area (120 Km radius) capturing different 
farming scales of dairy farm (small, medium and commercial) in the main dairy 
farming region of Zambia. Prior to this, there was little valuable information about the 
drivers for antibiotic use and AMR patterns in the country and generally in 
central/southern Africa. The findings of this study will help to guide for policy makers 
to institute measures tailored at controlling the emergence of AMR in communities. 
6.2 Use of antibiotics in livestock and emergence of AMR 
The use of antibiotics in livestock has ignited a global debate in relation to its 
connection with the emergence of AMR pathogens, especially in the context of human 
infections (O’neill, 2014; Van Den Bogaard and Stobberingh, 2000; World Health 
Organization, 2014). In view of this, it is important to understand antibiotic use and 
AMR levels in food production systems, and this study focused on the economically 
important dairy sector in central Zambia (Mulemba, 2009; Mumba et al., 2012). The 
findings presented in Chapter 3 indicate that tetracycline, penicillin and 
sulfamethoxazole were the most used antibiotics in the study area. In turn this 
correlated with resistance profiles and genotypes detected in the E. coli sentinel 
population (Chapters 3 and 4). Through access to a related human study in Lusaka and 
sequencing of human and cattle strains, there is evidence that the human isolates 
encode more resistance and the complexity of the resistance gene available is much 
higher than in the cattle subset. Both these findings indicate that AMR is evolving and 
maintained at more significant levels in the human population. This does not rule out 




2013), but the resistance genes detected were the most common and not an issue for 
resistance to antibiotics of last resort or significant clinical relevance in humans.  
Tetracycline was the predominantly observed AMR in my study encoded by tetA 
(60%), tetB (36%) and tetC (4%) in the positive isolates. To our knowledge, there are 
no similar studies in Africa to compare with the findings from my study. Further, most 
studies in dairy cattle elsewhere have focused on identifying and testing of AMR of 
pathogenic bacteria (Heringstad et al., 2000; Thomas et al., 2015; Dahmen et al., 
2013), even though the study of E. coli isolates from health cattle can also provide 
valuable AMR profiles of the enteric microbes (Levin et al., 1997). However, the 
findings from my study are in agreement with one closely related American study that 
surveyed AMR prevalence and genotypes of enteric bacteria isolated from faecal 
samples of health dairy heads from 23 herds across central and south-central 
Pennsylvania (Sawant et al., 2007). Sawant et al., (2007) predominantly isolated E. 
coli (87%) among all the species of bacteria from his study and 93% of them were 
resistance to tetracycline. However, contrary to my study the resistance to tetracycline 
in that study were mostly encoded by tetB (93%) while tetA encoded for 7% of the 
isolates. An indication that some resistance genes dominates in certain geographical 
areas.  
The predominance of tetracycline AMR profiles in our study have also been observed 
in other studies involving testing of coliforms isolated from humans and animals 
(Kyselková et al., 2015; Kesteman et al., 2013) and they have been shown to be carried 
on conjugative plasmids (Shin et al., 2015), which is responsible for their spread. 
However, other studies involving dairy herds have detected clinically important 
resistance genes such as AmpC- β-lactamase blaCMY-2 (Boyer and Singer, 2012; 
Daniels et al., 2009), an enzyme that is responsible for resistance to cephalosporins. In 
my study cephalosporins were not mentioned anywhere among the antibiotics that 
were used for treatment of cattle diseases probably that is the reason why such genes 




It is evident that WGS and sequence analysis of alleles will give further insights into 
transmission of AMR between animals and humans (in both directions) (Croucher and 
Didelot, 2015; Croucher et al., 2014). Many basic questions need to be answered 
including determining whether stopping or reducing the antibiotic use in livestock 
actually leads to a reduction in human AMR infections in the same ecological system? 
It can be argued that remarkable progress has been made towards information that will 
provide the insight required. Studies involving the phylogenetic analysis of WGS of 
bacteria linking it to the epidemiological data such as AMR profiles and host species 
help to explain the dynamics of AMR in multi-host environments (Woolhouse et al., 
2015; Hu et al., 2013; Dallman et al., 2015). However, despite these technological 
advances evidence for direct link between use of antibiotics in animals and AMR in 
human infections is still debatable and requires further research. 
6.3 Common used antibiotics based on selected countries or 
regional perspective 
At the start of the study I had assumed that lack of oversight with regard to 
antimicrobials in a developing nation such as Zambia may have resulted in poor 
practice and incorrect use leading to high levels of AMR as has been indicated in other 
studies (Kabwe et al., 2016; Kapata et al., 2013; Lukwesa, 2012; Lukali and Michelo, 
2015). However, while there is clear evidence that further structure/regulation is 
required, the evidence points to restricted and careful use, primarily only when 
required due to key infections. This perhaps contrasts with broader and routine use 
documented in middle income and developed countries (Lam, 2013; Jensen et al., 
2004; Hellman et al., 2013; Gorbach, 2001; Van Boeckel et al., 2015). As such the 
resistance levels were low by comparison even though different methodologies were 
used (Gibbons et al., 2014; De Jong et al., 2009; Cummings et al., 2014). My study 
has therefore provided novel information on the use of antibiotics in Zambian dairy 
herds, as in particular, the use of antibiotics in different farming systems was not well 
documented. As stated, antibiotics were used primarily for treatment of sick animals 
and there is little ascribed use for prevention and growth promotion in these sectors 




diseases and theileriosis were the main drivers for use of antibiotics in this study. A 
similar assertion for use of antibiotics among farmers in developing nations were made 
by another study (Grace, 2015).  
There is global pressure now for farmers to reduce the use of antibiotics in livestock 
production in order to help reduce the evolution and spread of AMR (Call et al., 2008; 
World Health Organization, 2001). Certainly, the findings from my study show that in 
smallholder farming systems there may be no real reason for any drastic measures to 
be applied to restrict the use of antibiotics. In this study, small holder farmers used the 
common affordable antibiotics, tetracycline and penicillins to treat various animal 
diseases. Almost 5% of the farmers did not use any antibiotics in this study (Chapter 
3). My study and other studies in different parts of the world suggest that tetracycline 
is the most used antibiotics among the livestock farmers (Gorbach, 2001; Eliopoulos 
and Roberts, 2003; Eagar et al., 2012). Although the data on the consumption of 
antibiotics by the food producing animals is scanty for Africa, one Kenyan study 
reported tetracycline and trimethoprim/sulfamethoxazole to have been the most 
consumed antibiotics in that country for the period from 1995 to 1995 (Mitema et al., 
2001). Other examples include a study by Redding et al., (2014), who assessed the use 
of antibiotics in dairy herds in the dairy farming area in Peru (lower income country 
in South America) and reported that tetracycline, penicillin and 
trimethoprim/sulfamethoxazole were the most used antibiotics. And that of De Briyne 
at al. (2014) who reported that tetracycline and penicillin were the most prescribed 
antibiotics in food animals among the 25 European countries. So my findings 
completely in line with use of common and inexpensive antibiotics and matches the 
main resistances found. 
A key aim of the study was to examine risk factors for AMR in the different scales. 
The commercial farms had well organised systems and had more access to the 
veterinary services and use of antibiotics. So, a priori, it might have been expected 
that these commercial operations may have a higher association with AMR. Due to 
compliance issues, the study sampled less commercial farms than planned and the 




such it was not possible to clearly address this point and possibly indicates differences 
in management practice impacting on AMR. However, clear risk factors were found 
and some of these were linked to the commercial units. For example the commercial 
operations predominantly farmed pure breed Friesian and/or Jerseys (exotic breeds). 
In this study, exotic breeds were significantly associated with AMR E. coli (p <0.001). 
It is not clear whether this is because the exotic breeds were more susceptible to 
livestock diseases and therefore received more antibiotics than the traditional and the 
cross breeds. It is evident that such breeds have higher milk yields (Ndambi et al., 
2007) and production stress could well affect disease resistance. Ongoing genetic 
analyses of cattle breeds in sub-Saharan Africa, through projects supported by the Bill 
and Melinda Gates Foundation, are aiming to determine the genetics of breeds that 
succeed in different environments as they cope with the burden of both milk 
production and local infectious diseases (http://www.gatesfoundation.org/). 
Furthermore, differences in the interaction of microbiota and different forage types 
among the exotic breeds and the local breeds in the tropics are not known. 
6.4 Possible sources of AMR in communities 
In the quest of controlling and monitoring the emergence of AMR in communities, the 
wider question about other possible sources of AMR microbes and/or AMR genes 
associated with human infections needs to be considered. It is certain that when 
antibiotics are used, microorganisms undergo selection pressure and can develop or 
acquire AMR (Lam, 2013). So it is expected that when antibiotics are used in livestock 
or humans, there is evolution of AMR among both commensal and pathogenic 
bacteria. My study has not only provided information on the use of antibiotics but also 
on the prevalence of AMR in the E. coli as a sentinel organism. The overall prevalence 
of AMR was estimated at 12.3; 95% CI: (94.7 – 19.8), with the highest prevalence to 
tetracycline, penicillin and sulfamethoxazole, in line with the common used 
antibiotics. Other studies in Zambia have estimated different AMR prevalences in 
cattle. For instance, Mubita et al., (2008) in a study involving pastoral cattle estimated 
AMR prevalences of (3.6% to 96.4%) among the E. coli that were tested with different 




Certainly the use of antibiotics has been reported as a risk factor of AMR in both 
human and livestock sectors (Duse et al., 2014; Gullberg et al., 2011), but the 
complexity of emergence of AMR is not fully understood. For instance resistance to 
tetracycline in microbes has been detected in the absence of prior exposure to 
tetracycline (Morley et al., 2011). Although this can be partly explained due to 
horizontal transfer of resistant microbes, resistance genes or the co-selection of 
resistance genes, the emergence of diversity of AMR genes is not fully understood in 
relation to antimicrobial use or indeed other selection pressures. Metagenomics studies 
have tried to demonstrate the diversity of the microbes and AMR genes that are found 
in human microbiota in relation to antibiotics that are only used in animals to 
demonstrate the possible source of AMR genes for humans (Forslund et al., 2013; Hu 
et al., 2013).  
However, one can actually argue that the main source of AMR microbes or AMR 
genes is the environment itself especially the soil as it harbours most of the microbes 
with resistance genes way back in the pre-antibiotic era (D’costa et al., 2011). The 
microbes in the environment are exposed to natural antibiotics and then develop 
resistance. Studies involving analysis of environmental samples have reported the 
presence of AMR to different classes of antibiotics in places where antibiotics have 
not been used before (D’costa et al., 2011). In addition, whatever the antibiotics used 
in animals and humans, a significant proportion of the drug is excreted into the 
environment thus creating an even greater AMR selection pressure among 
environmental microbes (Gillings, 2013). Antimicrobial resistant microbes can also be 
selected due to exposure of the bacteria to other toxic compounds, such as heavy 
metals (Baker-Austin et al., 2006). This  study was carried out in a region with high 
environmental contamination of heavy metals such as lead, zinc, copper and cadmium 
(Yabe et al., 2011) and impact of the pollution in that ecosystem is not known. It is not 
known if other natural factors also affect the evolution and sustainability of AMR in 
the environment. For instance, how do current global climate changes influence further 
evolution and sustainability of AMR microbes and resistance genes in the 
environment? The current study has examined one possible source of Antimicrobial 




a broader approach of studies involving analysis of environmental, animal and human 
samples. 
It is a known fact that intra or international trade leads to the spread of livestock 
infectious diseases (Cavaco et al., 2013) , hence the World Animal Organisation (OIE) 
has set up some trade rules barring export of livestock and products of livestock from 
certain countries based on the presence of certain diseases (Thiermann, 2005). 
However, there are still limited measures in place targeting the control of AMR in 
livestock and in food of animal origin during international trade (Aarestrup et al., 
2008). In addition, there are migratory movements of animals or birds from certain 
parts of the world that are very difficult to monitor for AMR and their role in 
dissemination of AMR is not fully understood (Sjölund et al., 2008). 
6.5 Direction of flow of antimicrobial resistance 
Curbing the spread of antimicrobial resistant microbes and AMR genes is dependent 
on determining the source and the direction of flow (Van Den Bogaard and 
Stobberingh, 2000; Snitkin et al., 2012). Ascertaining the direction of transfer of 
resistant microbes or resistance genes between humans, animals and the environment 
is complex and requires significant background data and long term studies (Sørensen 
et al., 2005). Surveys involving samples from livestock, humans or the environment 
have shown the presence of diverse resistance alleles, some of them are similar or 
identical across the different hosts and environment (Salipante et al., 2014; Norman et 
al., 2009). This as an indication of possible exchange, but the direction of spread is 
hard to determine (Norman et al., 2009). In the current study, it was clear that there 
were some common resistance genes that were detected in E. coli from both cattle and 
human hosts (e.g blaTEM), but no way of clearly knowing the origin. Critically, human 
strains did have resistance alleles, including to therapeutically significant 
antimicrobials that were not detected in the cattle population. If there was free 
exchange one would expect to see these alleles in both human and cattle isolates. So 
my work does provide evidence of limited or absent strain or allele interchange 




must therefore be arising somewhere else such as from the use of antibiotics that are 
only used in humans or spreading from other human, animal or environmental sources. 
There are advances arising from metagenome sequencing of the faeces, soil and 
microbiota of different animal species (Hu et al., 2013; D’costa et al., 2011; Modi et 
al., 2013). These arguably provide a wider picture of AMR types than can be obtained 
by analysis of a single indicator organism like E. coli. Moreover it can be applied not 
just to bacterial populations but also the ‘mobile metagenome’ like plasmids and 
phages to begin to understand what is moving and how (Modi et al., 2013). There are 
also questions about the role the unculturable microbiota (the ‘dark matter’ of 
microbiology) plays in receiving and donating AMR elements that might be revealed 
by this method (Sommer et al., 2009). Some authors have used metagenomics to show 
how AMR transfer in the phage metagenome blooms with use of in-feed antibiotics or 
during infection (Modi et al., 2013; Forsberg et al., 2014). 
6.6 The type of STEC detected in Zambian dairy herds 
Apart from AMR, the E. coli isolates in this study provided a good opportunity for 
further analysis in order to assess their health threat to both cattle and humans. 
Commensal E. coli were easy to isolate from cattle faecal samples with 99% (371/376) 
yielding E. coli. These isolates were tested for Shiga toxin encoding genes and genes 
indicative of enteroaggregative E. coli. Out of all these isolates from cattle 11% 
(41/371) had stx genes and none-had genes indicative of enteroaggregative E. coli. By 
contrast, the E. coli isolated from human stools had no detectable stx genes. The 
current study has shown that STEC are common in cattle in the study area, but they 
have also been reported widely in different parts of the world (Islam et al., 2014; Gyles, 
2007; Shaw et al., 2004; Cerqueira et al., 1999). 
The question is to establish whether the detected Shiga toxin pose a health threat to the 
host animal and whether they can infect and cause disease in humans through direct or 
indirect contact with cattle. Although few other studies have detected STEC and 




al. 2013) none of them have tried to address this fundamental public health question. 
It is a common belief that with these virulence factors, the detected E. coli could 
potentially cause disease in animals and humans, but further analysis from my study 
showed that the isolated STEC lack T3SS and therefore are less likely to colonise the 
human intestinal tract and would not be defined as EHEC. So those E.coli are less 
likely to pose a threat to humans based on my analysis. In cattle, the toxins do not 
affect the epithelial cells as cattle do not have GB3/CD77 receptors on their cells and 
as such are not likely to be a health threat to the host animal, so the possible benefit of 
Stx for E. coli in cattle is unclear. However, a recent study has indicated that Stx in E. 
coli can be used as a defence mechanism against grazing protozoa in the rumen of 
cattle (Schmidt et al., 2016).  
However, Stx phages in the commensal E. coli population have the potential to 
transduce into other E. coli backgrounds that possess a T3SS and then they may be 
able to cause infection in humans. It has been established through phylogenetic and 
verocytotoxicity analyses that the Stx from Zambian STEC are phylogenetically 
related to Stx in STEC from clinical cases in the UK and the toxins have a significant 
cytotoxic effect on Vero cells (Chapter 5). Advances in the analysis of whole genome 
sequences applied to STEC isolates from Africa generally distinguishes them from 
other STEC that cause disease in humans from Europe and America. The current 
research demonstrates the common presence of STEC and points to the fact that only 
a subset are likely to be an issue for human health. However, this assertion can be 
better addressed if STEC from different parts of the world can be finely analysed with 
molecular tools such as WGS to establish the nature of their genetic similarities and 
differences in relation to virulence factors.  
Another key observation from the current study was the fact that the commercial dairy 
operations had statistically less STEC than the smallholders, indicating that 
management practices, presumably feed and perhaps breed may impact on the 
acquisition and propagation of STEC in cattle. Further work in this area may inform 





6.7 Comments on the study methodologies 
Epidemiological principles and measures were taken into consideration in order to 
maintain a robust study and proper collection of data; the results of which could be 
used to make inferences about the cattle population in the area. However, possible 
weaknesses of the study are outlined below: 
Study design and cattle sampling. In this study, information about the names and 
location of farms that were enrolled was collected from District Veterinary Officers 
and Milk Collection Centres in the cooperatives whose accuracy could not be 
ascertained for this study. Some farms could have been omitted in the study. However, 
the advantage was that the identification of individual animals in the herds was not 
required at the time of study design. This made the study possible as there was no 
standard way of identifying cattle in Zambia and this could have posed substantial 
problems. Further, the sampling of animals was not adjusted according to the number 
per unit and this could have created a bias in estimating the proportions of animals 
with AMR E. coli in different herds. 
Data collection on the use of antibiotics. A questionnaire (Appendix 2) was used to 
collect information about the use of antibiotics. This could have been a source of bias 
as some small scale farmers do not keep updated written records on the treatment of 
their animals (assessment of record keeping was not part of the study). It is likely that 
some information that was collected on the use of antibiotics was missed or inaccurate. 
Similar assertions were made by Redding et al. (2014a) in a study where some dairy 
farmers in Nicaragua, could not accurately remember the type of antibiotics they used 
six months prior to his study period. However, this was the most plausible way of 
investigating the type of antibiotics being used in order to compare with the prevalence 
of AMR E. coli from cattle in the study area. Even where use is indicated, often not 
possible to state whether drugs were within expiry dates and given at effective doses, 




Even though the questionnaire was piloted and modified, the section on the farm 
characteristics did not go well during the main study. The questions on the type of feed 
supplements and the time of the year when they give them to their herds remain un 
answered in most cases. This could have been an indication that most of the farmers 
in the study did not have a fixed feeding programme. 
Isolation of E. coli and resistance testing. The isolation of single colonies of E. coli 
from faecal samples was carried out after an enrichment in BPW. This could have 
given a selection advantage to some strains of bacteria over others thus creating a 
possible bias. Antibiotic susceptible bacteria may have a growth advantage over 
antimicrobial resistant ones (Tenaillon et al., 2010). The other possible bias is on the 
selection of single colonies (1 E. coli isolate per faecal ample). Clearly this does not 
adequately represent the true AMR status of E. coli in the gut of the sampled animals, 
however this allowed a consistent estimation of prevalences and comparison of results 
across different farming systems. 
Whole genome sequencing and analysis. In this study all the AMR isolates were then 
whole genome sequenced in order to establish the genotypic basis of resistance. This 
allowed analysis not only at the phenotypic level but also a comparison with the 
molecular basis of resistance, as well as the study of virulence determinants. The in 
silico analysis of sequence data requires the use of higher computation techniques that 
is challenging and often a problem if using reference genome for assembly as only 
map shared reads not novel ones. In addition, the genomes were not closed before the 
analysis and this could have introduced a bias in our study. 
6.8 Future perspective and conclusion  
The subject of AMR combined with virulence in microorganisms is complex and can 
only be tackled in a holistic approach from different sectors of society including 
politicians, social scientists and natural scientists. The complex nature of this subject 
has been illustrated in this thesis on the prevalence of AMR in different farming 




study of this nature in case something of public health concern is found that may 
impact them economically. This was observed especially among the commercial 
farmers with many refusing to take part in the study. Later on, this affected the results 
as it was not possible to conclusively state whether the evolution of AMR in the 
different farming systems was significantly different. However, a big variation in 
management practices and the proportions of AMR in the E. coli from commercial 
farms was observed and indicates that more research is required in this area. In 
addition, it was found that breed differences may affect the evolution and spread of 
AMR (Chapter 3). This area needs further research to establish if the cross breeds are 
a better option for dairy farming in terms of AMR in Africa, presumably as more 
resilient to disease and therefore require less treatment. 
The link between the use of antibiotics in livestock and AMR that is observed in human 
infections still remains a big research challenge. However, a lot of novel information 
is being gained from the power of analysis of WGS. In this study, E. coli from humans 
certainly had more carriage of resistance alleles when compared to the E. coli from 
cattle (p< 0.001). It was established that there were minimal or no changes in specific 
resistance alleles between humans and cattle (Chapter 4). This area needs more 
research with metagenomics approaches coupled with epidemiological data to be able 
to identify all the possible alleles in the microbiota of different hosts in line with some 
of the approaches being used in recent studies (Yi et al., 2011; Hu et al., 2013). 
The subject of STEC is a matter of Public Health concern and requires studies in 
different geographical locations. The Germany 2011 E. coli disease outbreak was an 
eye opener and support the need to continuously monitor the emerging pathogens 
quick enough before they start to cause problems in humans or indeed animals. 
Analysis in Chapter 5, gives a novel finding that requires further studies involving 
different parts of the world to really analyse the STEC and compare different 
collections from different countries to be able to draw firm conclusions on the 
virulence of some STEC. The concluding remarks in Chapter 5 is that not all STEC 
are of immediate Public Health concern. However, further studies will be required in 




small scale and medium scales may be more associated with STEC than the 
commercial farms. 
The results from this thesis have led to the following recommendations for further 
research: 
1. To understand the interaction of host genetics, environmental factors and 
breed, including exotic and traditional cattle, that impact on disease resistance. 
In turn this leads to different treatment requirements and therefore the 
emergence of AMR. 
2. To understand the impact of different management systems on the biodiversity 
of the microbiota of dairy animals and how this affects AMR and pathogen 
maintenance and variation. 
3. To conduct longitudinal metagenomic studies in defined farmed ecosystems 
involving samples from animals, humans and the environment in order to 
















Appendix 1: Chapter 2. Field sampling and laboratory 
standard operating procedure 
Day 1: Sample collection 
Materials: 
 Disposable hand gloves, 
 Disposable rectal gloves, 
 Lubricating gel, 
 100 mL sterile pots, 
 20 mL sterile tubes, 
 10 mL sterile pipette, 
 Pipette bulb, 
 Cooler boxes, 
 Sample recording sheet, 
 Pencils/pens and, 
 Permanent markers, 





 Collect animals to be sampled in cattle crush. 
 Put disposable rectal glove on each arm. 
 Put lubricating gel on hand to be used for rectal exam. 
 Lift the tail using one hand. 
 Insert free hand into rectum to collect faeces. 
 Collect 20 – 50 g faeces into the gloved hand. 




 Ask assistant to open 100 mL sterile pot (to avoid contamination of outside of 
pot). 
 Transfer faeces to 100 mL sterile pot. 
 Remove rectal gloves and seal pot lid (to avoid contamination and pot leakage). 
 Label pot as described below. 
 Place labelled pot in cooler box. 
 Remove disposable hand gloves and place in waste bag. 
 Record geographical coordinates of farm, animals sampled and samples taken 
on farm. 
 Using bucket of disinfectant and brush, disinfect boots thoroughly before 
leaving farm. 
 Wash hands thoroughly before leaving farm.  
 On return to lab, store samples in refrigerator. 
Labelling:  
 The code used will capture details of farm location and sample type and will 
be used to identify each sample from farm level through laboratory. 
 Extra care should be taken on labelling to avoid mistakes (each sample to have 
a unique number, keep the number short (max 6 six digit). 
 The code used will capture sample number and sample type and will be used 
to identify each sample from farm level through laboratory. 
 Date of sampling. 
 District - (Each district was given two unique alphabetical letters e.g AB for 
Chongwe district, CF for Mazabuka District, etc.). 
  Farm - (Number the farms sequentially with the first visited farm as number1 
and up to the last farm in this case 104). So the farm identity will be the district 
letters and the number e.g (AB001 is the first farm that was sampled in the 
study and is found in Chongwe district). 
  Animal sample (faecal sample) – number the samples sequentially as from 1 
up to the last animal.  
 On return to the laboratory, enter the farm details, faecal sample numbers and 




Day 2: Sample enrichment 
Materials: 
 Samples from Day 1, 
 90 mL Buffered Peptone Water (BPW) per sample),  
 Sterile 100 mL pots, 
 Sterile 20 mL tubes, 
 Sterile spatulas, 
 Disposable gloves, 
 Weighing Scale, 
 Incubator at 37⁰C, 
 Pipette gun, 
 50 mL sterile pipettes, 
 Pipette,  
 1000 µL sterile pipette tips, 
 Permanent markers. 
Method: 
 Good laboratory technique is vital in this study. 
 Disinfect the bench with 70% alcohol before commencing work. 
 All spillages must be cleaned up immediately with 70% alcohol and paper 
towel. 
 Light the Bunsen burner and always work close to the flame. 
 Label a sterile 100 mL pot to correspond to each faecal sample taken on each 
farm. 
 Remove lid from pot and place empty pot on weighing scales. 
 Tare the scales to zero with the empty pot. 
 Use sterile spatula to take 10 g faeces from original sample pot and place in 
pot on scales. 
 When 10 g faeces is present in pot, remove from scales and close lid. 
 Weigh all samples before adding BPW to samples. 
 Make sure scales is set to zero between each sample. 




 Using sterile 50 mL pipette, add 90 mL BPW to the sample. 
 Seal lid and shake then loosen lid slightly and incubate at 37oC for 18 – 24 
hours. 
 Record all samples processed and materials used (including batch no’s) in lab 
book. 
Day 3: Plating out 
Materials: 
 Samples in BPW from Day 2, 
 Lactose MacConkey agar (LMAC) plates, 
 Sorbital MacConkey agar (SMAC) plates, 
 Disposal gloves, 
 Sterile loops (flammable or disposable ones), 
 Sterile swabs. 
Method: 
 Good laboratory technique is vital in this study. 
 Disinfect the bench with 70% alcohol before commencing work. 
 All spillages must be cleaned up immediately with 70% alcohol and paper 
towel. 
 Light the Bunsen burner and always work close to the flame. 
 Label 1 LMAC and 1 SMAC agar plate to correspond to each milk and faecal 
sample. 
 Work on milk samples before faecal samples to avoid cross contamination. 
 Dip a sterile swab in the Sample in BPW from day 2. 
 Inoculate the LMAC and SMAC plate with the swab to make a well on each 
plate. 
 Flame a metallic loop and streak from the well 4 times at an angle of 30o. 
 Flame the loop 
 Streak from the end of each previous streak line at an angle of 120°.  
 Flame the loop and steak a final zig-zag line from the last streaked point across 
the remainder of the plate. 




 Store all samples in BPW in refrigerator until isolation process is complete as 
loss of isolates or errors in recording may require further use of this sample. 










Day 4: Plating to TBX and DNA extraction from MacConkey plates 
Materials: 
 Inoculated LMAC and SMAC agar plates from day 3, 
 TBX Agar plates, 
 Sterile loops, 
 Disposable gloves, 
 Incubator at 37oC, 
 Sterile plain swabs in plastic applicator, 
 Eppendorf vials (1.5 mL), 
 DNA extraction Kit, 






 Disinfect the bench with 70% ethanol before commencing the work.  
 Light the bunsen fire and work close to the flame always. 
 Examine the LMAC agar plates for evidence of growth, contamination and to 
assess the quality of the streaking. 
 Record the results of the LMAC culture in the lab notebook. 
 If no growth on LMAC plate then retrieve sample in BPW from refrigerator 
and repeat process from Day 3. 
 Where lactose fermenting bacteria are observed on LMAC plates label TBX 
agar plates to correspond with the LMAC plates.  
 Flame the metallic loop. 
 With the sterile loop, touch a single well-isolated large lactose-fermenting 
colony (dark pink colour) on the LMAC plate. 
 Inoculate the bacteria onto one portion of a TBX agar plate to make a well. 
 Flame a metallic loop and streak from the well 4 times at an angle of 30°. 
 Flame the loop again. 
 Streak from the end of each previous streak line at an angle of 120°. 
 Flame the loop and steak a final zig-zag line from the last streaked point across 
the remainder of the plate. 
 Incubate plates at 37oC for 18-24 hours. 
 Examine SMAC agar plates for evidence of non-soribitol fermenting and non-
glucuronidase activity typical of E. coli O157. E. coli O157 appear as 
colourless colonies on SMAC. 
 Record the results of the SMAC culture in the lab notebook. 
 For each suspect E. coli O157 colony identified, label a corresponding blood 
agar plate. 





 Remove sterile swab from plastic applicator and take a sweep of the growth 
from the well on the LMAC plate for DNA extraction; try to leave isolated 
colonies behind in case needed for further subculture to TBX. 
 Replace swab in plastic applicator until ready for DNA extraction. 
 Store all LMAC and SMAC plates in refrigeration until isolation process is 
complete in case needed at later date. 
 Using the Wizard Genomic Purification kit from Promega DNA, extract the 
DNA from the sweep taken from LMAC plate. 
 Label and store DNA properly. 




Day 5: Identification of E. coli and E. coli O157 
Materials: 
 TBX and Blood agar plates from Day 4, 
 Blood Agar plates, 
 Sterile loops, 
 E. coli O157 latex agglutination test, 
 Incubator at 37oC, 
 Disposal gloves, 
 Control strain E. coli ATCC 25922. 
Method: 
 Disinfect the bench with 70% ethanol before commencing the work. 
 Light the bunsen burner and work close to flame. 
 Examine the TBX agar plates to determine if E. coli is present and to check for 
contaminants. 
 Green colonies on TBX indicate the presence of E. coli. 
 If isolate on TBX is not green then return to LMAC plate from Day 4 and select 
another lactose-fermenting colony for subculture to TBX agar.  
 Record all results in the lab notebook. 
 Label a blood agar plate to correspond to each E. coli-positive isolate on TBX. 
 Label the plates using the same code corresponding to the recording on the 
TBX plates. 
 Subculture the presumptive E. coli isolates to blood agar by streaking as 
described above. 
 Incubate blood agar plates at 37oC for 18-24 hours. 
 Examine the blood agar plates inoculated with suspect O157 isolates for 
growth and contamination. 
 The control strain will be inoculated and sub cultured on the Blood agar 
alongside with the other isolates. 
Plating on Blood Agar from TBX Agar 
Materials: 




 Sterile loops, 
 Disposal gloves, 
 Recording sheet, 
 Bunsen burner. 
Methods: 
 Spray the bench with 70% ethanol before commencing the work. 
 Wipe the bench with clean paper towel. 
 Light up the bunsen burner. 
 Check the growth on the TBX plates. 
 Put away the plates with mixed colonies (that is green and other colours). 
 Go back to the MacConkey plate and take another colony from that plate or 
purify the colony from the TBX plate. 
 Bring out the Blood agar plates. 
 Label the Blood agar plates corresponding to the labels on the TBX plates with 
pure E. coli cultures. 
 Flame the loop.  
 Touch a single green colony on TBX plate. 
  Plate on the side of Blood Agar plate to make a well. 
 Flame the loop. 
 Air cool the loop. 
 Streak the well 4 times at an oblique angle. 
 Flame the loop.  
 Make another streaking at almost perpendicular to the end of each streak in the 
previous step. 
 Finally make one zig zag streaking to end the process.  
 Replace back the lid. 
 Record in the recording book. 
 Repeat the process on all the plates. 
 Take the plates in the incubator at 37°C for overnight incubation. 





Plating of ATCC 25922 on Blood Agar 
Materials: 
 Blood Agar, 
 ATCC 25922 E. coli, 
 Sterile loops, 
 Disposal gloves, 
 Recording sheet, 
 Bunsen burner. 
Methods: 
 Bring out the working ATCC 25922 on Blood Agar from the fridge. 
 Bring out the Blood agar plates. 
 Label the Blood agar plates as ATCC 25922. 
 Flame the loop.  
 Touch a single colony on the Blood Agar. 
  Plate on the side of the new Blood Agar plate to make a well. 
 Flame the loop. 
 Air cool the loop. 
 Streak the well 4 times at an oblique angle. 
 Flame the loop.  
 Make another streaking at almost perpendicular to the end of each streak in the 
previous step. 
 Finally make one zig zag streaking to end the process. 
 Replace back the lid. 
 Record in the recording book. 
 Take the plates in the incubator at 37°C for overnight incubation. 
 Clean the bench and dispose the waste in the waste collection bin or bag. 
Day 6 : Plating on Mueller Hinton Agar, DNA extraction from isolates, Storage 
of E. coli strains 
Plating on Mueller Hinton Agar 
Materials: 




 Antibiotics disks –  (ampicillin, cefpodoxime, ciprofloxacin, tetracycline, 
gentamycin, sulfamethoxazole/trimethoprim), 
 Antibiotic disk dispenser, 
 0.5 McFarland, 
  Nutrient broth (5 mL), 
 Disposable gloves, 
 Normal saline (5 mL) ( Prepare by dissolving 1 tablet of saline in 100 mL of 
distilled water and then pipette 5 mL into each vial and then autoclave the 
vials), 
 Sterile swabs, 
 Pipette, 
 Pipette tips (200-1000 µL), 
 Recording sheet, 
 Incubator, 
 Control strain E. coli 25922. 
Methods: 
 Spray the bench with 70% ethanol before commencing the work. 
 Light up the bunsen burner. 
 Bring out the blood agar plates from the incubator. 
 Bring out the 5ml nutrient broth vials from the fridge. 
 Remove MHA plates, antimicrobial discs and dispensers from fridge at least 
30 minutes before commencing streaking. 
 Label the MHA plates. 
 Label the nutrient broth vials according to the labels on the blood agar plates. 
 Loosen the lids on the nutrient broths. 
 Flame the loop. 
 Air cool the loops. 
 Pick 2 to 4 colonies using sterile loop from the blood agar. 
 Pick the corresponding nutrient broth vial. 




 Care shall be taken to rub against the wall of the glass until the colony dissolves 
completely. 
 Screw the lid to close and tighten. 
 Repeat the process for all the plates. 
 Incubated at 37°C for approximately 2 to 6 hours. 
 After 2 to 6 hours, remove the vials from the incubator. 
 Line up the vials containing autoclaved normal saline. 
 Label the saline vials corresponding to the nutrient broth. 
 Pipette 200 to 600 µL of the nutrient broth containing the bacterial. 
 Add to 5 mL of normal saline. 
 Compare the turbidity of the inoculated normal saline to the 0.5 McFarland 
turbidity. 
 Use a white background to compare the turbidity. 
 When the turbidity is approximately equal. 
 Aseptically open the sterile swabs. 
 Dip a sterile swab in the saline solution containing bacteria equivalent to 0.5 
McFarland turbidity. 
 Squeeze against the wall of the bottle to remove excess water. 
  Streak on the Muller Hinton plate agar (streak from the top to the bottom then 
change to about 60° and spread from top to the bottom, then at about 60° streak 
from the top to the bottom). 
  The saline solutions should be plated within 15 minutes of preparation of the 
dilution and discs should be applied within 15 minutes of streaking the plate. 
 Line the plates side by side.  
 Remove the lid and put them by the side of the agars. 
 Pick up the antibiotic dispenser. 
 Check that all the disks are in place. 
 Adjust the dispenser to an appropriate media thickness (4 mm for the Oxoid 
pre-prepared media). 




 Ensure the disks are properly stuck on the media by gently touching the disks 
using a sterile loop. 
 Then close the plates and put them in an incubator at 37°C overnight. 
 Screw the lids on the nutrients broth to close and tighten. 
 Take the nutrient broth back in the incubator for overnight and ready for DNA 
extraction. 
Storage of E. coli isolates 
Materials: 
 TSB  + Glycerol solution prepared as follows: 
- Weigh out 30 g TSB powder and place in flask. 
- Soak with 850 mL distilled water (i.e. 85% H₂0). 
- When dissolved fully add 150 mL glycerol and mix thoroughly. 
- Dispense into 20 mL tubes and autoclave at 121°C for 15 min. 
- Allow to cool then freeze at -20°C until required. 
 Sterile swabs, 
 Eppendorf vials. 
Methods: 
 Thaw out the TSB+Glycerol solution. 
 First pipette 1 mL of TSB+ Glycerol solution into the 1.5 Eppendorf vials. 
 Label each vial according to the sample numbers. 
 Using a sterile swab, sweep the pure colony of the culture on blood agar plate. 
 Dissolve the bacteria in the TSB + Glycerol solution.  
 Place them in a box labelled corresponding to an inventory book for easy 
tracing. 
DAY 7 : Antimicrobial susceptibility reading and DNA extraction 
Materials: 
 Ruler or venire callipers, 
 Recording sheet, 
 Pencils/pens, 





 The reading is done using a ruler or venire callipers. 
 Bring out the MHA plates from the incubator. 
 Measure the diameter of the clear zone including the disk on a dark surface. 
 The measurements are recorded for each plate against each antibiotic disk.  
 Reading for the control strain E. coli 25922 is also done, recorded and 
compared to expected results to ensure quality control of test. 
 After that the readings are transferred into an excel spread sheet for analysis. 
DNA extraction 
Materials: 
 Wizard® DNA Purification Kit or Quiagen Dneasy Blood and Tissue Kit, 
 Ethanol, 
 Isopropanol, 
 Disposable gloves, 
 1.5 mL Eppendorf vials, 
 Micro centrifuge, 
 80°C and 37°C incubators or water baths, 
 Fine permanent markers, 
 Sterile swabs. 
Methods: 
 Bring out the nutrient broth agar vials from the incubator. 
 Line up the Eppendorf vials on a rack. 
 Label the Eppendorf vials according to the nutrient broth vials. 
 Pipette 1 mL of the nutrient broth into the Eppendorf vials. 
 Do for each nutrient broth vial. 
 Follow the DNA extraction procedure from the kit. 
      DNA storage 


















































Appendix 4:.Chapter 4. Resistance and genotypes patterns of 
E. coli from cattle (n=186) 
No. of 
isolates phenotype Resistance genes 
5 tet tetA 
2 tet tetB 
1 tet strA1,strB1,tetB 
6 tet strA4,strB1,sul2,tetA 
6 tet strA1,strB1,sul2,tetB 
1 amp aadA7,aph(3')-lc,blaTEM-1,strA1,strB1,tetC 
1 amp,tet tetA 
2 amp,tet blaTEM-1,tetA 
1 amp,tet blaTEM-1,tetB 
1 amp,tet blaTEM-1,strA1,strB1,tetB 
1 amp,tet blaTEM-1,strA1,strB1,tetA 
1 amp,tet blaTEM-1,strA4,strB1,sul3,tetA 
1 amp, tet aph(3')-la,blaTEM-1,strA4,strB1,sul2,tetA 
1 amp,tet blaTEM-1,catA1,strA4,strB1,sul2,tetB 
1 amp,tet blaTEM-1,strA1,strB1,tetB 
1 tet,sxt aadA5,dfrA7,strA4,strB1,sul2,tetA 
1 tet,sxt dfrA5,strA4,strB1,sul2,tetB 
1 tet,sxt aadA5,dfrA7,sul2,tetA 
1 amp,sxt blaTEM-1,catA1,dfrA7,strA4,strB1,sul1,sul2 
1 amp, cn aac-(3)-lId, blaTEM-1 
3 amp,tet,sxt blaTEM-1,dfrA8,strA4,strB1,sul2,tetB 




1 amp,tet,sxt blaTEM-1,dfrA7,strA4,strB1,sul1,sul2,tetA 
1 amp,tet,sxt blaTEM-1,strB1,tetB 
1 amp,tet,sxt blaTEM-1,dfrA8,strA4,strB1,sul2,tetB 
1 amp,tet,sxt blaTEM-1,dfrA7,strA4,strB1,sul1,sul2,tetA 
1 amp,tet,sxt blaTEM-1,dfrA5,strA4,strB1,sul2,tetA 




1 amp,tet,sxt blaTEM-1,dfrA10,strA4,strB1,sul1,sul2,tetA 
1 amp,tet,cn,sxt blaTEM-1,dfrA5,strA4,strB1,sul2,tetA 
1 amp,cip,tet,cn,sxt acc(3)-lId,aadA1,aph(3')-la 
1 0 dfrA5 
Note: The following phenotypic resistances are presented in the second column ampicillin (amp); 
tetracycline (tet); gentamicin (cn); trimethoprim/sulfamethoxazole (sxt); cefpodoxime 






Appendix 5:.Chapter 4. Resistance and genotypes patterns of 
E. coli from humans (n=77) 



































































arr-2- qnrS1- aac(3)-IIa, aac(6')Ib-cr-1-aadA2-blaCTX-M-15-blaOXA-30,-blaTEM-1, -
catA1-dfrA12-ere(A)- mph(A)-qepA2-strA4- strB1- sul1-sul-tetB 
aac(3)-IIa,-aac(6')Ib-cr-1-aadA2-blaCMY-4-blaCTX-M-15-blaDHA-1-blaNDM-1 blaOXA-2- 












Appendix 6: Conference abstracts  
1. Oral presentation:  
Infectious Disease Genomics conference, 14-16 October 2015. 
Wellcome Genome Campus 
Hinxton, Cambridge CB10 1RQ, UK 
Molecular characterisation and phylogenetics of Shiga toxin producing 
Escherichia coli (STEC) isolated from Zambian dairy cattle.  
Geoffrey Mainda1, Nadejda Lupolova1, John Bwalya Muma2, Barend M. deC. 
Bronsvoort1 ,Mark P. Stevens1, David L. Gally1  
1The Roslin Institute, University of Edinburgh, EH25 9RG, United Kingdom 
2Department of Disease Control, School of Veterinary Medicine, University of 
Zambia, P. O.  Box 32379, Lusaka 
It is an important public health challenge to understand the epidemiology of emerging 
zoonotic infectious diseases. Whole Genome Sequencing (WGS) allows extraction of 
different types of data to understand the population structure of the study organism as 
well as specifics associated with virulent subtypes. 
In this study, E. coli strains have been isolated from cattle from a cross sectional study 
of 104 dairy farms including small, medium and commercial operations in central 
Zambia. For comparison, samples from human patients with diarrhoea were collected 
from a hospital within the study area. Illumina WGS was carried out for 297 isolates 
(73 human and 224 bovine isolates) and their population structure examined based on 




phylogrouping. The study then focused on the presence of Shiga toxins in the isolates 
by both PCR and bioinformatics approaches. PCR analysis demonstrated that 11% 
(41/371) of the bovine isolates were positive for Shiga toxins; 54% (22/41) had both 
stx1 and stx2, 37% (15/41) had stx2 only and 10% (4/41) had stx1 only. Toxicity on 
Vero cells was demonstrated for 89% (16/18) of bovine strains tested. The overall 
estimated prevalence of STEC in cattle was 6% 95%CI: 2.47 - 10.18). In contrast, none 
of the sequenced human strains (0/73) contained stx. In order to understand why this 
prevalence in cattle was not reflected in the human population, the strain context in 
terms of serotype and intimin carriage (as a marker of possession of a type 3 secretion 
system) was investigated. Remarkably, only 2 of the 41 stx+ cattle strains were 
assigned into the seven major enterohaemorrhagic E. coli serogroups (O157, O26, 
O111, O103, O121, O145, 045) known to be associated with serious human disease in 
humans. In line with this, only 1 strain that contained stx also contained an intimin 
gene. 
The results of the WGS analysis indicate the Shiga toxin carriage and expression is 
common among E. coli strains isolated from dairy cattle in Zambia. However, the E. 
coli strains in which the toxins are present are remarkably diverse and generally are 











2. Poster presentation 
Edinburgh Infectious Diseases (EID) annual symposium - 2014  
Prevalence of antimicrobial resistance and genotypes of Escherichia coli isolated 
from Zambian dairy cattle across different production systems 
Geoffrey Mainda1, Mark Stevens1, Barend Bronsvoort1, David Gally1 
1The Roslin Institute & R(D)SVS, University of Edinburgh, Edinburgh, EH25 
9RG, UK. 
The aim of this work is to analyse antimicrobial resistance and associated risk factors 
in a specific area of Zambia. A cross sectional study was carried out to estimate the 
prevalence of antimicrobial resistant Escherichia coli isolated from dairy cattle in the 
central region involving 371 animals from 104 small, medium and commercial farms 
using the Kirby-Bauer disk diffusion method. Univariable and multivariable logistic 
regression models were used to identify and estimate the strength of association with 
putative risk factors. The overall population based prevalence of antimicrobial 
resistant E. coli after adjusting for the  sampling design was 12.3 %; 95% CI: 4.7 – 
19.8 and the specific prevalence in each farming type was 13.7%; 95%CI: 7.4 – 22.6 
for small scale, 13.0 %; 95% CI: 5.6 – 24.2 for medium scale and 12.3%; 95%CI: 2.5 
– 30 for commercial scale. The final multivariable logistic regression model suggested 
that farms that reported lumpy skin disease in the previous 12 months had statistically 
significantly increased odds of having an antimicrobial resistant E. coli (OR 2.254; 
95%CI:1.034 - 4.908). Ongoing analysis of whole genome sequence data of up to 200 
strains in this study will seek associations between antibiotic resistance and usage, 
evidence of clustering of individual or multidrug resistances and will examine the risks 
posed to human health of those strains of E. coli. Such results will then be compared 







Appendix 7. Permission for reproduction of figures 
 
ELSEVIER LICENSE 
TERMS AND CONDITIONS 




This is a License Agreement between Geoffrey Mainda ("You") and Elsevier ("Elsevier") 
provided by Copyright Clearance Center ("CCC"). The license consists of your order 
details, the terms and conditions provided by Elsevier, and the payment terms and 
conditions. 
All payments must be made in full to CCC. For payment instructions, please see 
information listed at the bottom of this form. 
Supplier 
Elsevier Limited 
The Boulevard,Langford Lane 
Kidlington,Oxford,OX5 1GB,UK 
Registered Company Number 1982084 
Customer name Geoffrey Mainda 
Customer address 4/4 craigend park 
  Edinburgh, EH16 5XY 
License number 3793711338166 
License date Jan 21, 2016 
Licensed content publisher Elsevier 
Licensed content publication The Lancet Infectious Diseases 
Licensed content title 
Global antibiotic consumption 2000 to 2010: an analysis 




Licensed content author 
Thomas P Van Boeckel,Sumanth Gandra,Ashvin 
Ashok,Quentin Caudron,Bryan T Grenfell,Simon A 
Levin,Ramanan Laxminarayan 
Licensed content date August 2014 
Licensed content volume 
number 
14 
Licensed content issue number 8 
Number of pages 9 
Start Page 742 
End Page 750 
Type of Use reuse in a thesis/dissertation  




Format both print and electronic  
Are you the author of this 
Elsevier article? 
No  
Will you be translating? No  
Original figure numbers Figure 1  
Title of your thesis/dissertation  
Molecular epidemiology of antimicrobial resistance 
(AMR) and Shiga toxin producing E. coli (STEC) in dairy 
herds of central Zambia 
 
Expected completion date Mar 2016  
Estimated size (number of 
pages) 
250  
Elsevier VAT number GB 494 6272 12 
Permissions price 0.00 GBP  
VAT/Local Sales Tax 0.00 GBP / 0.00 GBP 








TERMS AND CONDITIONS 




This is a License Agreement between Geoffrey Mainda ("You") and Elsevier ("Elsevier") 
provided by Copyright Clearance Center ("CCC"). The license consists of your order 
details, the terms and conditions provided by Elsevier, and the payment terms and 
conditions. 
All payments must be made in full to CCC. For payment instructions, please see 
information listed at the bottom of this form. 
Supplier 
Elsevier Limited 
The Boulevard,Langford Lane 
Kidlington,Oxford,OX5 1GB,UK 
Registered Company Number 1982084 
Customer name Geoffrey Mainda 
Customer address 4/4 craigend park 
  Edinburgh, EH16 5XY 
License number 3793900653366 
License date Jan 21, 2016 
Licensed content publisher Elsevier 
Licensed content publication The Lancet Infectious Diseases 
Licensed content title 





Licensed content author 
Giuseppe Cornaglia,Helen Giamarellou,Gian 
Maria Rossolini 
Licensed content date May 2011 
Licensed content volume number 11 
Licensed content issue number 5 
Number of pages 13 
Start Page 381 
End Page 393 
Type of Use reuse in a thesis/dissertation  
Portion figures/tables/illustrations  
Number of figures/tables/illustrations 1  
Format both print and electronic  
Are you the author of this Elsevier 
article? 
No  
Will you be translating? No  
Original figure numbers Figure 2  
Title of your thesis/dissertation  
Molecular epidemiology of antimicrobial 
resistance (AMR) and Shiga toxin producing E. 
coli (STEC) in dairy herds of central Zambia 
 
Expected completion date Mar 2016  
Estimated size (number of pages) 250  
Elsevier VAT number GB 494 6272 12 
Permissions price 0.00 USD  
VAT/Local Sales Tax 0.00 USD / 0.00 GBP 
Total 0.00 USD   







Aarestrup, F. M. & Engberg, J. 2001. Antimicrobial resistance of thermophilic 
Campylobacter. Veterinary Research, 32, 311-321. 
Aarestrup, F. M., Wegener, H. C. & Collignon, P. 2008. Resistance in bacteria of the 
food chain: epidemiology and control strategies. Expert Review of Anti-
Infective Therapy, 6, 733-750. 
Abdi, S., Ranjbar, R., Vala, M. H., Jonaidi, N., Bejestany, O. B. & Bejestany, F. B. 
2014. Frequency of blaTEM, blaSHV, blaCTX-M, and qnrA Among Escherichia 
coli Isolated From Urinary Tract Infection. Archives of Clinical Infectious 
Diseases, 9. 
Aiken, A. M., Allegranzi, B., Scott, J. A., Mehtar, S., Pittet, D. & Grundmann, H. 
2014. Antibiotic resistance needs global solutions. The Lancet Infectious 
Diseases, 14, 550-551. 
Allen, H. K., Donato, J., Wang, H. H., Cloud-Hansen, K. A., Davies, J. & Handelsman, 
J. 2010. Call of the wild: antibiotic resistance genes in natural environments. 
Nature Reviews Microbiology, 8, 251-259. 
Amaechi, N. 2014. A Survey on Antibiotic usage in Pigs and Poultry Birds in Abia 
State, Nigeria. Global Journal of Medical Research, 14. 
Anadón, A. 2006. WS14 The EU ban of antibiotics as feed additives (2006): 
alternatives and consumer safety. Journal of Veterinary Pharmacology and 
Therapeutics, 29, 41-44. 
Andersson, D. I. & Hughes, D. 2011. Persistence of antibiotic resistance in bacterial 
populations. FEMS Microbiology Reviews, 35, 901-911. 
Andersson, D. I. & Hughes, D. 2014. Microbiological effects of sublethal levels of 
antibiotics. Nature Reviews Microbiology, 12, 465-478. 
Andersson, D. I., Maisner Patin, S., Nilsson, A. & Kugelberg, E. 2007. The biological 
cost of antibiotic resistance. 
Anselin, L. 1995. Local indicators of spatial association—LISA. Geographical 




Argudín, M., Mendoza, M. C., Martín, M. C. & Rodicio, M. R. 2014. Molecular basis 
of antimicrobial drug resistance in Staphylococcus aureus isolates recovered 
from young healthy carriers in Spain. Microbial Pathogenesis. 
Arumugam, G., Srinivasan, S., Joshi, G., Gopal, D. & Ramalingam, K. 2015. 
Production and characterization of bioactive metabolites from piezotolerant 
deep sea fungus Nigrospora sp. in submerged fermentation. Journal of Applied 
Microbiology, 118, 99-111. 
Aslam, M., Checkley, S., Avery, B., Chalmers, G., Bohaychuk, V., Gensler, G., Reid-
Smith, R. & Boerlin, P. 2012. Phenotypic and genetic characterization of 
antimicrobial resistance in Salmonella serovars isolated from retail meats in 
Alberta, Canada. Food Microbiology, 32, 110-117. 
Avery, B., Parmley, E., Reid-Smith, R., Daignault, D., Finley, R. & Irwin, R. 2014. 
Canadian integrated program for antimicrobial resistance surveillance: Retail 
food highlights, 2003-2012. Canada Communicable Disease Report, 40, 29. 
Baker-Austin, C., Wright, M. S., Stepanauskas, R. & Mcarthur, J. 2006. Co-selection 
of antibiotic and metal resistance. Trends in Microbiology, 14, 176-182. 
Bankevich, A., Nurk, S., Antipov, D., Gurevich, A. A., Dvorkin, M., Kulikov, A. S., 
Lesin, V. M., Nikolenko, S. I., Pham, S. & Prjibelski, A. D. 2012. SPAdes: a 
new genome assembly algorithm and its applications to single-cell sequencing. 
Journal of Computational Biology, 19, 455-477. 
Bannerman, T. L., Peacock, S., Murray, P., Baron, E., Jorgensen, J., Landry, M. & 
Pfaller, M. 2006. Staphylococcus, Micrococcus, and other catalase-positive 
cocci. Manual of Clinical Microbiology: Volume 1, 390-411. 
Bauer, A., Kirby, W., Sherris, J. C., Turck & Turck, M. 1966. Antibiotic susceptibility 
testing by a standardized single disk method. American Journal of Clinical 
Pathology, 45, 493. 
Berge, A., Atwill, E. & Sischo, W. 2003. Assessing antibiotic resistance in fecal 
Escherichia coli in young calves using cluster analysis techniques. Preventive 
Veterinary Medicine, 61, 91-102. 
Bielaszewska, M., Mellmann, A., Zhang, W., Köck, R., Fruth, A., Bauwens, A., Peters, 
G. & Karch, H. 2011. Characterisation of the Escherichia coli strain associated 
with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a 




Billiouw, M., Vercruysse, J., Marcotty, T., Speybroeck, N., Chaka, G. & Berkvens, D. 
2002. Theileria parva epidemics: a case study in eastern Zambia. Veterinary 
Parasitology, 107, 51-63. 
Bioinformatics, B. 2011. FASTQC: A quality control tool for high throughput 
sequence data. Cambridge, UK: Babraham Institute. 
Blair, J. M., Richmond, G. E. & Piddock, L. J. 2014. Multidrug efflux pumps in Gram-
negative bacteria and their role in antibiotic resistance. Future Microbiology, 
9, 1165-1177. 
Boerlin, P., Mcewen, S. A., Boerlin-Petzold, F., Wilson, J. B., Johnson, R. P. & Gyles, 
C. L. 1999. Associations between virulence factors of Shiga toxin-producing 
Escherichia coli and disease in humans. Journal of Clinical Microbiology, 37, 
497-503. 
Boetzer, M. & Pirovano, W. 2012. Toward almost closed genomes with GapFiller. 
Genome Biology, 13, 1. 
Boyer, T. C. & Singer, R. S. 2012. Quantitative Measurement of blaCMY-2 in a 
Longitudinal Observational Study of Dairy Cattle Treated with Ceftiofur. 
Foodborne Pathogens and Disease, 9, 1022-1027. 
Broens, E., Graat, E., Van Der Wolf, P., Van De Giessen, A. & De Jong, M. 2011. 
Prevalence and risk factor analysis of livestock associated MRSA-positive pig 
herds in The Netherlands. Preventive Veterinary Medicine, 102, 41-49. 
Broom, J., Broom, A., Plage, S., Adams, K. & Post, J. 2016. Barriers to uptake of 
antimicrobial advice in a UK hospital: a qualitative study. Journal of Hospital 
Infection. 
Buchholz, U., Bernard, H., Werber, D., Böhmer, M. M., Remschmidt, C., Wilking, H., 
Deleré, Y., An Der Heiden, M., Adlhoch, C. & Dreesman, J. 2011. German 
outbreak of Escherichia coli O104: H4 associated with sprouts. New England 
Journal of Medicine, 365, 1763-1770. 
Buckley, C., Trembizki, E., Baird, R. W., Chen, M., Donovan, B., Freeman, K., Goire, 
N., Guy, R., Lahra, M. M. & Regan, D. 2015. Multitarget PCR assay for direct 
detection of penicillinase-producing Neisseria gonorrhoeae for enhanced 
surveillance of gonococcal antimicrobial resistance. Journal of Clinical 
Microbiology, 53, 2706-2708. 





Bywater, R. 2004. Veterinary use of antimicrobials and emergence of resistance in 
zoonotic and sentinel bacteria in the EU. Journal of Veterinary Medicine, 
Series B, 51, 361-363. 
Bywater, R., Deluyker, H., Deroover, E., De Jong, A., Marion, H., Mcconville, M., 
Rowan, T., Shryock, T., Shuster, D. & Thomas, V. 2004. A European survey 
of antimicrobial susceptibility among zoonotic and commensal bacteria 
isolated from food-producing animals. Journal of Antimicrobial 
Chemotherapy, 54, 744-754. 
Call, D. R., Davis, M. A. & Sawant, A. A. 2008. Antimicrobial resistance in beef and 
dairy cattle production. Animal Health Research Reviews, 9, 159-167. 
Camacho, C., Coulouris, G., Avagyan, V., Ma, N., Papadopoulos, J., Bealer, K. & 
Madden, T. L. 2009. BLAST+: architecture and applications. BMC 
Bioinformatics, 10, 421. 
Carattoli, A. 2009. Resistance plasmid families in Enterobacteriaceae. Antimicrobial 
Agents and Chemotherapy, 53, 2227-2238. 
Cavaco, L. M., Aarestrup, F. M. & Krcméry, V. 2013. Resistance in bacteria of the 
food chain: epidemiology and control strategies. Microbial Drug Resistance, 
Future Medicine Ltd, Brastislava, Slovakia, 136-158. 
Cerna, J. F., Nataro, J. P. & Estrada-Garcia, T. 2003. Multiplex PCR for detection of 
three plasmid-borne genes of enteroaggregative Escherichia coli strains. 
Journal of Clinical Microbiology, 41, 2138-2140. 
Cerqueira, A. M., Guth, B. E., Joaquim, R. M. & Andrade, J. R. 1999. High occurrence 
of Shiga toxin-producing Escherichia coli (STEC) in healthy cattle in Rio de 
Janeiro State, Brazil. Veterinary Microbiology, 70, 111-121. 
Chambers, H. F. & Deleo, F. R. 2009. Waves of resistance: Staphylococcus aureus in 
the antibiotic era. Nature Reviews Microbiology, 7, 629-641. 
Chantziaras, I., Boyen, F., Callens, B. & Dewulf, J. 2014. Correlation between 
veterinary antimicrobial use and antimicrobial resistance in food-producing 
animals: a report on seven countries. Journal of Antimicrobial Chemotherapy, 
69, 827-834. 
Chase-Topping, M., Gally, D., Low, C., Matthews, L. & Woolhouse, M. 2008. Super-
shedding and the link between human infection and livestock carriage of  




Chatterjee, S. S. & Otto, M. 2013. Improved understanding of factors driving 
methicillin-resistant Staphylococcus aureus epidemic waves. Clinical 
Epidemiology, 5, 205. 
Chin, C.-S., Sorenson, J., Harris, J. B., Robins, W. P., Charles, R. C., Jean-Charles, R. 
R., Bullard, J., Webster, D. R., Kasarskis, A. & Peluso, P. 2011. The origin of 
the Haitian cholera outbreak strain. New England Journal of Medicine, 364, 
33-42. 
Chiou, C.-S. & Jones, A. 1995. Expression and identification of the strA-strB gene 
pair from streptomycin-resistant Erwinia amylovora. Gene, 152, 47-51. 
Chishimba, K., Hang’ombe, B., Muzandu, K., Mshana, S., Matee, M., Nakajima, C. 
& Suzuki, Y. 2016. Detection of Extended-Spectrum Beta-Lactamase-
Producing Escherichia coli in Market-Ready Chickens in Zambia. 
International Journal of Microbiology, 2016. 
Chitnis, A. S., Holzbauer, S. M., Belflower, R. M., Winston, L. G., Bamberg, W. M., 
Lyons, C., Farley, M. M., Dumyati, G. K., Wilson, L. E. & Beldavs, Z. G. 
2013. Epidemiology of community-associated Clostridium difficile infection, 
2009 through 2011. JAMA Internal Medicine, 173, 1359-1367. 
Clermont, O., Bonacorsi, S. & Bingen, E. 2000. Rapid and simple determination of the 
Escherichia coli phylogenetic group. Applied and Environmental 
Microbiology, 66, 4555-4558. 
Clermont, O., Christenson, J. K., Denamur, E. & Gordon, D. M. 2013. The Clermont 
Escherichia coli phylo‐typing method revisited: improvement of specificity 
and detection of new phylo‐groups. Environmental Microbiology Reports, 5, 
58-65. 
Clermont, O., Gordon, D. & Denamur, E. 2015. A guide to the various phylogenetic 
classification schemes for Escherichia coli and the correspondence among 
schemes. Microbiology, mic. 0.000063. 
Cobbaut, K., Berkvens, D., Houf, K., De Deken, R. & De Zutter, L. 2009. Escherichia 
coli O157 prevalence in different cattle farm types and identification of 
potential risk factors. Journal of Food Protection®, 72, 1848-1853. 
Colijn, C. & Gardy, J. 2014. Phylogenetic tree shapes resolve disease transmission 
patterns. Evolution, Medicine, and Public Health, 2014, 96-108. 
Connell, H., Poulsen, L. K. & Klemm, P. 2000. Expression of type 1 and P fimbriae 




bladder and kidney. International Journal of Medical Microbiology, 290, 587-
597. 
Control, C. F. D. & Prevention 2006. Emergence of Mycobacterium tuberculosis with 
extensive resistance to second-line drugs--worldwide, 2000-2004. MMWR. 
Morbidity and Mortality Weekly Report, 55, 301. 
Coque, T. M., Novais, Â., Carattoli, A., Poirel, L., Pitout, J., Peixe, L., Baquero, F., 
Cantón, R. & Nordmann, P. 2008. Dissemination of clonally related 
Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-
15. Emerging Infectious Diseases, 14, 195. 
Cornaglia, G., Giamarellou, H. & Rossolini, G. M. 2011. Metallo-β-lactamases: a last 
frontier for β-lactams? The Lancet Infectious Diseases, 11, 381-393. 
Cortés, C., De La Fuente, R., Blanco, J., Blanco, M., Blanco, J., Dhabi, G., Mora, A., 
Justel, P., Contreras, A. & Sanchez, A. 2005. Serotypes, virulence genes and 
intimin types of verotoxin-producing Escherichia coli and enteropathogenic E. 
coli isolated from healthy dairy goats in Spain. Veterinary Microbiology, 110, 
67-76. 
Croucher, N. J. & Didelot, X. 2015. The application of genomics to tracing bacterial 
pathogen transmission. Current Opinion in Microbiology, 23, 62-67. 
Croucher, N. J., Page, A. J., Connor, T. R., Delaney, A. J., Keane, J. A., Bentley, S. 
D., Parkhill, J. & Harris, S. R. 2014. Rapid phylogenetic analysis of large 
samples of recombinant bacterial whole genome sequences using Gubbins. 
Nucleic Acids Research, gku1196. 
Croxen, M. A., Law, R. J., Scholz, R., Keeney, K. M., Wlodarska, M. & Finlay, B. B. 
2013. Recent advances in understanding enteric pathogenic Escherichia coli. 
Clinical Microbiology Reviews, 26, 822-880. 
Cummings, K. J., Aprea, V. A. & Altier, C. 2014. Antimicrobial resistance trends 
among Escherichia coli isolates obtained from dairy cattle in the northeastern 
United States, 2004–2011. Foodborne Pathogens and Disease, 11, 61-67. 
D’costa, V. M., King, C. E., Kalan, L., Morar, M., Sung, W. W., Schwarz, C., Froese, 
D., Zazula, G., Calmels, F. & Debruyne, R. 2011. Antibiotic resistance is 
ancient. Nature, 477, 457-461. 
Daalen, F., Geerlings, S., Prins, J. & Hulscher, M. 2016. A survey to identify barriers 
of implementing an antibiotic checklist. European Journal of Clinical 




Dahmen, S., Métayer, V., Gay, E., Madec, J.-Y. & Haenni, M. 2013. Characterization 
of extended-spectrum beta-lactamase (ESBL)-carrying plasmids and clones of 
Enterobacteriaceae causing cattle mastitis in France. Veterinary Microbiology, 
162, 793-799. 
Dallman, T. J., Ashton, P. M., Byrne, L., Perry, N. T., Petrovska, L., Ellis, R., Allison, 
L., Hanson, M., Holmes, A. & Gunn, G. J. 2015. Applying phylogenomics to 
understand the emergence of Shiga-toxin-producing Escherichia coli O157: 
H7 strains causing severe human disease in the UK. Microbial Genomics, 1. 
Daniels, J. B., Call, D. R., Hancock, D., Sischo, W. M., Baker, K. & Besser, T. E. 
2009. Role of ceftiofur in selection and dissemination of blaCMY-2-mediated 
cephalosporin resistance in Salmonella enterica and commensal Escherichia 
coli isolates from cattle. Applied and Environmental Microbiology, 75, 3648-
3655. 
Dantas, G. & Sommer, M. O. 2014. How to fight back against antibiotic resistance. 
American Scientist, 102, 42-51. 
Davies, S. & Gibbens, N. 2013. UK Five Year Antimicrobial Resistance Strategy 2013 
to 2018. Department of Health, London. 
De Briyne, N., Atkinson, J., Borriello, S. & Pokludová, L. 2014. Antibiotics used most 
commonly to treat animals in Europe. Veterinary Record, vetrec-2014-102462. 
De Jong, A., Bywater, R., Butty, P., Deroover, E., Godinho, K., Klein, U., Marion, H., 
Simjee, S., Smets, K. & Thomas, V. 2009. A pan-European survey of 
antimicrobial susceptibility towards human-use antimicrobial drugs among 
zoonotic and commensal enteric bacteria isolated from healthy food-producing 
animals. Journal of Antimicrobial Chemotherapy, 63, 733-744. 
Desper, R. & Gascuel, O. 2002. Fast and accurate phylogeny reconstruction algorithms 
based on the minimum-evolution principle. Journal of Computational Biology, 
9, 687-705. 
Dhar, A. & Minin, V. N. 2015. Maximum Likelihood Methods for Phylogenetic 
Inference. 
Dibner, J. & Richards, J. 2005. Antibiotic growth promoters in agriculture: history and 
mode of action. Poultry Science, 84, 634-643. 
Doumith, M., Day, M., Hope, R., Wain, J. & Woodford, N. 2012. Improved multiplex 
PCR strategy for rapid assignment of the four major Escherichia coli 




Duse, A., Waller, K. P., Emanuelson, U., Unnerstad, H. E., Persson, Y. & Bengtsson, 
B. 2014. Risk factors for antimicrobial resistance in fecal Escherichia coli from 
preweaned dairy calves. Journal of Dairy Science. 
Eagar, H., Swan, G. & Van Vuuren, M. 2012. A survey of antimicrobial usage in 
animals in South Africa with specific reference to food animals. Journal of the 
South African Veterinary Association, 83, 15-23. 
Edberg, S., Rice, E., Karlin, R. & Allen, M. 2000. Escherichia coli: the best biological 
drinking water indicator for public health protection. Journal of Applied 
Microbiology, 88, 106S-116S. 
Eliopoulos, G. M. & Huovinen, P. 2001. Resistance to trimethoprim-
sulfamethoxazole. Clinical Infectious Diseases, 32, 1608-1614. 
Eliopoulos, G. M. & Roberts, M. C. 2003. Tetracycline therapy: update. Clinical 
Infectious Diseases, 36, 462-467. 
Ellis-Iversen, J., Smith, R. P., Van Winden, S., Paiba, G. A., Watson, E., Snow, L. C. 
& Cook, A. J. 2008. Farm practices to control E. coli O157 in young cattle-a 
randomised controlled trial. Veterinary Research, 39, 1-12. 
Eriksson, E., Aspan, A., Gunnarsson, A. & Vågsholm, I. 2005. Prevalence of 
verotoxin-producing Escherichia coli (VTEC) O157 in Swedish dairy herds. 
Epidemiology and Infection, 133, 349-358. 
Eriksson, L. 2013. Prevalence of subclinical mastitis and udder pathogens in small 
holder dairy farms in Mapepe, Batoka and Choma areas in Zambia. 
Evans, M. E., Simbartl, L. A., Kralovic, S. M., Jain, R. & Roselle, G. A. 2014. 
Clostridium difficile infections in Veterans Health Administration acute care 
facilities. Infection Control, 35, 1037-1042. 
Fagan, P. K., Hornitzky, M. A., Bettelheim, K. A. & Djordjevic, S. P. 1999. Detection 
of Shiga-Like Toxin (stx1 and stx2), Intimin (eaeA), and Enterohemorrhagic 
Escherichia coli (EHEC) Hemolysin (EHEC hlyA) Genes in Animal Feces by 
Multiplex PCR. Applied and Environmental Microbiology, 65, 868-872. 
Fang, H., Ataker, F., Hedin, G. & Dornbusch, K. 2008. Molecular epidemiology of 
extended-spectrum β-lactamases among Escherichia coli isolates collected in 
a Swedish hospital and its associated health care facilities from 2001 to 2006. 
Journal of Clinical Microbiology, 46, 707-712. 
Farrokh, C., Jordan, K., Auvray, F., Glass, K., Oppegaard, H., Raynaud, S., Thevenot, 




producing Escherichia coli (STEC) and their significance in dairy production. 
International Journal of Food Microbiology, 162, 190-212. 
Feingold, B. J., Silbergeld, E. K., Curriero, F. C., Van Cleef, B. A., Heck, M. E. & 
Kluytmans, J. A. 2012. Livestock density as risk factor for livestock-associated 
methicillin-resistant Staphylococcus aureus, the Netherlands. Emerging 
Infectious Diseases, 18, 1841. 
Fleming, A., Chain, E. & Florey, H. 1964. Sir Alexander Fleming-Nobel Lecture: 
Penicillin. Nobel Lectures, Physiology or Medicine 1942-1962. 
Folster, J. P., Pecic, G., Mccullough, A., Rickert, R. & Whichard, J. M. 2011. 
Characterization of bla CMY-encoding plasmids among Salmonella isolated in 
the United States in 2007. Foodborne Pathogens and Disease, 8, 1289-1294. 
Forsberg, K. J., Patel, S., Gibson, M. K., Lauber, C. L., Knight, R., Fierer, N. & Dantas, 
G. 2014. Bacterial phylogeny structures soil resistomes across habitats. Nature, 
509, 612. 
Forslund, K., Sunagawa, S., Kultima, J. R., Mende, D. R., Arumugam, M., Typas, A. 
& Bork, P. 2013. Country-specific antibiotic use practices impact the human 
gut resistome. Genome Research, 23, 1163-1169. 
Frank, C., Werber, D., Cramer, J. P., Askar, M., Faber, M., An Der Heiden, M., 
Bernard, H., Fruth, A., Prager, R. & Spode, A. 2011. Epidemic profile of Shiga-
toxin–producing Escherichia coli O104: H4 outbreak in Germany. New 
England Journal of Medicine, 365, 1771-1780. 
Freeman, J. & Wilcox, M. H. 1999. Antibiotics and Clostridium difficile. Microbes 
and Infection, 1, 377-384. 
Friesema, I., Van Der Zwaluw, K., Schuurman, T., Kooistra-Smid, M., Franz, E., Van 
Duynhoven, Y. & Van Pelt, W. 2014. Emergence of Escherichia coli encoding 
Shiga toxin 2f in human Shiga toxin-producing E. coli (STEC) infections in 
the Netherlands, January 2008 to December 2011. Euro Surveill, 19, 26-32. 
Fuller, L. E. 2015. ZAMBIA COUNTRY REPORT. 
Gal-Mor, O., Boyle, E. C. & Grassl, G. A. 2014. Same species, different diseases: how 
and why typhoidal and non-typhoidal Salmonella enterica serovars differ. 
Frontiers in Microbiology, 5. 
Gangcuangco, L. M., Alejandria, M., Henson, K. E., Alfaraz, L., Ata, R. M., Lopez, 
M. & Saniel, M. 2015. Prevalence and risk factors for trimethoprim–




uncomplicated urinary tract infection in a developing country. International 
Journal of Infectious Diseases, 34, 55-60. 
Gerbin, C. S. 2014. Enhancing US-Japan Cooperation to Combat Antimicrobial 
Resistance. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and 
Science, 12, 337-345. 
Gerding, D. N., Johnson, S., Peterson, L. R., Mulligan, M. E. & Silva, J. 1995. 
Clostridium difficile-associated diarrhea and colitis. Infection Control, 16, 459-
477. 
Gibbons, J. F., Boland, F., Buckley, J. F., Butler, F., Egan, J., Fanning, S., Markey, B. 
K. & Leonard, F. C. 2014. Patterns of antimicrobial resistance in pathogenic 
Escherichia coli isolates from cases of calf enteritis during the spring-calving 
season. Veterinary Microbiology, 170, 73-80. 
Gieraltowski, L. Multistate Outbreak of Multidrug-Resistant Salmonella Heidelberg 
Infections Linked to Foster Farms Brand Chicken—United States, 2013.  2014 
CSTE Annual Conference, 2014. Cste. 
Gilbert, J. M., White, D. G. & Mcdermott, P. F. 2007. The US national antimicrobial 
resistance monitoring system. 
Gill, C. J., Phiri-Mazala, G., Guerina, N. G., Kasimba, J., Mulenga, C., Macleod, W. 
B., Waitolo, N., Knapp, A. B., Mirochnick, M. & Mazimba, A. 2011. Effect of 
training traditional birth attendants on neonatal mortality (Lufwanyama 
Neonatal Survival Project): randomised controlled study. Bmj, 342, d346. 
Gillings, M. R. 2013. Evolutionary consequences of antibiotic use for the resistome, 
mobilome and microbial pangenome. Frontiers in Microbiology, 4. 
Glynn, M. K., Bopp, C., Dewitt, W., Dabney, P., Mokhtar, M. & Angulo, F. J. 1998. 
Emergence of Multidrug-Resistant Salmonella enterica SerotypeTyphimurium 
DT104 Infections in the United States. New England Journal of Medicine, 338, 
1333-1339. 
Goodyear, K. L. 2002. Veterinary surveillance for antimicrobial resistance. Journal of 
Antimicrobial chemotherapy, 50, 612-614. 
Gorbach, S. L. 2001. Antimicrobial use in animal feed--time to stop. The New England 
Journal of Medicine, 345, 1202. 
Gottesman, B. S., Carmeli, Y., Shitrit, P. & Chowers, M. 2009. Impact of quinolone 
restriction on resistance patterns of Escherichia coli isolated from urine by 




Grace, D. 2015. Review of evidence on antimicrobial resistance and animal agriculture 
in developing countries. 
Grad, Y. H., Lipsitch, M., Feldgarden, M., Arachchi, H. M., Cerqueira, G. C., 
Fitzgerald, M., Godfrey, P., Haas, B. J., Murphy, C. I. & Russ, C. 2012. 
Genomic epidemiology of the Escherichia coli O104: H4 outbreaks in Europe, 
2011. Proceedings of the National Academy of Sciences, 109, 3065-3070. 
Grave, K., Lingaas, E., Bangen, M. & Rønning, M. 1999. Surveillance of the overall 
consumption of antibacterial drugs in humans, domestic animals and farmed 
fish in Norway in 1992 and 1996. Journal of Antimicrobial Chemotherapy, 43, 
243-252. 
Guenther, S., Ewers, C. & Wieler, L. H. 2011. Extended-spectrum beta-lactamases 
producing E. coli in wildlife, yet another form of environmental pollution? 
Frontiers in Microbiology, 2. 
Guindon, S. & Gascuel, O. 2003. A simple, fast, and accurate algorithm to estimate 
large phylogenies by maximum likelihood. Systematic Biology, 52, 696-704. 
Gullberg, E., Cao, S., Berg, O. G., Ilbäck, C., Sandegren, L., Hughes, D. & Andersson, 
D. I. 2011. Selection of resistant bacteria at very low antibiotic concentrations. 
PLoS Pathog, 7, e1002158. 
Gyles, C. 2007. Shiga toxin-producing An overview. Journal of animal science, 85, 
E45-E62. 
Habeenzu, C., Mitarai, S., Lubasi, D., Mudenda, V., Kantenga, T., Mwansa, J. & 
Maslow, J. 2007. Tuberculosis and multidrug resistance in Zambian prisons, 
2000–2001. The International Journal of Tuberculosis and Lung Disease, 11, 
1216-1220. 
Hancock, D., Besser, T., Lejeune, J., Davis, M. & Rice, D. 2001. The control of VTEC 
in the animal reservoir. International Journal of Food Microbiology, 66, 71-
78. 
He, M., Miyajima, F., Roberts, P., Ellison, L., Pickard, D. J., Martin, M. J., Connor, T. 
R., Harris, S. R., Fairley, D. & Bamford, K. B. 2013. Emergence and global 
spread of epidemic healthcare-associated Clostridium difficile. Nature 
Genetics, 45, 109-113. 
Hedges, S. B., Marin, J., Suleski, M., Paymer, M. & Kumar, S. 2015. Tree of life 





Heffernan, R., Mostashari, F., Das, D., Karpati, A., Kulldorff, M. & Weiss, D. 2004. 
Syndromic surveillance in public health practice, New York City. Emerg Infect 
Dis, 10, 858-864. 
Hellman, J., Olsson-Liljequist, B., Bengtsson, B. & Greko, C. 2013. SWEDRES-
SVARM 2012. Use of antimicrobials and occurrence of antimicrobial 
resistance in Sweden. Solna/Uppsala: Swedish Institute for Communicable 
Disease Control and National Veterinary Institute. 
Hendriksen, R. S., Joensen, K. G., Lukwesa-Musyani, C., Kalondaa, A., 
Leekitcharoenphon, P., Nakazwe, R., Aarestrup, F. M., Hasman, H. & 
Mwansa, J. C. 2013. Extremely drug-resistant Salmonella enterica serovar 
Senftenberg infections in patients in Zambia. Journal of Clinical Microbiology, 
51, 284-286. 
Heringstad, B., Klemetsdal, G. & Ruane, J. 2000. Selection for mastitis resistance in 
dairy cattle: a review with focus on the situation in the Nordic countries. 
Livestock Production Science, 64, 95-106. 
Herold, S., Karch, H. & Schmidt, H. 2004. Shiga toxin-encoding bacteriophages–
genomes in motion. International Journal of Medical Microbiology, 294, 115-
121. 
Hosmer Jr, D. W. & Lemeshow, S. 2004. Applied Logistic Regression, John Wiley & 
Sons. 
Hosmer Jr, D. W., Lemeshow, S. & Sturdivant, R. X. 2013. Applied Logistic 
Regression, John Wiley & Sons. 
Hu, Y., Yang, X., Qin, J., Lu, N., Cheng, G., Wu, N., Pan, Y., Li, J., Zhu, L. & Wang, 
X. 2013. Metagenome-wide analysis of antibiotic resistance genes in a large 
cohort of human gut microbiota. Nature Communications, 4. 
Hudzicki, J. 2009. Kirby-Bauer disk diffusion susceptibility test protocol. Am Soc 
Microbiol. 
Hulscher, M. E., Van Der Meer, J. W. & Grol, R. P. 2010. Antibiotic use: how to 
improve it? International Journal of Medical Microbiology, 300, 351-356. 
Humphry, R. W., Cameron, A. & Gunn, G. J. 2004. A practical approach to calculate 





Hussein, H. & Sakuma, T. 2005. Invited review: prevalence of Shiga toxin-producing 
Escherichia coli in dairy cattle and their products. Journal of Dairy Science, 
88, 450-465. 
Inouye, M., Dashnow, H., Raven, L., Schultz, M. B., Pope, B. J., Tomita, T., Zobel, J. 
& Holt, K. E. 2014. SRST2: Rapid genomic surveillance for public health and 
hospital microbiology labs. Genome Med, 6, 90. 
Islam, M. Z., Musekiwa, A., Islam, K., Ahmed, S., Chowdhury, S., Ahad, A. & 
Biswas, P. K. 2014. Regional variation in the prevalence of E. coli O157 in 
cattle: A meta-analysis and meta-regression. PloS One, 9. 
Isogai, E., Makungu, C., Yabe, J., Sinkala, P., Nambota, A., Isogai, H., Fukushi, H., 
Silungwe, M., Mubita, C. & Syakalima, M. 2005. Detection of Salmonella invA 
by isothermal and chimeric primer-initiated amplification of nucleic acids 
(ICAN) in Zambia. Comparative Immunology, Microbiology and Infectious 
Diseases, 28, 363-370. 
Iweriebor, B. C., Iwu, C. J., Obi, L. C., Nwodo, U. U. & Okoh, A. I. 2015. Multiple 
antibiotic resistances among Shiga toxin producing Escherichia coli O157 in 
feces of dairy cattle farms in Eastern Cape of South Africa. BMC Microbiology, 
15, 213. 
Jacob, M. E., Callaway, T. R. & Nagaraja, T. 2009. Dietary interactions and 
interventions affecting Escherichia coli O157 colonization and shedding in 
cattle. Foodborne Pathogens and Disease, 6, 785-792. 
Jacoby, G. A. 2009. AmpC β-lactamases. Clinical Microbiology Reviews, 22, 161-
182. 
Jaros, P., Cookson, A. L., Campbell, D. M., Duncan, G. E., Prattley, D., Carter, P., 
Besser, T. E., Shringi, S., Hathaway, S. & Marshall, J. C. 2014. Geographic 
divergence of bovine and human shiga toxin–producing Escherichia coli 
O157: H7 genotypes, New Zealand. Emerging Infectious Diseases, 20, 1980. 
Jensen, V. F., Jacobsen, E. & Bager, F. 2004. Veterinary antimicrobial-usage statistics 
based on standardized measures of dosage. Preventive Veterinary Medicine, 
64, 201-215. 
Joshi, M., Pollock, N. & Garrison, K. 2004. Antimicrobial Resistance 
Stakeholders’“Call for Action” Meeting: Lusaka, November 12, 2004. 
Submitted to the USAID by the Rational Pharmaceutical Management Plus 




Kaase, M., Pfennigwerth, N., Lange, F., Anders, A. & Gatermann, S. G. 2015. 
Molecular epidemiology of VIM-1 producing Escherichia coli from Germany 
referred to the National Reference Laboratory. International Journal of 
Medical Microbiology, 305, 784-789. 
Kabwe, M., Tembo, J., Chilukutu, L., Chilufya, M., Ngulube, F., Lukwesa, C., Kapasa, 
M., Enne, V., Wexner, H. & Mwananyanda, L. 2016. Etiology, Antibiotic 
Resistance and Risk Factors for Neonatal Sepsis in a Large Referral Center in 
Zambia. The Pediatric Infectious Disease Journal. 
Kaluba, E. Smallholder dairy production in Zambia.  Future of Livestock Industries in 
East and Southern Africa: Proceedings of the Workshop Held at Kadoma 
Ranch Hotel, Zimbabwe, 20-23 July 1992, 1993. ILRI (aka ILCA and ILRAD), 
137. 
Kandrotaite, K., Smigelskas, K., Janusauskiene, D., Jievaltas, M., Maciulaitis, R. & 
Briedis, V. 2013. Development of a short questionnaire to identify the risk of 
nonadherence to antibiotic treatment. Current Medical Research and Opinion, 
29, 1555-1563. 
Kanfer, I., Skinner, M. F. & Walker, R. B. 1998. Analysis of macrolide antibiotics. 
Journal of Chromatography A, 812, 255-286. 
Kao, J.-H., Chan, T.-C., Lai, F., Lin, B.-C., Sun, W.-Z., Chang, K.-W., Leu, F.-Y. & 
Lin, J.-W. 2016. Spatial analysis and data mining techniques for identifying 
risk factors of Out-of-Hospital Cardiac Arrest. International Journal of 
Information Management. 
Kapata, N., Chanda‐Kapata, P., Bates, M., Mwaba, P., Cobelens, F., Grobusch, M. P. 
& Zumla, A. 2013. Multidrug‐resistant TB in Zambia: review of national data 
from 2000 to 2011. Tropical Medicine & International Health, 18, 1386-1391. 
Kaper, J. B., Nataro, J. P. & Mobley, H. L. 2004. Pathogenic Escherichia coli. Nature 
Reviews Microbiology, 2, 123-140. 
Karch, H., Leopold, S. R., Kossow, A., Mellmann, A., Köck, R. & Bauwens, A. 2015. 
Enterohemorrhagic E. coli (EHEC): Environmental-Vehicle-Human Interface. 
Zoonoses-Infections Affecting Humans and Animals. Springer. 
Kelly, P., Baboo, K., Wolff, M., Ngwenya, B., Luo, N. & Farthing, M. 1996. The 
prevalence and aetiology of persistent diarrhoea in adults in urban Zambia. 
Acta tropica, 61, 183-190. 
Kesteman, O. C., Denamur, E., El Mniai, L. A., Marcel, C., Perrier, M., Visseaux, T., 




Khachatryan, A. R., Hancock, D. D., Besser, T. E. & Call, D. R. 2004. Role of calf-
adapted Escherichia coli in maintenance of antimicrobial drug resistance in 
dairy calves. Applied and Environmental Microbiology, 70, 752-757. 
Kohanski, M. A., Dwyer, D. J. & Collins, J. J. 2010. How antibiotics kill bacteria: 
from targets to networks. Nature Reviews Microbiology, 8, 423-435. 
Kollef, M. H. & Fraser, V. J. 2001. Antibiotic resistance in the intensive care unit. 
Annals of Internal Medicine, 134, 298-314. 
Komba, E., Mdegela, R., Msoffe, P., Nielsen, L. & Ingmer, H. 2015. Prevalence, 
Antimicrobial Resistance and Risk Factors for Thermophilic Campylobacter 
Infections in Symptomatic and Asymptomatic Humans in Tanzania. Zoonoses 
and Public Health. 
Köser, C. U., Ellington, M. J., Cartwright, E. J., Gillespie, S. H., Brown, N. M., 
Farrington, M., Holden, M. T., Dougan, G., Bentley, S. D. & Parkhill, J. 2012. 
Routine use of microbial whole genome sequencing in diagnostic and public 
health microbiology. PLoS Pathogens, 8, e1002824. 
Krüger, A., Lucchesi, P. M. & Parma, A. E. 2011. Verotoxins in bovine and meat 
verotoxin-producing Escherichia coli isolates: type, number of variants, and 
relationship to cytotoxicity. Applied and Environmental Microbiology, 77, 73-
79. 
Kuroda, K., Suzuki, R., Ihara, K., Miyagi, H., Watanabe, H., Sato, K., Hang’ombe, B. 
M., Mubita, C., Isogai, N. & Mulenga, E. 2013. Detection of virulence genes 
of Escherichia coli and Salmonella spp. from fecal samples of Kafue lechwe 
(Kobus leche kafuensis) and pastoral cattle in the interface areas of Zambia. 
African Journal of Microbiology Research, 7, 504-508. 
Kuznetsova, A., Brockhoff, P. B. & Christensen, R. H. B. 2013. lmerTest: Tests for 
random and fixed effects for linear mixed effect models (lmer objects of lme4 
package). R Package Version, 2.0-0. 
Kyselková, M., Jirout, J., Vrchotová, N., Schmitt, H. & Elhottová, D. 2015. Spread of 
tetracycline resistance genes at a conventional dairy farm. Frontiers in 
Microbiology, 6. 
Lam, T. J. Antibiotic usage and resistance in dairy cattle in the Netherlands.  
Countdown Symposium 2013 Melbourne, Australia., 2013. 27. 
Larkin, M. A., Blackshields, G., Brown, N., Chenna, R., Mcgettigan, P. A., Mcwilliam, 
H., Valentin, F., Wallace, I. M., Wilm, A. & Lopez, R. 2007. Clustal W and 




Lejeune, J. T., Hancock, D., Wasteson, Y., Skjerve, E. & Urdahl, A. M. 2006. 
Comparison of E. coli O157 and Shiga toxin-encoding genes (stx) prevalence 
between Ohio, USA and Norwegian dairy cattle. International Journal of Food 
Microbiology, 109, 19-24. 
Leopold, S. J., Van Leth, F., Tarekegn, H. & Schultsz, C. 2014. Antimicrobial drug 
resistance among clinically relevant bacterial isolates in sub-Saharan Africa: a 
systematic review. Journal of Antimicrobial Chemotherapy, dku176. 
Leski, T. A., Bangura, U., Jimmy, D. H., Ansumana, R., Lizewski, S. E., Stenger, D. 
A., Taitt, C. R. & Vora, G. J. 2013. Multidrug-resistant tet (X)-containing 
hospital isolates in Sierra Leone. International Journal of Antimicrobial 
Agents, 42, 83-86. 
Levin, B., Lipsitch, M., Perrot, V., Schrag, S., Antia, R., Simonsen, L., Walker, N. M. 
& Stewart, F. 1997. The population genetics of antibiotic resistance. Clinical 
Infectious Diseases, 24, S9-S16. 
Levy, S. B., Mcmurry, L. M., Barbosa, T. M., Burdett, V., Courvalin, P., Hillen, W., 
Roberts, M. C., Rood, J. I. & Taylor, D. E. 1999. Nomenclature for new 
tetracycline resistance determinants. Antimicrobial Agents and Chemotherapy, 
43, 1523-1524. 
Li, H. & Durbin, R. 2010. Fast and accurate long-read alignment with Burrows–
Wheeler transform. Bioinformatics, 26, 589-595. 
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., 
Abecasis, G. & Durbin, R. 2009. The sequence alignment/map format and 
SAMtools. Bioinformatics, 25, 2078-2079. 
Li, R., Lai, J., Wang, Y., Liu, S., Li, Y., Liu, K., Shen, J. & Wu, C. 2013. Prevalence 
and characterization of Salmonella species isolated from pigs, ducks and 
chickens in Sichuan Province, China. International Journal of Food 
Microbiology, 163, 14-18. 
Lin, J., Nishino, K., Roberts, M. C., Tolmasky, M., Aminov, R. I. & Zhang, L. 2015. 
Mechanisms of antibiotic resistance. Frontiers in Microbiology, 6. 
Liu, L., Li, Y., Li, S., Hu, N., He, Y., Pong, R., Lin, D., Lu, L. & Law, M. 2012. 
Comparison of next-generation sequencing systems. BioMed Research 
International, 2012. 
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, 
G., Dong, B. & Huang, X. 2016. Emergence of plasmid-mediated colistin 




microbiological and molecular biological study. The Lancet Infectious 
Diseases, 16, 161-168. 
Livermore, D. M. & Woodford, N. 2006. The β-lactamase threat in 
Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends in Microbiology, 
14, 413-420. 
Livi-Bacci, M. 2012. A Concise History of World Population, John Wiley & Sons. 
Louise, C. B. & Obrig, T. G. 1995. Specific interaction of Escherichia coli 0157: H7-
derived Shiga-like toxin II with human renal endothelial cells. Journal of 
Infectious Diseases, 172, 1397-1401. 
Lowman, W., Sriruttan, C., Nana, T., Bosman, N., Duse, A., Venturas, J., Clay, C. & 
Coetzee, J. 2011. NDM-1 has arrived: first report of a carbapenem resistance 
mechanism in South Africa. SAMJ: South African Medical Journal, 101, 873-
875. 
Lukali, V. & Michelo, C. 2015. Factors Associated with Irrational Drug use at a 
District Hospital in Zambia: Patient Record-based Observations. Medical 
Journal of Zambia, 42, 25-30. 
Lukwesa, C. 2012. A survey of antibiotic prescribing patterns and in-vitro antibiotic 
susceptibility patterns at the University Teaching Hosptal, Lusaka, Zambia, 
1998. 
Lumley, T. 2004. Analysis of complex survey samples. Journal of Statistical Software, 
9, 1-19. 
Luna-Gierke, R., Griffin, P., Gould, L., Herman, K., Bopp, C., Strockbine, N. & Mody, 
R. 2014. Outbreaks of non-O157 Shiga toxin-producing Escherichia coli 
infection: USA. Epidemiology and Infection, 142, 2270-2280. 
Madoroba, E., Gelaw, A., Hlokwe, T. & Mnisi, M. 2013. Prevalence of Campylobacter 
foetus and Trichomonas foetus among cattle from Southern Africa. African 
Journal of Biotechnology, 10, 10311-10314. 
Magnet, S., Courvalin, P. & Lambert, T. 2001. Resistance-nodulation-cell division-
type efflux pump involved in aminoglycoside resistance in Acinetobacter 
baumannii strain BM4454. Antimicrobial Agents and Chemotherapy, 45, 
3375-3380. 
Magnet, S., Smith, T.-A., Zheng, R., Nordmann, P. & Blanchard, J. S. 2003. 




aminoglycoside acetyltransferase. Antimicrobial Agents and Chemotherapy, 
47, 1577-1583. 
Mahmood, T. & Yang, P.-C. 2012. Western blot: technique, theory, and trouble 
shooting. North American Journal of Medical Sciences, 4, 429. 
Mainda, G., Bessell, P. B., Muma, J. B., Mcateer, S. P., Chase-Topping, M. E., 
Gibbons, J., Stevens, M. P., Gally, D. L. & Barend, M. 2015. Prevalence and 
patterns of antimicrobial resistance among Escherichia coli isolated from 
Zambian dairy cattle across different production systems. Scientific Reports, 5. 
Majowicz, S. E., Scallan, E., Jones-Bitton, A., Sargeant, J. M., Stapleton, J., Angulo, 
F. J., Yeung, D. H. & Kirk, M. D. 2014. Global Incidence of Human Shiga 
Toxin–Producing Escherichia coli Infections and Deaths: A Systematic 
Review and Knowledge Synthesis. Foodborne Pathogens and Disease, 11, 
447-455. 
Makela, P., Beloeil, P. A., Rizzi, V., Boelaert, F. & Deluyker, H. 2012. Harmonisation 
of monitoring zoonoses, antimicrobial resistance and foodborne outbreaks. 
EFSA Journal, 10. 
Manenzhe, R. I., Zar, H. J., Nicol, M. P. & Kaba, M. 2014. The spread of 
carbapenemase-producing bacteria in Africa: a systematic review. Journal of 
Antimicrobial Chemotherapy, dku356. 
March, S. B. & Ratnam, S. 1986. Sorbitol-MacConkey medium for detection of 
Escherichia coli O157: H7 associated with hemorrhagic colitis. Journal of 
Clinical Microbiology, 23, 869-872. 
March, S. B. & Ratnam, S. 1989. Latex agglutination test for detection of Escherichia 
coli serotype O157. Journal of Clinical Microbiology, 27, 1675-1677. 
Marshall, B. M. & Levy, S. B. 2011. Food animals and antimicrobials: impacts on 
human health. Clinical Microbiology Reviews, 24, 718-733. 
Martin, M. 2011. Cutadapt removes adapter sequences from high-throughput 
sequencing reads. EMBnet. Journal, 17, pp. 10-12. 
Mather, A., Reid, S., Maskell, D., Parkhill, J., Fookes, M., Harris, S., Brown, D., Coia, 
J., Mulvey, M. & Gilmour, M. 2013. Distinguishable epidemics of multidrug-
resistant Salmonella Typhimurium DT104 in different hosts. Science, 341, 
1514-1517. 
Mellmann, A., Harmsen, D., Cummings, C. A., Zentz, E. B., Leopold, S. R., Rico, A., 




characterization of the German enterohemorrhagic Escherichia coli O104: H4 
outbreak by rapid next generation sequencing technology. PloS One, 6, 
e22751. 
Melnyk, A. H., Wong, A. & Kassen, R. 2015. The fitness costs of antibiotic resistance 
mutations. Evolutionary Applications, 8, 273-283. 
Melton-Celsa, A. & O’brien, A. 2000. Shiga toxins of Shigella dysenteriae and 
Escherichia coli. Bacterial Protein Toxins. Springer. 
Memariani, M., Peerayeh, S. N., Salehi, T. Z. & Mostafavi, S. K. S. 2015. Occurrence 
of SHV, TEM and CTX-M β-Lactamase Genes Among Enteropathogenic 
Escherichia coli Strains Isolated From Children With Diarrhea. Jundishapur 
Journal of Microbiology, 8. 
Mendelson, M., Røttingen, J.-A., Gopinathan, U., Hamer, D. H., Wertheim, H., 
Basnyat, B., Butler, C., Tomson, G. & Balasegaram, M. 2016. Maximising 
access to achieve appropriate human antimicrobial use in low-income and 
middle-income countries. The Lancet, 387, 188-198. 
Meyer, M. 2004. Use and Environmental Occurrence of Veterinary Pharmaceuticals 
in United States Agriculture. Pharmaceuticals in the Environment. Springer. 
Mitema, E., Kikuvi, G., Wegener, H. C. & Stohr, K. 2001. An assessment of 
antimicrobial consumption in food producing animals in Kenya. Journal of 
Veterinary Pharmacology and Therapeutics, 24, 385-390. 
Modi, S. R., Lee, H. H., Spina, C. S. & Collins, J. J. 2013. Antibiotic treatment expands 
the resistance reservoir and ecological network of the phage metagenome. 
Nature, 499, 219-222. 
Mohammed, M. J., Marston, C. K., Popovic, T., Weyant, R. S. & Tenover, F. C. 2002. 
Antimicrobial susceptibility testing of Bacillus anthracis: comparison of 
results obtained by using the National Committee for Clinical Laboratory 
Standards broth microdilution reference and Etest agar gradient diffusion 
methods. Journal of Clinical Microbiology, 40, 1902-1907. 
Morris, A. & Masterton, R. 2002. Antibiotic resistance surveillance: action for 
international studies. Journal of Antimicrobial Chemotherapy, 49, 7-10. 
Mshana, S. E., Matee, M. & Rweyemamu, M. 2013a. Antimicrobial resistance in 
human and animal pathogens in Zambia, Democratic Republic of Congo, 
Mozambique and Tanzania: an urgent need of a sustainable surveillance 




Mshana, S. E., Matee, M. & Rweyemamu, M. 2013b. Antimicrobial resistance in 
human and animal pathogens in Zambia, Democratic Republic of Congo, 
Mozambique and Tanzania: an urgent need of a sustainable surveillance 
system. Annals of Clinical Microbiology and Antimicrobials, 12, 28. 
Mubita, C., Muma, J. B., Munyeme, M., Mulenga, E., Chitambo, M., Fukushi, H., 
Yasuda, J., Isogai, H. & Isogai, E. 2015. Isolation of Escherichia coli from 
cattle and lechwe antelopes at the livestock/wildlife interface area of the Kafue 
flats in Zambia. African Journal of Microbiology Research, 9, 938-944. 
Mubita, C., Syakalima, M., Chisenga, C., Munyeme, M., Bwalya, M., Chifumpa, G., 
Sinkala, P., Simuunza, M. & Fukushi, H. 2008. Antibiograms of faecal 
Escherichia coli and Enterococci species isolated from pastoralist cattle in the 
interface areas of the Kafue basin in Zambia. Veterinarski arhiv, 78, 179. 
Mulemba, H. 2009. The Livestock Sector in Zambia and Rising Food Prices Country 
Briefing–Zambia. International Institute for Sustainable Development, 
Manitoba, Canada. 
Mumba, C. & Pandey, G. 2012. Assessment of Opportunities for Improving Dairy 
Production, Marketing, and Adoption of Good Animal Husbandry Practices 
within Traditional Cattle Keeping areas of Zambia. Netherlands Development 
Organisation (SNV). 
Mumba, C., Pandey, G. & Van Der Jagt, C. 2013. Milk production potential, marketing 
and income opportunities in key traditional cattle keeping areas of Zambia. 
Livestock Research for Rural Development, 25. 
Mumba, C., Samui, K., Pandey, G. & Tembo, G. 2012. Econometric analysis of the 
socio-economic factors affecting the profitability of smallholder dairy farming 
in Zambia. Livest. Res. Rural Dev, 24. 
Mushtaq, S., Warner, M., Cloke, J., Afzal-Shah, M. & Livermore, D. M. 2010. 
Performance of the Oxoid MIC Evaluator™ Strips compared with the Etest® 
assay and BSAC agar dilution. Journal of Antimicrobial Chemotherapy, 
dkq206. 
Mwamungule, S., Chimana, H. M., Malama, S., Mainda, G., Kwenda, G. & Muma, J. 
B. 2015. Contamination of health care workers’ coats at the University 
Teaching Hospital in Lusaka, Zambia: the nosocomial risk. Journal of 
Occupational Medicine and Toxicology, 10, 34. 
Mwansa, J., Mutela, K., Zulu, I., Amadi, B. & Kelly, P. 2002. Antimicrobial sensitivity 
in enterobacteria from AIDS patients, Zambia.(Dispatches). Emerging 




Ndambi, O. A., Hemme, T. & Latacz-Lohmann, U. 2007. Dairying in Africa-Status 
and recent developments. Livestock Research for Rural Development, 19. 
Neel, R. 2012. Multidrug resistance of isolates of methicillin resistant Staphylococcus 
aureus (MRSA) in paper currency notes from restaurants and hotels in Lusaka 
in Zambia. Int J Pharm Sci, 5, 363-366. 
Neven, D., Katjiuongua, H., Adjosoediro, I., Reardon, T., Chuzu, P. N., Tembo, G. & 
Ndiyoi, M. 2006. Food sector transformation and standards in Zambia: 
Smallholder farmer participation and growth in the dairy sector. Michigan 
State University, Department of Agricultural, Food, and Resource Economics. 
Ngoma, M., Suzuki, A., Takashima, I. & Sato, G. 1993. Antibiotic resistance of 
Escherichia coli and Salmonella from apparently healthy slaughtered cattle and 
pigs, and diseased animals in Zambia. Japanese Journal of Veterinary 
Research, 41, 1-10. 
Norman, A., Hansen, L. H. & Sørensen, S. J. 2009. Conjugative plasmids: vessels of 
the communal gene pool. Philosophical Transactions of the Royal Society of 
London B: Biological Sciences, 364, 2275-2289. 
Nukaga, M., Mayama, K., Hujer, A. M., Bonomo, R. A. & Knox, J. R. 2003. Ultrahigh 
resolution structure of a class A β-lactamase: on the mechanism and specificity 
of the extended-spectrum SHV-2 enzyme. Journal of Molecular Biology, 328, 
289-301. 
O’neill, J. 2014. Antimicrobial resistance: tackling a crisis for the health and wealth of 
nations. Review on antimicrobial resistance. 
Ogura, Y., Mondal, S. I., Islam, M. R., Mako, T., Arisawa, K., Katsura, K., Ooka, T., 
Gotoh, Y., Murase, K. & Ohnishi, M. 2015. The Shiga toxin 2 production level 
in enterohemorrhagic Escherichia coli O157: H7 is correlated with the 
subtypes of toxin-encoding phage. Scientific Reports, 5. 
Okeke, I. N., Klugman, K. P., Bhutta, Z. A., Duse, A. G., Jenkins, P., O'brien, T. F., 
Pablos-Mendez, A. & Laxminarayan, R. 2005a. Antimicrobial resistance in 
developing countries. Part II: strategies for containment. The Lancet Infectious 
Diseases, 5, 568-580. 
Okeke, I. N., Laxminarayan, R., Bhutta, Z. A., Duse, A. G., Jenkins, P., O'brien, T. F., 
Pablos-Mendez, A. & Klugman, K. P. 2005b. Antimicrobial resistance in 
developing countries. Part I: recent trends and current status. The Lancet 




Olsson-Liljequist, B., Larsson, P., Walder, M. & Miörner, H. 1997. Antimicrobial 
susceptibility testing in Sweden. III. Methodology for susceptibility testing. 
Scandinavian Journal of Infectious Diseases. Supplementum, 105, 13. 
Organization, W. H. 2007. The global MDR-TB & XDR-TB response plan 2007-2008. 
Orndorff, P. E. 2016. Use of bacteriophage to target bacterial surface structures 
required for virulence: a systematic search for antibiotic alternatives. Current 
Genetics, 1-5. 
Pandey, G. & Muliokela, S. 2006. Smallholder dairy farming: A tool for HIV. AIDS 
Mitigation and Food in-Security. 9th May. 
Pareek, C. S., Smoczynski, R. & Tretyn, A. 2011. Sequencing technologies and 
genome sequencing. Journal of Applied Genetics, 52, 413-435. 
Paterson, D. L. & Bonomo, R. A. 2005. Extended-spectrum β-lactamases: a clinical 
update. Clinical Microbiology Reviews, 18, 657-686. 
Paton, A. W. & Paton, J. C. 1998. Detection and Characterization of Shiga Toxigenic 
Escherichia coli by Using Multiplex PCR Assays for stx1, stx2, eaeA, 
Enterohemorrhagic E. coli hlyA, rfbO111, and rfbO157. Journal of Clinical 
Microbiology, 36, 598-602. 
Payne, S. L. B. 2014. The Art of Asking Questions: Studies in Public Opinion, 3, 
Princeton University Press. 
Pearce, M., Evans, J., Mckendrick, I., Smith, A., Knight, H., Mellor, D., Woolhouse, 
M., Gunn, G. & Low, J. 2006. Prevalence and virulence factors of Escherichia 
coli serogroups O26, O103, O111, and O145 shed by cattle in Scotland. 
Applied and Environmental Microbiology, 72, 653-659. 
Peirano, G. & Pitout, J. D. 2010. Molecular epidemiology of Escherichia coli 
producing CTX-M β-lactamases: the worldwide emergence of clone ST131 
O25: H4. International Journal of Antimicrobial Agents, 35, 316-321. 
Pereira, R., Siler, J., Ng, J., Davis, M., Grohn, Y. & Warnick, L. 2014. Effect of on-
farm use of antimicrobial drugs on resistance in fecal Escherichia coli of 
preweaned dairy calves. Journal of Dairy Science, 97, 7644-7654. 
Phongsamart, W., Srifeungfung, S., Chatsuwan, T., Nunthapisud, P., 
Treerauthaweeraphong, V., Rungnobhakhun, P., Sricharoenchai, S. & 
Chokephaibulkit, K. 2014. Changing trends in serotype distribution and 




diseases in Central Thailand, 2009–2012. Human Vaccines & 
Immunotherapeutics, 10, 1866-1873. 
Pruimboom-Brees, I. M., Morgan, T. W., Ackermann, M. R., Nystrom, E. D., Samuel, 
J. E., Cornick, N. A. & Moon, H. W. 2000. Cattle lack vascular receptors for 
Escherichia coli O157: H7 Shiga toxins. Proceedings of the National Academy 
of Sciences, 97, 10325-10329. 
Ramirez, M. S. & Tolmasky, M. E. 2010. Aminoglycoside modifying enzymes. Drug 
Resistance Updates, 13, 151-171. 
Rasko, D. A., Webster, D. R., Sahl, J. W., Bashir, A., Boisen, N., Scheutz, F., Paxinos, 
E. E., Sebra, R., Chin, C.-S. & Iliopoulos, D. 2011. Origins of the E. coli strain 
causing an outbreak of hemolytic–uremic syndrome in Germany. New England 
Journal of Medicine, 365, 709-717. 
Redding, L., Cubas-Delgado, F., Sammel, M., Smith, G., Galligan, D., Levy, M. & 
Hennessy, S. 2014. The use of antibiotics on small dairy farms in rural Peru. 
Preventive Veterinary Medicine, 113, 88-95. 
Regulation Ojeu 2003. No 1831/2003 of the European Parliament and the Council of 
22 September 2003 on additives for use in animal nutrition. Official J Eur 
Union. 
Rey, J., Blanco, J. E., Blanco, M., Mora, A., Dahbi, G., Alonso, J. M., Hermoso, M., 
Hermoso, J., Alonso, M. P. & Usera, M. A. 2003. Serotypes, phage types and 
virulence genes of Shiga-producing Escherichia coli isolated from sheep in 
Spain. Veterinary Microbiology, 94, 47-56. 
Rice, P., Longden, I. & Bleasby, A. 2000. EMBOSS: the European molecular biology 
open software suite. Trends in Genetics, 16, 276-277. 
Rinttilä, T., Kassinen, A., Malinen, E., Krogius, L. & Palva, A. 2004. Development of 
an extensive set of 16S rDNA‐targeted primers for quantification of pathogenic 
and indigenous bacteria in faecal samples by real‐time PCR. Journal of Applied 
Microbiology, 97, 1166-1177. 
Roberts, M. C. 2005. Update on acquired tetracycline resistance genes. FEMS 
Microbiology Letters, 245, 195-203. 
Robinson, T. P., Franceschini, G. & Wint, W. 2007. The Food and Agriculture 




Rohde, H., Qin, J., Cui, Y., Li, D., Loman, N. J., Hentschke, M., Chen, W., Pu, F., 
Peng, Y. & Li, J. 2011. Open-source genomic analysis of Shiga-toxin–
producing E. coli O104: H4. New England Journal of Medicine, 365, 718-724. 
Ronquist, F. & Huelsenbeck, J. P. 2003. MrBayes 3: Bayesian phylogenetic inference 
under mixed models. Bioinformatics, 19, 1572-1574. 
Rostagno, M. H. 2009. Can stress in farm animals increase food safety risk? 
Foodborne Pathogens and Disease, 6, 767-776. 
Saini, V., Mcclure, J., Scholl, D. T., Devries, T. J. & Barkema, H. W. 2013. Herd-level 
relationship between antimicrobial use and presence or absence of 
antimicrobial resistance in gram-negative bovine mastitis pathogens on 
Canadian dairy farms. Journal of Dairy Science, 96, 4965-4976. 
Salipante, S. J., Roach, D. J., Kitzman, J. O., Snyder, M. W., Stackhouse, B., Butler-
Wu, S. M., Lee, C., Cookson, B. T. & Shendure, J. 2014. Large-scale genomic 
sequencing of extraintestinal pathogenic Escherichia coli strains. Genome 
Research, gr. 180190.114. 
Sarmah, A. K., Meyer, M. T. & Boxall, A. B. 2006. A global perspective on the use, 
sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics 
(VAs) in the environment. Chemosphere, 65, 725-759. 
Sawant, A. A., Hegde, N. V., Straley, B. A., Donaldson, S. C., Love, B. C., Knabel, S. 
J. & Jayarao, B. M. 2007. Antimicrobial-resistant enteric bacteria from dairy 
cattle. Applied and Environmental Microbiology, 73, 156-163. 
Scheutz, F., Nielsen, E. M., Frimodt-Moller, J., Boisen, N., Morabito, S., Tozzoli, R., 
Nataro, J. & Caprioli, A. 2011. Characteristics of the enteroaggregative Shiga 
toxin/verotoxin-producing Escherichia coli O104: H4 strain causing the 
outbreak of haemolytic uraemic syndrome in Germany, May to June 2011. 
Euro Surveill, 16, 19889. 
Scheutz, F., Teel, L. D., Beutin, L., Piérard, D., Buvens, G., Karch, H., Mellmann, A., 
Caprioli, A., Tozzoli, R. & Morabito, S. 2012. Multicenter evaluation of a 
sequence-based protocol for subtyping Shiga toxins and standardizing Stx 
nomenclature. Journal of Clinical Microbiology, 50, 2951-2963. 
Schmidt, C. E., Shringi, S. & Besser, T. E. 2016. Protozoan Predation of Escherichia 
coli O157: H7 Is Unaffected by the Carriage of Shiga Toxin-Encoding 
Bacteriophages. PloS One, 11. 





Schnippel, K., Shearer, K., Evans, D., Berhanu, R. & Ndjeka, N. 2015. Predictors of 
mortality and treatment success during treatment for rifampicin-resistant 
tuberculosis within the South African National TB Programme, 2009 to 2011: 
a cohort analysis of the national case register. International Journal of 
Infectious Diseases, 39, 89-94. 
Schwalbe, R., Steele-Moore, L. & Goodwin, A. C. 2007. Antimicrobial Susceptibility 
Testing Protocols, Crc Press. 
Seemann, T. 2014. Prokka: rapid prokaryotic genome annotation. Bioinformatics, 
btu153. 
Seltmann, G. & Holst, O. 2013. The bacterial cell wall, Springer Science & Business 
Media. 
Shaban, R. Z., Simon, G. I., Trott, D. J., Turnidge, J. & Jordan, D. 2014. Surveillance 
and reporting of antimicrobial resistance and antibiotic usage in animals and 
agriculture in Australia. 
Sharma, S., Madan, M., Agrawal, C. & Asthana, A. K. 2014. Genotype MTBDR plus 
assay for molecular detection of rifampicin and isoniazid resistance in 
Mycobacterium tuberculosis. Indian Journal of Pathology and Microbiology, 
57, 423. 
Shaw, D., Jenkins, C., Pearce, M., Cheasty, T., Gunn, G., Dougan, G., Smith, H., 
Woolhouse, M. & Frankel, G. 2004. Shedding patterns of verocytotoxin-
producing Escherichia coli strains in a cohort of calves and their dams on a 
Scottish beef farm. Applied and Environmental Microbiology, 70, 7456-7465. 
Shin, S. W., Shin, M. K., Jung, M., Belaynehe, K. M. & Yoo, H. S. 2015. Prevalence 
of Antimicrobial Resistance and Transfer of Tetracycline Resistance Genes in 
Escherichia coli Isolated from Beef Cattle. Applied and Environmental 
Microbiology, AEM. 01511-15. 
Simuunza, M., Weir, W., Courcier, E., Tait, A. & Shiels, B. 2011. Epidemiological 
analysis of tick-borne diseases in Zambia. Veterinary Parasitology, 175, 331-
342. 
Sjölund, M., Bonnedahl, J., Hernandez, J., Bengtsson, S., Cederbrant, G., Pinhassi, J., 
Kahlmeter, G. & Olsen, B. 2008. Dissemination of multidrug-resistant bacteria 
into the Arctic. Emerging Infectious Diseases, 14, 70-72. 
Sköld, O. 2000. Sulfonamide resistance: mechanisms and trends. Drug Resistance 




Snitkin, E. S., Zelazny, A. M., Thomas, P. J., Stock, F., Henderson, D. K., Palmore, T. 
N. & Segre, J. A. 2012. Tracking a hospital outbreak of carbapenem-resistant 
Klebsiella pneumoniae with whole-genome sequencing. Science Translational 
Medicine, 4, 148ra116-148ra116. 
Söderlund, R., Jernberg, C., Ivarsson, S., Hedenström, I., Eriksson, E., Bongcam-
Rudloff, E. & Aspán, A. 2014. Molecular Typing of Escherichia coli O157: 
H7 Isolates from Swedish Cattle and Human Cases: Population Dynamics and 
Virulence. Journal of Clinical Microbiology, 52, 3906-3912. 
Sommer, M. O., Dantas, G. & Church, G. M. 2009. Functional characterization of the 
antibiotic resistance reservoir in the human microflora. Science, 325, 1128-
1131. 
Sørensen, S. J., Bailey, M., Hansen, L. H., Kroer, N. & Wuertz, S. 2005. Studying 
plasmid horizontal transfer in situ: a critical review. Nature Reviews 
Microbiology, 3, 700-710. 
Stamatakis, A. 2006. RAxML-VI-HPC: maximum likelihood-based phylogenetic 
analyses with thousands of taxa and mixed models. Bioinformatics, 22, 2688-
2690. 
Sundqvist, M., Geli, P., Andersson, D. I., Sjölund-Karlsson, M., Runehagen, A., Cars, 
H., Abelson-Storby, K., Cars, O. & Kahlmeter, G. 2010. Little evidence for 
reversibility of trimethoprim resistance after a drastic reduction in 
trimethoprim use. Journal of Antimicrobial Chemotherapy, 65, 350-360. 
Tadesse, D. A., Zhao, S., Tong, E., Ayers, S., Singh, A., Bartholomew, M. J. & 
Mcdermott, P. F. 2012. Antimicrobial drug resistance in Escherichia coli from 
humans and food animals, United States, 1950–2002. Emerg Infect Dis, 18, 
741-9. 
Tamura, K., Stecher, G., Peterson, D., Filipski, A. & Kumar, S. 2013. MEGA6: 
molecular evolutionary genetics analysis version 6.0. Molecular Biology and 
Evolution, 30, 2725-2729. 
Tenaillon, O., Skurnik, D., Picard, B. & Denamur, E. 2010. The population genetics 
of commensal Escherichia coli. Nature Reviews Microbiology, 8, 207-217. 
Tenover, F. C. 2006. Mechanisms of antimicrobial resistance in bacteria. The 
American Journal of Medicine, 119, S3-S10. 
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, 




patterns produced by pulsed-field gel electrophoresis: criteria for bacterial 
strain typing. Journal of Clinical Microbiology, 33, 2233. 
Testing, E. C. O. a. S. 2011. Breakpoint tables for interpretation of MICs and zone 
diameters, version 1.3. Basel: EUCAST. 
Thaker, M., Spanogiannopoulos, P. & Wright, G. D. 2010. The tetracycline resistome. 
Cellular and Molecular Life Sciences, 67, 419-431. 
Thiermann, A. B. 2005. Globalization, international trade and animal health: the new 
roles of OIE. Preventive Veterinary Medicine, 67, 101-108. 
Thomas, V., De Jong, A., Moyaert, H., Simjee, S., El Garch, F., Morrissey, I., Marion, 
H. & Vallé, M. 2015. Antimicrobial susceptibility monitoring of mastitis 
pathogens isolated from acute cases of clinical mastitis in dairy cows across 
Europe: VetPath results. International Journal of Antimicrobial Agents, 46, 13-
20. 
Thomson, K. S. 2001. Controversies about extended-spectrum and AmpC beta-
lactamases. Emerging Infectious Diseases, 7, 333. 
Van Belkum, A., Durand, G., Peyret, M., Chatellier, S., Zambardi, G., Schrenzel, J., 
Shortridge, D., Engelhardt, A. & Dunne, W. M. 2013. Rapid clinical 
bacteriology and its future impact. Annals of Laboratory Medicine, 33, 14-27. 
Van Boeckel, T. P., Brower, C., Gilbert, M., Grenfell, B. T., Levin, S. A., Robinson, 
T. P., Teillant, A. & Laxminarayan, R. 2015. Global trends in antimicrobial 
use in food animals. Proceedings of the National Academy of Sciences, 112, 
5649-5654. 
Van Boeckel, T. P., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B. T., Levin, S. A. 
& Laxminarayan, R. 2014. Global antibiotic consumption 2000 to 2010: an 
analysis of national pharmaceutical sales data. The Lancet Infectious Diseases, 
14, 742-750. 
Van Den Bogaard, A. E. & Stobberingh, E. E. 2000. Epidemiology of resistance to 
antibiotics: links between animals and humans. International Journal of 
Antimicrobial Agents, 14, 327-335. 
Vernet, G., Mary, C., Altmann, D. M., Doumbo, O., Morpeth, S., Bhutta, Z. A. & 
Klugman, K. P. 2014. Surveillance for antimicrobial drug resistance in under-




Vinué, L., Corcoran, M. A., Hooper, D. C. & Jacoby, G. A. 2015. Mutations that 
enhance the ciprofloxacin resistance of Escherichia coli with qnrA1. 
Antimicrobial Agents and Chemotherapy, AAC. 02167-15. 
Viola, C. & Devincent, S. J. 2006. Overview of issues pertaining to the manufacture, 
distribution, and use of antimicrobials in animals and other information 
relevant to animal antimicrobial use data collection in the United States. 
Preventive Veterinary Medicine, 73, 111-131. 
Wellington, E. M., Boxall, A. B., Cross, P., Feil, E. J., Gaze, W. H., Hawkey, P. M., 
Johnson-Rollings, A. S., Jones, D. L., Lee, N. M. & Otten, W. 2013. The role 
of the natural environment in the emergence of antibiotic resistance in Gram-
negative bacteria. The Lancet Infectious Diseases, 13, 155-165. 
Wells, J., Shipman, L., Greene, K., Sowers, E., Green, J., Cameron, D., Downes, F., 
Martin, M., Griffin, P. & Ostroff, S. 1991. Isolation of Escherichia coli 
serotype O157: H7 and other Shiga-like-toxin-producing E. coli from dairy 
cattle. Journal of Clinical Microbiology, 29, 985-989. 
Winokur, P., Brueggemann, A., Desalvo, D., Hoffmann, L., Apley, M., Uhlenhopp, 
E., Pfaller, M. & Doern, G. 2000. Animal and human multidrug-resistant, 
cephalosporin-resistant Salmonella isolates expressing a plasmid-mediated 
CMY-2 AmpC β-lactamase. Antimicrobial Agents and Chemotherapy, 44, 
2777-2783. 
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P. & Edmond, 
M. B. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 
24,179 cases from a prospective nationwide surveillance study. Clinical 
Infectious Diseases, 39, 309-317. 
Woolhouse, M., Ward, M., Van Bunnik, B. & Farrar, J. 2015. Antimicrobial resistance 
in humans, livestock and the wider environment. Philosophical Transactions 
of the Royal Society of London B: Biological Sciences, 370, 20140083. 
Woolhouse, M. E., Webster, J. P., Domingo, E., Charlesworth, B. & Levin, B. R. 2002. 
Biological and biomedical implications of the co-evolution of pathogens and 
their hosts. Nature Genetics, 32, 569-577. 
World Health Organization 2000. Anti-tuberculosis drug resistance in the world. 
World Health Organization 2001. WHO global strategy for containment of 
antimicrobial resistance. 
World Health Organization 2014. Antimicrobial resistance: Global Report on 




Yabe, J., Nakayama, S. M., Ikenaka, Y., Muzandu, K., Ishizuka, M. & Umemura, T. 
2011. Uptake of lead, cadmium, and other metals in the liver and kidneys of 
cattle near a lead‐zinc mine in Kabwe, Zambia. Environmental Toxicology and 
Chemistry, 30, 1892-1897. 
Yang, F. L., Shen, C., He, B. X., Yang, Y. Y. & Li, X. S. 2015. The prevalence of 
heifer mastitis and its associated risk factors in Huanggang, Central China. 
Tropical Animal Health and Production, 1-6. 
Yi, H., Cho, Y.-J., Hur, H.-G. & Chun, J. 2011. Genome sequence of Escherichia coli 
AA86, isolated from cow feces. Journal of Bacteriology, 193, 3681-3681. 
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K. & Walsh, 
T. R. 2009. Characterization of a new metallo-β-lactamase gene, blaNDM-1, and 
a novel erythromycin esterase gene carried on a unique genetic structure in 
Klebsiella pneumoniae sequence type 14 from India. Antimicrobial Agents and 
Chemotherapy, 53, 5046-5054. 
Youn, J.-H., Park, Y. H., Hang’ombe, B. & Sugimoto, C. 2014. Prevalence and 
characterization of Staphylococcus aureus and Staphylococcus 
pseudintermedius isolated from companion animals and environment in the 
veterinary teaching hospital in Zambia, Africa. Comparative Immunology, 
Microbiology and Infectious Diseases, 37, 123-130. 
Zager, E. M. & Mcnerney, R. 2008. Multidrug-resistant tuberculosis. BMC Infectious 
Diseases, 8, 10. 
Zankari, E., Hasman, H., Cosentino, S., Vestergaard, M., Rasmussen, S., Lund, O., 
Aarestrup, F. M. & Larsen, M. V. 2012a. Identification of acquired 
antimicrobial resistance genes. Journal of Antimicrobial Chemotherapy, 67, 
2640-2644. 
Zankari, E., Hasman, H., Kaas, R. S., Seyfarth, A. M., Agersø, Y., Lund, O., Larsen, 
M. V. & Aarestrup, F. M. 2012b. Genotyping using whole-genome sequencing 
is a realistic alternative to surveillance based on phenotypic antimicrobial 
susceptibility testing. Journal of Antimicrobial Chemotherapy, dks496. 
Zhao, S. Phenotype and Genotype Correlations of Antimicrobial Resistance in 
Campylobacter Using in Vitro Antimicrobial Susceptibility Testing and Whole 
Genome Sequencing.  2015 Annual Meeting (July 25-28, 2015), 2015. Iafp. 
Zulu, D. N. 2008. Genetic characterization of Zambian native cattle breeds. Virginia 




Zweifel, C., Cernela, N. & Stephan, R. 2013. Detection of the Emerging Shiga Toxin-
Producing Escherichia coli O26: H11/H-ST29 in Human Patients and Healthy 
Cattle in Switzerland. Applied and Environmental Microbiology, AEM. 01728-
13. 
 
